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Abstract 
 
Adenosine  5’  triphosphate  (ATP)-gated  P2X7  receptors  (P2X7Rs)  are  known  to  act  as 
conduits  for  photoreceptor  and  retinal  ganglion  cell  (RGC)  damage,  consequences  of 
various neurodegenerative conditions within the visual pathway. Growing evidence supports 
the notion that P2X7Rs and associated inflammatory mediators may coordinate microglia, 
the resident immune cells of the central nervous system (CNS), to play a genuine role in 
modulating neurotransmission. 
This study aimed to characterise the role of P2X7Rs in modulating outer and inner retinal 
function within the rod-mediated pathway, and in the putative microglial-mediated modulation 
of signal transmission in the retina. Excitatory components of outer and inner retinal function 
were assessed by recording light-evoked, extracellular transretinal electroretinogram (ERG), 
and ON and OFF retinal ganglion cell (RGC) field excitatory postsynaptic potential (fEPSP) 
responses from the acutely isolated, dark-adapted, mouse retina. Alterations to microglial 
morphology, under similar conditions, were also explored. 
Initial experiments confirmed the excitatory responses as predominantly mediated via the 
‘classic’ rod photoreceptor – rod-ON bipolar cell – AII amacrine cell pathway. With the use of 
selective  P2X7R  antagonists,  it  was  shown  that  P2X7R  activation  directly  modulated 
photoreceptor, ON bipolar cell and ON RGC function, but not OFF RGC function, through 
partially independent mechanisms. 
A novel finding of this study demonstrated that acute application of the microglia-activating 
bacterial  component,  lipopolysaccharide  (LPS)  modulated  inner  retinal  function,  possibly 
through a P2X7R- and Pannexin-1-associated mechanism of microglial ATP release. These 
results were supported by observations of early morphometric changes to microglia caused 
by P2X7R activation and LPS, as revealed by immunofluorescence labelling and confocal 
laser scanning microscopy. 
Since  changes  in  neurotransmission  and  microglial  function  are  early  indicators  of 
neuropathology,  these  results  contribute  to  the  understanding  of  early  neural-immune 
interactions in retinal disease, and in the central nervous system as a whole.  
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Chapter 1 
Introduction 
 
The perception of a visual scene begins when light within the visible range enters the cornea 
of the eye, projecting onto the surface of the retina, a highly specialised, sensory appendage 
of the central nervous system (CNS). Regardless of the amount of absolute light reflected by 
objects in a given field of view, it is the contrast difference between objects that serves as 
the stimulus processed by the visual system (Kandel et al., 2000; Carpenter, 1984). 
 
The mammalian visual system, by adjusting  its sensitivity accordingly, has a remarkable 
ability  to  function  over  a  substantial  range  of  luminances.  This  allows  it  to  reliably 
discriminate contrast changes against varying levels of background illumination (Dowling, 
2012). Visual sensitivity is inversely related to visual threshold, which is the minimum light 
intensity required to evoke a visual response. In turn, visual threshold is directly proportional 
to  background  illumination.  Thus,  low  background  illumination  produces  a  lower  visual 
threshold, which results in a higher visual sensitivity. The ability of the retinal circuitry to 
adapt to light and dark background luminances ensures that visual sensitivity is maintained, 
regardless of extreme ambient light intensities (Kandel et al., 2000; Dowling, 2012). 
 
Some  differences  in  the  visual  pathway  between vertebrate  species  exist.  However,  the 
fundamental aspects of retinal processing remain relatively conserved between the different 
species due to the same basic organisation of  the retinal circuitry (Dowling, 2012). Rod-
dominated mammals such as the mouse are physiologically more adapted for scotopic and 
low mesopic vision (Huberman and Niell, 2011). The present discussion will describe the 
1 
basic  circuitry  and  cellular  organisation  of  the  mammalian  retina,  with  a  focus  on  the 
processing of visual information mediated through the vertical rod pathways (fig. 1.1).  
 
1.1 ON and OFF centre-surround receptive field organisation 
Contrast-dependent aspects of the visual scene are processed by ON and OFF parallel 
channels that are formed at the level of the bipolar cells, and remain segregated throughout 
the visual pathway until integration in the brain. ON subclasses respond to light increments 
and OFF cells respond to light decrements (Schiller, 1992). Bipolar and retinal ganglion cells 
have concentric antagonistic centre-surround receptive fields (Kuffler, 1953; Dacheux and 
Miller,  1981).  An  ON-centre  cell  discharges  when  light  is  directed  to  the  centre  of  its 
receptive field, but is inhibited when the surround is illuminated by a ring of light. Conversely, 
an OFF-centre cell is inhibited by a light stimulus directed to its centre, but fires when the 
centred illumination is removed, or when its surround is illuminated (Schiller, 1992). Thus, 
the opposite polarities of ON- and OFF-centre cells and their surround render them optimally 
responsive to differential stimulation of their receptive fields. For both ON- and OFF-centre 
types, collective stimulation of centre and surround regions of their receptive fields result in 
attenuated  centre-dominant  responses  (Schiller,  1992).  Retinal  ganglion  cells  may  also 
respond to both onset and termination of stimuli, and are termed ON-OFF cells. In the dark-
adapted state, the surrounds of the receptive fields are significantly attenuated (Schiller, 
1992, 2010). 
 
1.2 Cellular Organisation of Retinal Circuitry 
The mammalian retina is a transparent tissue with a thickness of 200 – 300 µm (Buttery et 
al., 1991). Its laminar structure comprises three nuclear and two plexiform (synaptic) layers, 
containing  five  major  classes  of  neurons:  photoreceptors,  bipolar  cells,  horizontal  cells, 
2 
amacrine cells and retinal ganglion cells. The retina also consists of three dominant classes 
of glial cells: Müller cells, astrocytes and microglia (Dowling, 2012).  
 
1.2.1 Photoreceptors 
The rod and cone photoreceptors are the light-sensitive neurons, and can be distinguished 
on the basis of their morphology and biochemical (visual pigment) composition. Both cell 
types  are  comprised  of  an  outer  segment  which  protrudes  towards  the  retinal  pigment 
epithelium, a nucleus-containing inner segment that resides in the outer nuclear layer (ONL), 
and  a  mitochondria-rich  synaptic  terminal  in  the  outer  plexiform  layer  (OPL)  (Sjӧstrand, 
1953;  Carter-Dawson  and  LaVail,  1979).  The  outer  segment  is  comprised  of  numerous 
stacks of membranous discs, which contain the photosensitive opsin proteins  (Sjӧstrand, 
1953). Rods contain the visual pigment rhodopsin, which optimally absorbs light quanta of 
wavelength  ~500  nm,  and  are  maximally  sensitive  under  low  light  (scotopic)  conditions 
(Wald, 1968). Cones use alternative visual pigments that optimally absorb light of different 
wavelengths (short, medium or long), and which form the basis of chromatic discrimination, 
under higher luminance (photopic) levels (Wald, 1968). The adult mouse retina is dominated 
by rod cells, with cones forming less than 3% of the photoreceptor mosaic (Carter-Dawson 
and LaVail, 1979; Jeon et al., 1998). Light traverses the full thickness of the retina, before it 
is  mostly  absorbed  by  the  photoreceptors,  which  transduce  the  subsequent  chemical 
changes in their visual pigment into electrical signals that are then propagated to  bipolar 
cells in a vertical processing pathway in the outer plexiform layer. 
 
1.2.2 Bipolar Cells 
In  the  mammalian  retina,  there  are  at  least  ten  subtypes  of  bipolar  cells,  one  of  which 
synapses exclusively with rod photoreceptors, whereas the others are cone-related (Kolb, 
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1970; Boycott and Kolb, 1973; Kolb et al., 1981). Further subdivisions of these interneurons 
are  established  on  the  basis  of  the  size  of  their  dendritic  trees,  the  types  of  synaptic 
connections made with their respective photoreceptors, and in which sublamina of the inner 
plexiform layer their axons terminate. The dendrites of rod-bipolar cells form invaginating 
synapses  with  rod  terminals,  termed  rod  spherules,  and  their  axon  terminals  end  in  the 
proximal part (sublamina b) of the inner plexiform layer, indicating that these cells are of the 
ON-type. Similarly, the dendrites of cone-BCs that form invaginating synapses with cone 
terminals (cone pedicles) also have terminating axons in the proximal sublamina b of the 
inner plexiform layer. The dendritic arbour size of rod-BCs is considerably larger than that of 
cone-BCs. Another cone-BC, which forms superficial synaptic contacts along the flattened 
base of the cone terminal, with its axon terminating in the distal part (sublamina a) of the 
inner plexiform layer, is known as the flat- or OFF-bipolar cell. In general, the cell bodies of 
invaginating BCs, whether rod- or cone-related, reside in the distal part of the inner nuclear 
layer,  whereas  those  of  the  flat-BCs  lie  more  centrally  within  the  inner  nuclear  layer 
(Dowling, 1970; Kolb, 1970; Boycott and Kolb, 1973; Kolb et al., 1981; Ghosh et al., 2004). 
 
1.2.3 Horizontal and Amacrine Cells 
Lateral inhibitory inputs to photoreceptor and bipolar cell terminals are formed by horizontal 
cells in the outer plexiform layer, which contribute to the bipolar cell antagonistic centre-
surround receptive fields under photopic conditions. As a generalisation of the mammalian 
retina, the axon terminals of HCs end exclusively in the rod terminal, where a single bipolar 
cell process is flanked by two lateral HC processes within the rod spherule. Conversely, the 
dendritic terminals of HCs connect exclusively to cone pedicles, thus forming a unidirectional 
signal transduction pathway. The cell bodies of horizontal cells reside in the distal part of the 
inner nuclear layer (Kolb, 1970, 1974; Boycott, 1988; Trümpler et al., 2008). The contribution 
of horizontal cells to rod ON-bipolar receptive fields remains controversial as these bipolar 
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cells  have  considerably  weak  or  no  antagonistic  surround  (Bloomfield  and  Xin,  2000; 
Bloomfield and Dacheux, 2001). 
 
The lateral inhibitory pathways in the inner plexiform layer are formed by amacrine cells, the 
cell  bodies  of  which  are  located  in  the  proximal  part  of  the  inner  nuclear  layer.  These 
interneurons are the most heterogeneous cell-type in the retina, with 20 to 30 morphological 
variations described in the mammal (Kolb, 1997). The most important type in the functioning 
of the rod pathway is the AII amacrine cell, and is amongst the most common AC type in the 
mammalian retina. The AII cell has a narrow dendritic field, with lobular appendages that 
receive input from rod-BCs, while its output occurs through gap junctions to ON cone-BCs in 
sublamina b of the IPL. OFF cone-BC terminals in sublamina b, and ON-centre ganglion cell 
dendrites in sublamina a of the IPL also receive direct synaptic input from AII cells (Kolb et 
al., 1981; Strettoi et al., 1992).  
 
1.2.4 Ganglion Cells 
Ganglion cells are the final output neurons of the retina, carrying the visual signal along the 
optic nerve to the brain. Classically, mammalian retinal ganglion cells fall into three distinct 
groups  (alpha,  beta  and  gamma),  corresponding  to  their  morphological  and  functional 
properties. All groups contain cells that exhibit concentric centre surround organisation. Their 
cell bodies reside in the ganglion cell layer and dendritic processes branch in IPL sublamina 
a (OFF), b (ON), or both (ON-OFF). The sizes of the dendritic trees and receptive fields are 
comparable (Wässle, 2004; Balasubramanian and Sterling, 2009). Alpha cells have large 
dendritic tree (approx. 200 µm in mouse) and axon diameters, whereas those of beta cells 
are relatively smaller. The circular dendritic trees of alpha and beta cells are arranged in 
regular arrays to cover the whole retinal surface, with minimal overlap of their peripheral 
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processes. The dendritic tree size and density of alpha and beta cells exhibit an inverse 
relation whereby the dendritic trees are large and cell density is low in the peripheral retina, 
whereas the opposite is apparent in the central retina (Wässle, 2004). Additionally, ON- and 
OFF-centre  sub-types  are  always  arranged  as  pairs,  which  cover  the  same  visual  field 
(Peichl and Wässle, 1979). Alpha cells exhibit brisk-transient responses that are a function 
of non-linear inputs originating in presynaptic bipolar and amacrine cells. The latency and 
conduction times of alpha cells are fast, compared to those of the beta cell, allowing alpha 
cell visual responses to reach the brain earlier. Beta cell responses are brisk-sustained and 
exhibit characteristics of linear spatial summation, which may reflect a direct and dominant 
input component from bipolar cells  (Wässle, 2004). 
 
The mammalian retina consists of at least 18 to 23 morphologically distinct ganglion cells. In 
the  rod-dominant  cat  retina,  approximately  3%  of  ganglion  cells  are  of  the  alpha  type, 
whereas  beta  cells  comprise  50%  of  total  ganglion  cells  (Kolb  et  al.,  1981).  The  rod-
dominant mouse retina, in which 22 morphological types have been characterised (Völgyi et 
al., 2009), most likely corresponds to the ganglion cell ratios of the cat. It is thought that 
more complex features of the visual image are encoded by other retinal ganglion cells that 
fall into the gamma cell group. These include direction-selective cells, which are bi-stratified 
ON-OFF cells and respond transiently to a stimulus moving in a preferred direction (Wässle, 
2004). Additionally, visual pigment-containing intrinsically photosensitive ganglion cells have 
been  identified  in  the  mouse  retina.  Others  include  ganglion  cells  that  are  specifically 
responsive to approaching stimuli, particular orientations or edges. The dendritic trees of 
each  cell  type  provide  complete  coverage  of  the  retinal  surface.  Thus,  a  full-field  light 
stimulus is capable of activating many ganglion cells of any given type (Wässle, 2004). 
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The retina exhibits a substantial convergence of neurons from the outer to the inner layers, 
along the vertical pathways. In the rod system alone, a single beta ganglion cell receives 
input from 1500 rods, 100 rod ON-BCs and 5 AII cells (Sterling et al., 1988), indicating the 
integration of an array of afferent inputs to encode a diverse range of complex functional 
features in the visual scene. Further, alpha and beta cells in rod-dominant mammals do not 
appear to specifically encode scotopic or photopic pathways, as the responses of these cells 
are generally comprised of mixed rod and cone signals (Enroth-Cugell, 1977). Importantly, 
regardless of the visual feature they encode, all ganglion cell types exhibit concentric ON-, 
OFF- or ON-OFF-centre surround organisation.  
 
1.2.5 Glial Cells 
The mammalian retina generally contains three main types of glial cells.  Müller cells and 
astrocytes  constitute  the  major  retinal  macroglial  populations,  which  have  numerous 
functions including providing metabolic support to neurons.  Retinal astrocytes are largely 
restricted  to  the  RGC  axon-containing  nerve  fibre  layer  and  are  not  thought  to  play  a 
significant role in modulating neuronal function within the retina (Newman, 2004). Microglia 
are  the  resident  immune  cells  of  the  retina,  and  are  imperative  for  orchestrating  the 
neuroinflammatory  response  to  metabolic  stressors  and  other  foreign  bodies  in  the 
microenvironment (Streit et al., 1999; Chen et al., 2002; Langmann, 2007).  
 
1.2.5.1 Müller glia  
Müller cells are radial glia. They typically span the entire thickness of the retina, with their 
nucleus residing centrally, in the INL. Each of the distal and proximal portions of the retina 
contains a broad Müller cell process protruding from the soma, to form membranous regions 
at either end of the tissue. Müller cells form junctions homogenously, and with photoreceptor 
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inner segments to form the outer limiting membrane. In the GCL, the processes expand into 
end feet, which form the inner limiting membrane, between the retinal tissue and the vitreous 
humour. All other retinal cell bodies and processes are typically in close proximity of the finer 
Müller glial processes which extend laterally from the main body. Müller cells are important 
in  regulating  potassium  ion  (K
+)  flux  in  the  extracellular  space,  as  well  as  regulating 
neurotransmitter uptake, and thus may play a role in shaping visual responses in the retina 
(Dowling, 1970; Miller and Dowling, 1970; Dreher et al., 1992; Bringmann et al., 2006).   
 
1.2.5.2 Microglia 
Microglia  in  the  healthy  mammalian  retina  reside  predominantly  in  the  outer  and  inner 
plexiform layers (Hume et al., 1983; Perry et al., 1985; Ashwell et al., 1989; Santos et al., 
2008) (fig. 1.3). Microglia are highly ramified in structure, with numerous processes when in 
their ‘resting’ state, but are thought to be far from quiescent. These immune cells constantly 
monitor neuronal synapses in their locality, as shown in other areas of the CNS (Béchade et 
al., 2013), although very little is known of these microglial functions in the retina. Activated 
microglia typically take on an amoeboid appearance, with few, short or no processes, and 
have  the  capacity  to  secrete  a  vast  array  of  molecular  signals,  including  cytokines, 
chemokines,  ATP  and  reactive  oxygen  species,  all  of  which  trigger  further  inflammatory 
cascades. These activated microglia proliferate and migrate to the site of cellular stress, and 
provide  imperative  trophic  support  to  the  injured  neuron,  in  addition  to  phagocytosing 
surrounding cellular debris (Streit et al., 1999; Chen et al., 2002; Langmann, 2007) (fig. 1.4).  
 
1.3 Synaptic Mechanisms and Neurochemistry  
All  neuronal  cells  in  the  retina  respond  to  illumination  with  slow,  graded  membrane 
potentials,  with  the  exception  of  retinal  ganglion  cells,  which  respond  by  firing  action 
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potentials.  The ON and OFF vertical signalling pathways and their modulation by  lateral 
interactions, are a result of the array of neurotransmitters and their receptors that mediate 
synaptic  transmission  between  the  cells  of  the  retina  (Schiller,  1992,  2010).  The  major 
excitatory neurotransmitter in the retina is glutamate, with γ-aminobutyric acid (GABA) and 
glycine as the major inhibitory neurotransmitters.  
 
1.3.1 Outer Retinal Processing 
The phototransduction cascade, which converts the absorption of photons into an electrical 
signal,  is  shown  in  fig.  1.2.  The  propagation  of  a  light-evoked  response  from  the  rod 
photoreceptor to the rod-bipolar cell occurs within a specialised, invaginating structure, the 
rod spherule  (Kolb, 1970; Carter-Dawson and LaVail, 1979; Singer, 2007). The dendritic 
process of the rod-bipolar cell is directly apposed to the rod photoreceptor glutamate release 
site, the ribbon synapse (Nomura et al., 1994). These synapses are elongated structures 
that  allow  the  rapid  and  continuous  release  of  glutamate-containing  vesicles  into  the 
extracellular  space,  and  are  thus  specialised  for  the  transmission  of  analogue  signals 
(Lagnado, 2000; Holt et al., 2004). Glutamate is tonically released from photoreceptors in the 
dark,  through  a  tightly  regulated  calcium-dependent  mechanism  (Okawa  and  Sampath, 
2007). Rod-bipolar cells are continuously hyperpolarised through the activation of the group 
III metabotropic glutamate receptor, mGluR6, which is located on the rod-bipolar dendrite 
(Slaughter and Miller, 1981; Massey et al., 1983; Nawy and Jahr, 1990; Masu et al., 1995). 
The  activation  of  mGluR6  stimulates  the  hydrolysis  of  cGMP,  a  G-protein-activated 
mechanism that results in the closure of cation channels, believed to be of the transient 
receptor potential (TRP) family (Morgans et al., 2009). Thus, rod-bipolar cells are maintained 
in a hyperpolarised state in the dark. A light stimulus results in the cessation of glutamate 
release from photoreceptors and the subsequent depolarisation of  rod-bipolar cells, likely 
due  to  the opening  of  TRPM1  channels  (Nawy  and  Jahr,  1990;  Shiells  and  Falk,  1990; 
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Nakajima et al., 1993; Morgans et al., 2009). The fast excitatory responses of OFF bipolar 
cells were determined to be mediated by the activation of ionotropic AMPA receptors (Sasaki 
and  Kaneko,  1996).  Therefore,  the  continuous  glutamate  release  in  the  dark  tonically 
depolarises  OFF-bipolar  cells,  which  become  hyperpolarised  during  the  light-evoked 
cessation of glutamate release. 
 
Inhibitory horizontal cell axon processes are also located within the rod spherule, with their 
dendrites positioned postsynaptically to cones (Kolb, 1970, 1974). Similar to OFF-bipolar 
cells, horizontal cells are depolarised in the dark, and hyperpolarise in response to light, due 
to the expression of AMPA/KA receptors on the cell surface (Cohen and Miller, 1999). The 
role of horizontal cells in modulating bipolar cell centre-surround receptive fields remains 
unclear (Bloomfield and Dacheux, 2001). However, electrical coupling through gap junctions 
and inhibitory GABAergic feedback to cones are mechanisms that are thought to play a role. 
Interestingly, rod-bipolar cells do not display antagonistic surround properties under scotopic 
conditions (Bloomfield and Xin, 2000). Indeed, it is widely believed that rod-mediated signals 
are not largely influenced by horizontal cell feedback (Bloomfield and Dacheux, 2001).  
 
1.3.2 Inner Retinal Processing 
The presynaptic rod bipolar cell terminals convey the light-evoked signal to ON- and OFF-
centre ganglion cells  in the  inner plexiform layer, through internuncial AII amacrine cells 
(Bloomfield  and  Dacheux,  2001).  Bipolar  cells  make  glutamatergic  ribbon  synapses  with 
their postsynaptic structures, although they are not of the invaginating type as in the outer 
plexiform  layer.  Typically,  two  postsynaptic  processes  from  separate  amacrine  cells  are 
located directly apposed to the bipolar cell axon terminal ribbon, making an arrangement 
known as a dyad (Grunert and Martine, 1991; Strettoi et al., 1992; Kolb, 1997). Reciprocal 
inhibitory  feedback  onto  rod  bipolar  cell  terminals  may  be  driven  by  a  GABAergic  AC 
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process, within the dyad. In the mammalian retina, ionotropic GABAA receptors have been 
localised  to  amacrine,  bipolar  and  ganglion  cells,  suggesting  a  role  in  both  pre-  and 
postsynaptic modulation, whereas GABAc receptors have only been found presynaptically on 
bipolar cells, indicating a specific role in feedback inhibition of bipolar cell output (Wässle et 
al., 1998). The other half of the rod bipolar cell output is directed towards the AII amacrine 
cell  process,  which  transfers  the  scotopic  signal  to  the  ganglion  cell.  The  rod-mediated 
pathway  does  not  consist  of  separate  ganglion  cells  specifically  for  scotopic  signal 
processing. Thus, ganglion cells typically receive mixed signals from both rod- and cone-
mediated pathways.  
 
In the proximal part of the  inner plexiform layer, AII processes are coupled to ON-cone 
bipolar  cell  terminals  via  excitatory  gap  junctions  (Kolb,  1997),  mediating  the  transfer  of 
scotopic  signals  through  a  feed-forward  mechanism.  In  turn,  the  ON-cone  bipolar  cells 
convey  the  scotopic  signal  to  ON-centre  ganglion  cells  via  conventional  glutamatergic 
synapses. Conversely, the AII amacrine cell transfers the rod-mediated OFF signal to OFF-
cone bipolar cells via an inhibitory glycinergic synapse. As with the ON pathway, the OFF 
signal is then propagated from the OFF-cone bipolar cell to the OFF-centre ganglion cell 
through an excitatory synapse (Bloomfield and Dacheux, 2001). 
 
ON- and OFF-centre retinal ganglion cell responses are mediated by the activation of post-
synaptic AMPA/KA and NMDA receptors (Brandstätter et al., 1998). Retinal ganglion cells 
produce depolarised responses in the presence of the agonists, AMPA, KA and NMDA, and 
are inhibited by their respective antagonists  (Slaughter and Miller, 1983; Lukasiewicz and 
Mcreynolds, 1985; Coleman and Miller, 1988; Boos et al., 1990; Massey and Miller, 1990; 
Mittman  et  al.,  1990;  Ikeda  et  al.,  1992;  Yazejian  and  Fain,  1992;  Zhou  et  al.,  1994; 
Lukasiewicz et al., 1995, 1997). Thus, it is established that cone bipolar cells also release 
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glutamate,  directly  onto  ganglion  cell  dendrites.  The  relative  synaptic  arrangement  and 
properties of AMPA and NMDA receptors has been suggested to contribute to the range of 
processing  in  the  inner  plexiform  layer.  Furthermore,  glutamate  transporters  and  their 
function in glutamate clearance from the synapse is also thought to play an important role in 
shaping retinal ganglion cell responses (Higgs and Lukasiewicz, 1999; Lukasiewicz, 2005). 
In the dark-adapted state, the receptive field properties of ganglion cells are known to alter in 
parallel to a shift from cone- to rod-mediated pathways. The ganglion cell receptive field 
centre  increases  in  size,  with  surround  inhibition  diminishing  accordingly.  This  results  in 
ganglion  cell  responses  becoming  more  sustained  and  characteristic  of  their  centre 
response (Sharpe and Stockman, 1999; Bloomfield and Dacheux, 2001). 
 
Alternative  pathways  for  rod-mediated  scotopic  signal  transmission  have  also  been 
characterised.  Rod-cone  gap  junction  coupling  is  thought  to  play  a  role  under  higher 
luminance levels, possibly in the mesopic range. Through this pathway, rods directly transfer 
their signal to ON and OFF cone bipolar cells and then to their corresponding ganglion cells, 
bypassing the requirement for the internuncial AII cells. Additionally, a direct transfer of the 
rod  signals  to  the  OFF  cone  bipolar  cell  has  also  been  found,  via  a  flat,  conventional 
synapse  (Sharpe  and  Stockman,  1999;  Bloomfield  and  Dacheux,  2001;  Bloomfield  and 
Völgyi, 2009). Rod and cone circuitry for signal transmission under dark-adapted conditions 
is summarised in fig. 1.1. 
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Rod  and  cone  circuitry  for  signal  transmission  under  dark 
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Figure 1.2 
 
Phototransduction cascade. 
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Figure 1.3 
 
Distribution of microglia in the mouse retina. 
 
16 
Figure 1.4  Functional states of microglia. 
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13Figure 1.1 Rod and cone circuitry for signal transmission under dark adapted conditions. 
The pathways illustrated are highly schematic and focus on rod-mediated transmission of 
light-evoked  signals,  which  is  the  dominant  pathway  under  scotopic  and  low  mesopic 
conditions.  Rod  and  cone  pathways  are  concurrent,  but  the  rod-mediated  signal  is 
transduced to the inner retina via cone circuitry. Light increments and decrements are 
processed  by  ON  and  OFF  sub-classes  of  cells,  respectively.  Rod  and  cone 
photoreceptors release glutamate, which induces a sustained hyperpolarisation of ON rod 
and cone bipolar cells (rBC and cBC, respectively) through the constitutive activation of 
group III metabotropic glutamate receptors (mGluR6), within ribbon synapses. Under low 
light  conditions,  OFF  cBCs  are  concomitantly  depolarised  through  the  activation  of 
ionotropic glutamate receptors (AMPA/KA - Rs). Light increments suppress rod and cone 
glutamate release, activating ON rBCs and cBCs. Rod BCs transfer their signal to ON and 
OFF  cBCs  through  AII  amacrine  cells  via  electrical  (Cx36)  and  glycinergic  synapses, 
respectively. Retinal ganglion cells (RGCs) receive signals from cBCs, relaying them to 
the brain via the optic nerve. Postsynaptic ionotropic glutamate receptors (AMPA/KA- and 
NMDA - Rs) on both ON and OFF RGCs mediate fast excitatory neurotransmission to 
transduce the visual signal to the brain. Inner retinal activity and surround responses of 
cells are highly regulated by amacrine cell-mediated GABAergic signalling (not shown). 
Direct electrical coupling between rods and cones has also been found in mice, where 
rod-mediated  signals  are  transduced  directly  through  the  cone  circuitry,  rather  than 
through AII cells (not shown), under higher luminances. ONL, outer nuclear layer; OPL, 
outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion 
cell layer. 
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Figure 1.2 Phototransduction cascade. The outer segment (OS) of rod photoreceptors 
(left) contains numerous membranous discs, which provide the site for phototransduction. 
The cascade shown here (right) is highly schematic, and focuses on the main enzymatic 
steps  required  to  transduce  a  light-evoked  signal  into  an  alteration  in  photoreceptor 
membrane potential. 1a, In the dark-adapted state, rods contain a high concentration of 
the second messenger molecule, cyclic guanosine 3’, 5’-monophosphate (cGMP), which 
activates cGMP-gated cation channels in the outer segment. Thus, under such conditions, 
a dark current is carried by the inward flux of sodium ions (Na+) at the outer segments, 
which maintains the rods in a depolarised state, constitutively releasing glutamate (1b). 2, 
The  absorption  of  a photon by  rhodopsin  triggers  a  cascade  of  events  that  ultimately 
results in altered ion flux across the photoreceptor membrane, and thus leads to a change 
in membrane potential. Rhodopsin is a G-protein-associated molecule, comprised of 11-
cis-retinal,  a  chromophore,  and  an  opsin  protein.  Light-induced  bleaching  of  the 
photopigment triggers a series of biochemical steps that break down rhodopsin into 11-
trans-retinal and opsin. 3, An intermediate form of the breakdown process, metarhodopsin 
II, subsequently mediates the activation of phosphodiesterase (PDE), via the interaction of 
transducin (T). 4, PDE hydrolyses the second messenger molecule cGMP, leading to the 
closure of cGMP-gated channels and the subsequent hyperpolarisation of the rod plasma 
membrane.  The  deactivation  of  metarhodopsin  II,  transducin  and  PDE  results  in  the 
cessation  of  the  phototransduction  cascade.  During  light  exposure,  rod  sensitivity  is 
maintained  due  to  its  capacity  to  regenerate  the  rhodopsin  pigment,  and  its  ability  to 
partially  recover  from  the  initial  light-evoked  hyperpolarisation.  The  11-trans-retinal 
product formed upon bleaching of rhodopsin is transported to the RPE, where it is then 
converted back to 11-cis-retinal through a series of biochemical stages. Ultimately, 11-cis-
retinal is transported back into the rod outer segments to bind with opsin and regenerate 
rhodopsin. Visual threshold varies with the proportion of regenerated rhodopsin. 5, In the 
dark-adapted state, intracellular calcium concentration is relatively high, attenuating the 
action of guanylate cyclase (GC), a cGMP-generating enzyme. The light-induced closure 
of  cGMP-gated  cation  channels  results  in  a  fall  in  intracellular  calcium,  which 
subsequently  enhances  guanylate  cyclase-mediated  cGMP  generation.  Thus,  the 
increase in cGMP results in the opening of cation channels in the outer segment and the 
partial recovery of the rod photoreceptor towards its depolarised state. Figure partially 
reproduced from Dowling (2012). 
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Figure 1.3 Distribution of microglia in the mouse retina. A, Transverse sections show the 
dispersion of resident monocytes of the retina, immunolabelled for the microglia-specific 
molecular  marker  IBA1  (red).  In  the healthy  adult  mouse  retina, microglia  are  located 
almost exclusively in the outer and inner plexiform layers, and ganglion cell layer, but not 
in the nuclear layers (Hoechst-staining; blue). B, A ramified microglial cell, with its soma 
and processes residing in the outer plexiform layer. A single process extending from the 
microglial cell body traverses into the  inner nuclear  layer. Adapted from Santos et al. 
(2008). 
16Figure  1.4  Functional  states  of  microglia.  Activation  of  microglia  is  a  highly  graded 
phenomenon,  and  largely  dependent  on  specific  molecular  triggers  present  in  the 
microenvironment. The figure illustrates the fundamental concept of three main microglial 
activation  states,  and  highlights  the  potential  occurrence  of  ‘alerted’  cells.  Under 
physiological conditions, microglia reside in their ‘resting’ state. Cells of this functional 
phenotype  exhibit  typically  long  and  thin  processes  that  branch  out  and  ramify.  The 
processes  are  highly  dynamic  and  constantly  survey  their  microenvironment  for  any 
potential molecular ‘danger’ signals (e.g. ATP). Loss of constitutive calming signals, or the 
presence  of  mild  activating  triggers  due  to  trauma  or  other  stressors,  may  lead  to  a 
transition  to  an  ‘alerted’  state  of  early  activation,  where  microglia  may  appear  hyper-
ramified. Microglia become ‘reactive’ in the presence of damaged neurons and systemic 
influences. Such cells have characteristically shorter and thicker processes. If neuronal 
recovery is apparent, reactive microglia may revert back to a relatively resting state, and 
may  also  exhibit  a  post-activated  phenotype.  However,  if  neuronal  damage  persists, 
reactive  microglia  shift  to  a  fully  activated  and  phagocytic  phenotype  which  appear 
amoeboid in shape, with very few or no processes. At this point, microglia may undergo 
cell  death.  Specific  arrays  of  molecular  markers  are  released  by  microglia,  at  each 
functional stage. Therefore, alterations in microglial morphology are important indicators of 
changes  in  microglial  function.  (Figure,  Streit  et  al.,  1999;  Hanisch  and  Kettenmann, 
2007). 
Resting (ramified) 
microglia 
Reactive (activated) 
microglia 
Phagocytic microglia 
Hyper-ramified microglia 
(intermediate stage) 
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Chapter 2 
Extracellular ATP in the Retina  
 
The purinergic nucleotide, ATP (adenosine 5’ triphosphate), is abundant in all metabolically 
active cells. As an ubiquitous intracellular molecule, ATP acts as a biochemical currency of 
energy linked with various metabolic pathways. ATP is readily releasable and also acts as 
an  extracellular  signalling  molecule  associated  with  the  activation  of  neuroinflammatory 
pathways and the modulation of neuronal synaptic transmission. The purinergic signalling 
system is widespread throughout the central and peripheral nervous systems (Burnstock, 
2007), and appears to act as a bi-directional signal  in neural-immune interactions. As a 
neuroactive  molecule  in  the  PNS,  ATP  mediates  fast  excitatory  and  inhibitory  synaptic 
signalling to smooth muscle (Burnstock et al., 1970, 1972). In the CNS, ATP contributes to 
glutamatergic input to postsynaptic neurons (Pankratov et al., 1998), and in some areas, 
may  itself  evoke  excitatory  postsynaptic  currents  (Edwards  et  al.,  1992).  ATP  is  also 
released by non-excitable cells, including macroglial and microglial populations in the CNS 
(Ferrari et al., 1997; Newman, 2001), and may act as a gliotransmitter to modulate neuronal 
excitability. As a component of the innate immune system, ATP is considered as a danger-
associated molecule, crucial for the activation of astrocytes and microglia, and the induction 
of  early  inflammatory  pathways  under  pathological  conditions  (Ferrari  et  al.,  2006). 
Furthermore, extracellular ATP is typically released from reactive astrocytes and acts as a 
chemoattractant for microglia, which in turn may release more ATP in a positive feedback 
mechanism.  Thus,  ATP  is  associated  with  neuropathic  pain,  trauma,  ischemia  and  the 
exacerbation of various neurodegenerative diseases (Burnstock et al., 2011). The present 
discussion  considers  mechanisms  of  storage,  release  and  degradation  of  ATP  in  the 
mammalian retina. 
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2.1 ATP storage and release in the retina 
The bulk of intracellular ATP is generated by mitochondrial oxidative phosphorylation, within 
the cell (Sperlagh and Vizi, 1996), rendering all metabolically active cells potential sources of 
ATP secretion into the extracellular microenvironment. Under physiological conditions, the 
typical cytoplasmic concentration of ATP ranges between 1-10 mM (Fukuda et al., 1983; 
Sperlagh and Vizi, 1996). Damage to the integrity of the cell membrane could result in the 
cytolytic  release  of  ATP  into  the  extracellular  environment,  as  a  result  of  cell  necrosis. 
Additionally,  various  mechanisms  of  controlled  ATP  release  have  been  identified.  In  the 
CNS, activity-dependent ATP release from neurons can occur through the exocytosis of 
ATP-containing synaptic vesicles (Abbracchio et al., 2009). Extrasynaptic and non-vesicular 
pathways, for example through volume-regulated anion channels (VRAC) and gap junction-
related pores such as connexins and pannexins, have also been shown in neurons. Similar 
non-vesicular mechanisms of ATP release have been identified in glia, epithelial cells and 
other  non-neuronal  populations  (Fields,  2011).  These  also  include  the  cystic  fibrosis 
transmembrane conductance regulator (CFTR), which is associated with the ATP-binding 
cassette (ABC) family of transporter proteins. In general, non-vesicular mechanisms of ATP 
release tend to occur under conditions that evoke the activation of inflammatory pathways, 
such as damage to the cell membrane, hypoxia, mechanical stress and cell death, although 
there are some notable exceptions, involving vesicular ATP release from non-neuronal cells 
Thus, activation of such mechanisms is dependent upon a diverse array of stimuli. In the 
retina, various ATP secretory pathways from both neuronal and non-neuronal cells have 
been identified. 
 
2.1.2 ATP release from non-neuronal cells in the retina 
ATP efflux from RPE cells into the subretinal space is suggested to occur through a variety 
of  distinct,  stimulus-dependent  mechanisms,  and  appears  important  for  communication 
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between the RPE and photoreceptor outer segments (Mitchell and Reigada, 2008). The RPE 
is  essential  for  photoreceptor  function,  and  plays  a  significant  supporting  role  in  the 
regeneration of the rhodopsin visual pigment, shedding and regeneration of photoreceptor 
outer segments, and the homeostatic regulation of extracellular ionic concentrations within 
the subretinal space (Mitchell and Reigada, 2008). ATP release from human RPE cells can 
be triggered by hyperosmotic stress (Eldred et al., 2003). Glutamate- and NMDA-dependent 
ATP release was shown to occur from cultured human ARPE-19 cells through a calcium-
related  mechanism.  The  calcium-dependence  of  this  effect  was  inhibited  by  apyrase-
hydrolysis of ATP (Reigada et al., 2006). Importantly, low micromolar concentrations of ATP 
triggered secondary ATP release approximately 10 min post-initial ATP application (Reigada 
et al., 2005), supporting the notion that ATP acts as an autostimulatory signal to amplify itself 
within the local microenvironment. Alternative secretory pathways have also been identified 
by  the  same  authors,  involving  CFTR-dependent  ATP  efflux  as  well  as  vesicular  ATP 
secretion from human cultured RPE cells as a result of hypotonic challenge (Reigada and 
Mitchell, 2005). Furthermore, calcium elevation-triggered ATP release from the RPE through 
connexin hemichannels, during retinal development has also been characterised (Pearson et 
al., 2005). 
 
Glial  cells  in  the  retina  are  likely  to  have  a  more  direct  modulatory  role  in  synaptic 
transmission than other non-neuronal cell types. Müller cells have shown to act as sources 
of  extracellular  ATP.  Although  the  precise  release  pathway  is  unclear,  these  glial  cells 
release ATP upon mechanical stimulation, a mechanism mediated by the propagation of 
intercellular calcium waves through gap junctions (Newman, 2001). In addition, a glutamate-
mediated, calcium-independent ATP release mechanism has been identified in Müller cells 
that have undergone hypotonic stress (Uckermann et al., 2006).  
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Conversely, mechanisms of ATP release from retinal microglia remain uncertain. In rat brain 
cultures, these resident immune cells are known to express functional nucleotide-releasing 
machinery associated with ABC proteins such as CFTR,  which when inhibited, prevented 
microglial ATP efflux (Ballerini et al., 2002). Furthermore, macrophages express pannexin-1 
hemichannels,  which  are  directly  involved  in  the  ATP-mediated  release  of  the  pro-
inflammatory cytokine, IL-1β (Pelegrin and Surprenant, 2006, 2009). On neurons, pannexin-
1 has been shown to act as a conduit for ATP release (Xia et al., 2012), thereby suggesting 
that microglial ATP-release could also occur through this pore. 
 
2.1.3 ATP release from neuronal cells in the retina 
A number of release pathways associated with the exocytosis of ATP-containing vesicles at 
central synapses, have been identified. The concentration of ATP within a synaptic vesicle 
ranges  between  1  –  200 mM,  and  has  been  found  to  be  packaged  together with  other 
classical neurotransmitter molecules (Sperlagh and Vizi, 1996; Pankratov et al., 2006). Thus, 
ATP  co-release  has  been  shown  in  cholinergic  (rat  caudate  nucleus),  glutamatergic 
(hippocampus) and GABAergic synapses (hypothalamus and spinal cord) (Richardson and 
Brown, 1987; Jo and Schlichter, 1999; Mori et al., 2001; Jo and Role, 2002). ATP release 
also occurs from separate pools of vesicles or from separate ATPergic neurons altogether 
(Robertson and Edwards, 1998; Pankratov et al., 2007). ATP release was not detected in 
the  absence  of  calcium,  in  rodent  hippocampal  slices  and  rat  caudate  nucleus 
synaptosomes,  suggesting  that  the  release  of  ATP-containing  vesicles  from  presynaptic 
terminals is calcium-dependent (Richardson and Brown, 1987; Wieraszko et al., 1989). In 
the retina, the calcium-dependent endogenous ATP release was shown in cultures enriched 
in amacrine cell-like neurons (Santos et al., 1999). 
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ATP  is  incorporated  into  synaptic  vesicles  through  the  chloride-dependent  vesicular 
nucleotide transporter (VNUT), which is highly expressed in the brain and adrenal glands 
(Sawada et al., 2008). In the retina, VNUT mRNA was detected in laser micro-dissected 
sections of the photoreceptor, inner nuclear and ganglion cell layers (Vessey and Fletcher, 
2012). The presence of retinal VNUT raises the possibility of synaptic ATP release in the 
outer and inner retinal layers, where it may directly modulate visual processing along the 
vertical pathways. However, the exact localisation of the transporter at retinal synapses, as 
determined by immunohistochemistry, is yet to be clarified.  
 
Non-vesicular, mechanical strain-induced ATP release from retinal ganglion cells has also 
been  characterised.  This  effect  was  found  to  be mediated  by  pannexin-1  hemichannels, 
which themselves require an autostimulatory ATP signal (Xia et al., 2012). Ganglion cells in 
the isolated rat retina have shown to release ATP in response to light illumination, an effect 
which  is  blocked  by  suramin  and  TTX  (Newman,  2005).  Additionally,  glutamatergic 
depolarisation of cultured amacrine-like neurons evoked release of ATP, which was found to 
be dependent on calcium influx through voltage-gated channels (Santos et al., 1999). 
 
2.2 Degradation of extracellular ATP in the retina 
Once  ATP  is  released  into  the  extracellular  environment,  it  is  rapidly  hydrolysed  into  its 
derivatives (ADP, AMP and adenosine) by the action of ectonucleotidases enzymes, residing 
on  the  external  side  of  the  plasma  membrane  (Zimmermann,  2000;  Burnstock,  2007). 
Various  families  of  ectonucleotides  have  been  described,  including  ectonucleoside 
triphosphate  diphosphohydrolase  (E-NTPDase)  and  ectonucleotide 
pyrophosphatase/phosphodiesterase  (E-NPP).  Both  types  of  ecto-enzymes  have  been 
localised  in  human  RPE  cells  (Mitchell  and  Reigada,  2008).  Müller  glial  cells  are 
immunoreactive for E-NTPDases, although there is some dispute over whether these are of 
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the E-NTPDase-1 or -2 subtype (Iandiev et al., 2007; Ricatti et al., 2009). Microglia in the 
neural parenchyma abundantly express an array of ectonucleotidases, suggesting that these 
cells are proficient in the control of extracellular ATP concentration (Dalmau et al., 1998). 
Prominent immunoreactivity for E-NTPDase was localised to the inner and outer plexiform 
layers in the mouse retina. E-NTPDase-1 was primarily expressed in the ganglion cell layer, 
and on horizontal cell processes, with some pre-synaptic expression in the inner plexiform 
layer. Conversely, E-NTPDase-2 was principally localised to ON-bipolar cell dendrites in the 
outer plexiform layer (Ricatti et al., 2009). Functional ectonucleotidases activity in both the 
inner and outer plexiform layers of the rat retina have been characterised (Puthussery et al., 
2006;  Puthussery  and  Fletcher,  2007).  The  authors  employed  an  enzyme  histochemical 
assay whereby the negatively charged phosphate generated during ATP-degradation, forms 
an electron-dense product when reacted with positively charged cerium ions. This reaction 
product  was  heavily  localised  to  the  plexiform  layers  but  not  to  the  ganglion  cell  layer 
(Puthussery et al., 2006). This is in contrast to the E-NTPDase-1-specific immunoreactivity 
seen in the mouse GCL, and highlights a limitation of the enzyme histochemical assay, that 
the  specific  ectoncleotidase  subtype  cannot  be  distinguished.  In  summary, 
ectonucleotidases are profusely expressed in the rodent retina, primarily in the outer and 
inner plexiform layers, which strongly suggests that ATP is present as a bioactive ligand in 
the mammalian retina, with a highly abundant system in place to eliminate excess ligand.  
 
2.3 ATP receptors 
ATP-gated  neurotransmission  occurs  through  the  activation  of  G-protein  coupled  P2Y or 
ATP-mediated P2X-gated ion channel receptor subtypes. There are seven subtypes of P2X 
receptors (1-7), each of which can mediate fast neurotransmission through the opening of 
small  cationic  ion  channels  when  activated  by  ATP  (North,  2002).  The  P2X7  receptor 
(P2X7R)  is  the  most  diverse  receptor  subtype  of  the  P2X  family  in  both  structure  and 
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function. It has been associated with glial and neuronal pathology and is well-known for its 
association  with  the  pannexin-1  hemichannel  and  neuroinflammation  (Pelegrin  and 
Surprenant, 2006). Moreover, recent evidence has come to light that P2X7Rs may play a 
number of significant roles in the direct or indirect  regulation of neurotransmission in the 
CNS (Sperlágh et al., 2006). Microglia, astrocytes and retinal Müller glial cells all express 
P2X7Rs (see Chapter 3) and are thought to be influenced by extracellular ATP through this 
receptor subtype. 
 
The role of ATP and P2X7R activation in the neuromodulation of visual responses, through a 
direct effect on neurons or indirectly through glial activation remains largely unexplored in 
the  mammalian  retina.  It  is  therefore  the  focus  of  this  literature  review  and  subsequent 
investigation to explore and highlight the role of P2X7Rs in modulating synaptic signalling, 
and  its  association  with  immunological  control  of  synaptic  function  in  the  healthy  and 
pathological central nervous system, and primarily in the mammalian retina.  
 
 
. 
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Chapter 3 
Properties of P2X7Rs 
 
 
3.1 Molecular structure of P2X7Rs 
The P2X7 receptor (P2X7R) was first isolated and cloned from rat superior cervical ganglia 
and medial habenula (Surprenant et al., 1996). The receptor subunit is 595 amino acids in 
length,  of  which  the  first  395  residues  share  35  to  40%  homology  with  the  other  P2X 
receptor  subunits  (Surprenant  et  al.,  1996).  All  receptor  subunits  show  basic  structural 
homology  of  two  hydrophobic  transmembrane  domains  (TM1  and  TM2)  and  a  large 
extracellular loop, with both amino and carboxyl termini located intracellularly (North, 2002) 
(fig. 3.2). However, the P2X7R carboxyl terminal (295 amino acids) is considerably longer 
than that found in other receptor subtypes (27-129 amino acids) (Surprenant et al., 1996; 
Sperlágh et al., 2006). Importantly, the P2X7R exhibits a biphasic agonist-evoked response, 
dependent upon the agonist exposure time. Similar to other P2X subtypes, a brief agonist 
application  induces  a  reversible,  transient  inward  current  through  a  non-selective  ion 
channel, permeable to small cations. Repeated or prolonged agonist application gives rise to 
a sustained current, which could ultimately lead to cell death, assumed to be associated with 
the opening of a large pore that is permeable to molecules of high molecular weight (< 900 
Da) (Surprenant et al., 1996; Sperlágh et al., 2006). The unique intracellular C-terminus is 
assumed to contribute  significantly, to  the pore  forming properties of the P2X7R (Costa-
Junior et al., 2011). 
 
The P2X7R was first functionally characterised in the J774 mouse macrophage cell line. High 
concentrations  of  ATP  (2-5  mM)  rapidly  induced  a  large  non-selective  conductance  ion 
channel, which was fully reversible (Buisman et al., 1988). This receptor, which was later 
25 
termed the P2Z receptor (DiVirgilio, 1995) is upregulated in monocytes and macrophages 
and is understood to play an important role in cytokine- and ATP-mediated inflammatory 
responses, often resulting in the activation of apoptotic pathways, through the opening of a 
cytolytic pore. The study by Surprenant and colleagues (1996), which showed that the P2Z 
receptor-activation also evoked small ion channel-gated currents, similar to P2X receptors, 
led to the use of the now generally accepted term, P2X7 receptor. 
 
The  characterisation  of  two  distinct  P2X7R  properties  (transient  inward  current  and  pore 
formation)  has  generally  been  carried  out  in  transfected  cell  expression  systems  (e.g. 
HEK293 cells) and macrophage cell lines in which they are known to be natively expressed. 
While electrophysiological recordings or fluorescent calcium uptake assays have often been 
used  to  identify  P2X7R-mediated  inward  currents,  the  function  of  the  large  pore  can  be 
examined through the uptake of large fluorescent dyes such as YO-PRO-1 and ethidium 
bromide, by P2X7R-expressing cells. 
 
3.1.1 ATP binding site 
The ATP binding site is proposed to be localised within the 280-amino acid long extracellular 
loop,  a  sequence  which  is  generally  conserved  among  P2XR  subtypes  (Coddou  et  al., 
2011). It is also predicted that the actual ligand-binding domain lies within an anti-parallel 
six-stranded  beta-pleated  sheet  of  the  ectodomain,  which  also  contains  a  cysteine-rich 
metal-binding domain (Freist et al., 1998).  
 
Site-directed  mutagenesis  studies  of  the  human  P2X7R  have  identified  specific  residues 
essential for ATP-binding in the P2X7R. A point mutation, which substituted arginine with 
glutamic  acid  at  residue  307  (R307Q)  abolished  ATP-mediated  barium  ion  influx  and 
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ethidium  dye  uptake  into  peripheral  macrophages,  although  protein  levels  and  surface 
expression  were  normal.  Furthermore,  lysine  residues  located  towards  the  ends  of  the 
extracellular  loop  are  thought  to  contribute  to  the  formation  of  the  ATP-binding  site  by 
interacting  with  neighbouring  P2X  subunits,  possibly  through  the  formation  of  disulphide 
bonds, in the hetero- or homotrimeric receptor complexes (Wilkinson et al., 2006; Marquez-
Klaka et al., 2007). Thus, it is proposed that these conserved positively charged lysine and 
arginine residues may be associated with binding the negatively charged phosphate of ATP 
(Roberts et al., 2006). Additionally, phenylalanine residues at positions 185 and 291, when 
mutated to alanine, have been implicated in the binding of the adenine ring of ATP (Roberts 
and Evans, 2004; Roberts et al., 2006). 
 
The notion that the interface between subunits forms an ATP-binding site, also suggests that 
there  are  three  possible  ligand-binding  domains,  as  P2XRs  are  only  functional  when 
assembled  as  trimeric  complexes.  However,  the  number  of  ATP  molecules  needed  to 
activate the receptor remains elusive. Indeed, the P2X2/3R heterotrimer requires only two 
functional binding sites, although three could be available (Wilkinson et al., 2006). However, 
it has been suggested that the human P2X7R contains a total of four, two each of low and 
high affinity binding sites (Klapperstück et al., 2001). The low affinity binding site has been 
suggested to correspond to the linearly activating and slowly deactivating P2X7R currents, 
while the high affinity binding site is thought to regulate the slowly deactivating current, only. 
It is not clear whether it is necessary for all binding sites to be occupied for P2X7R function 
(Klapperstück et al., 2001). Furthermore, it has been suggested that ATP4
-, not ATP, is the 
true ligand that activates the P2X7R, which may explain the low affinity of ATP at the P2X7R, 
although this notion requires further support (Cockcroft and Gomperts, 1980; Steinberg et 
al., 1987; Sperlágh et al., 2006).  
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Thus, the putative ATP binding site  is  proposed to be located on the interface between 
adjacent P2X7R subunits. Although the extracellular domain is generally conserved among 
the  different  P2XR  subtypes,  receptor-specific  properties  have  been  revealed  in 
mutagenesis  studies  (Coddou  et  al.,  2011).  Therefore,  the  exact  location  of  the  ligand 
binding sites, and the number of occupied sites required to activate the functional P2X7R 
remain  to  be  determined.  Moreover,  species  differences  in  the  P2X7R  structure  further 
obscure the possible location of the ATP binding site. 
 
3.1.2 P2X7R subunit assembly and ion channel formation 
It  is  known  that  all  P2XR  subunits  form  functional  homo-oligomeric  complexes,  with  the 
exception of P2X6 (Torres et al., 1999). Furthermore, it was shown that the P2X1-6 subunits 
were able to form functional hetero-oligomeric complexes, with the P2X7 subunit being the 
exception (Torres et al., 1999). It is now established that the full repertoire of the functional 
P2XR family include six homomeric channels and six heteromeric channels associated with 
subunit pairings, which form trimeric structural arrangements (North, 2002; Dubyak, 2007). 
The notion that P2X7R subunits preferentially form functional homotrimeric complexes has 
been the generally supported view (Torres et al., 1999; Nicke, 2008; Boumechache et al., 
2009). However, this has been questioned over recent years as it was found that the P2X7 
subunit could associate with P2X4 to form functional heteromers (Guo et al., 2007). It has 
been  suggested  (Nicke,  2008;  Boumechache  et  al.,  2009)  that  the  evidence  supporting 
heterotrimeric P2X4/7 complexes was elusive as the agonist-evoked responses might have 
been due to the formation of individual homotrimeric receptors, instead of the suggested 
heteromer.  Indeed,  it  could  also  be  possible  that  a  heterotrimeric  complex  consisting  of 
2P2X4/1P2X7 or 1P2X4/2P2X7 subunits, give rise to at least one ATP-binding site on the 
interface between two homomeric subunits. Moreover, a further complexity subsists, as it 
was  found  that  native  P2X7Rs  are  expressed  as  functional  hexameric  complexes  in 
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peripheral macrophages, whereas they exist as monomers in microglia of the brain (Kim et 
al., 2001).  
 
The ion channel formed by the activated P2X7 receptor is thought to resemble that of other 
P2X receptors. The ion pore is lined with both transmembrane domains (TM1 and TM2) of 
each subunit, giving rise to six domains in total, each contributing to cationic transport across 
the membrane (Rassendren et al., 1997a; Egan et al., 1998, 2006; Haines et al., 2001). The 
narrow pore is suggested to be between 8 and 20 Å in diameter (Virginio et al., 1999). 
 
3.1.3 The P2X7R carboxyl terminus 
In  recent  years,  there has been much progression  towards  understanding  the  structure-
function  relationship  of  the  P2X7R,  although  the  precise  receptor  structure  and  motif 
composition still remains to be defined. The carboxyl terminus (C-terminus) of the P2X7R is 
currently under intense investigation, as it is proposed to be involved in P2X7R function and 
expression, including ion channel gating properties, pore formation (Surprenant et al., 1996; 
Denlinger et al., 2001; Gu et al., 2001; Adriouch et al., 2002; Wiley et al., 2002; Pelegrin and 
Surprenant, 2006; Iglesias et al., 2008), cell surface expression and membrane trafficking of 
the receptor (Denlinger et al., 2003; Smart et al., 2003; Wiley et al., 2003; Feng et al., 2005; 
Gonnord et al., 2009; Jindrichova et al., 2012), and downstream signalling events associated 
with receptor phosphorylation and calmodulin binding (Wang et al., 2003; Roger et al., 2008, 
2010). A BLAST alignment search for structural motifs in the C-terminus identified that the 
mouse  P2X7R  contained  a  Src  homology  domain  (SH3;  residues  441-460),  which  was 
located  inside  a  TNFR1-like  death  domain  (residues  436-508),  and  a  bacterial 
lipopolysaccharide  (LPS)  binding  site  (residues 573-590)  (Denlinger  et  al.,  2001).  These 
motifs are likely to bind to intracellular signalling components, and stimulate the activation of 
specific inflammatory cellular cascades. 
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In a later study, it was observed that T-lymphocytes from the BALBc mouse strain were 
more sensitive to ATP stimulation than T-lymphocytes of the C57BL/6 strain (Adriouch et al., 
2002). A point mutation was identified at residue 451 of the C57BL/6 P2X7R C-terminus, 
where  proline  was  replaced  by  leucine  (P451L).  HEK293  cells  transfected  with  P2X7Rs 
expressing either P451 or L451, showed that ATP was more effective at inducing YO-PRO-1 
uptake and Ca
2+ influx in cells expressing the BALBc P2X7R, when proline was present at 
residue 451. Therefore, it was proposed that the P451L mutation in the SH3 domain of the 
C57BL/6,  P2X7R  impairs  receptor-mediated  ion  channel  function  and  pore  formation, 
corresponding to a  loss of  function mutation  (Adriouch et al., 2002). The BALBc P2X7R 
shared C-terminus sequence homology with its rat and human counterparts. However, a 
recent  species-comparison  functional  study  observed  that  the  apparent  loss  of  function 
P451L mutation did not affect C57BL/6 P2X7R responses and showed similar properties to 
the BALBc P2X7R (Donnelly-Roberts et al., 2009a). 
 
A  similarly  placed mutation  in  the  human  P2X7R  found  in  some  individuals  with  chronic 
lymphocytic leukaemia, where glutamine is replaced by alanine at residue 496 (E496A), also 
shows a loss of function in the receptor and leads to impaired activation of the  P2X7R-
induced apoptotic pathway (Gu et al., 2001; Wiley et al., 2002). Quite recently, it has also 
been suggested that the P2X7R-mediated large pore formation could be associated with the 
recruitment and activation of Pannexin-1 (Panx-1) hemichannels, which are in turn linked 
with  the  SH3  domain  of  the  C-terminus  (Pelegrin  and  Surprenant,  2006;  Iglesias  et  al., 
2008).  The  SH3  and  death  domains  are  also  associated  with  phosphorylation  sites  that 
interact with HSP90 (heat shock protein) and protein kinase C in human macrophages and 
astrocytes, respectively (Adinolfi et al., 2003; Wang et al., 2003). Therefore, it is likely that 
the SH3 and death domains play an important role in the P2X7R-mediated pore formation 
and apoptosis, through protein recruitment and interactions at the intracellular C-terminus of 
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the  receptor,  and  that  these  P2X7R  functions  are  essential  in  mediating  immunological 
responses of cells of the monocytic lineage.  
 
Mutagenesis studies in the distal portion of the C-terminus, which includes a set of highly 
conserved  cysteine  residues,  have  shown  the  importance  of  this  amino  acid  sequence 
(residues  551-581)  in  membrane  trafficking  and  cell  surface  expression  of  the  P2X7R  
(Denlinger et al., 2003; Smart et al., 2003; Wiley et al., 2003; Feng et al., 2005; Gonnord et 
al.,  2009;  Jindrichova  et al.,  2012).  Interactions  between  the P2X7R  C-terminus  and  the 
calcium-binding  protein,  calmodulin,  have  been  implicated  in  the  regulation  of  P2X7R-
activated ion channel. Point mutations at residues 541 and 552 (I541T and S552C) in the rat 
P2X7R  caused  a  large  depression  of  calcium  currents  and  blocked  the  co-
immunoprecipitation of P2X7R and calmodulin protein, seen in cells expressing the wild-type 
rat  P2X7R.  In  a  follow-up  study,  it  was  shown  that  the  wild-type  human  P2X7R,  which 
exhibited slower ATP-induced currents than the rat P2X7R, did not co-immunoprecipitate 
with calmodulin. This suggested that calmodulin does not normally associate with the human 
P2X7R, although it does with the rat orthologue (Roger et al., 2008, 2010).  
 
3.1.4 Species differences 
The rat P2X7R amino acid sequence shares an 80% and 85% homology with that of the 
human and mouse P2X7R, respectively (Surprenant et al., 1996; Rassendren et al., 1997b; 
Chessell et al., 1998a). Furthermore, it is unclear whether species differences in amino acid 
homology in the extracellular region (Young et al., 2007) or the C-terminus (Gu et al., 2001; 
Adriouch et al., 2002) of the P2X7R underlie the observed species differences in agonist and 
antagonist potencies at the receptor (Donnelly-Roberts et al., 2009a).  
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3.2 Pharmacological properties of P2X7R 
The  P2X7R  can  be  functionally  distinguished  from  other  P2XR  subtypes  by  its  unique 
pharmacological fingerprint and its permeability to large cations and fluorescent dyes. Much 
of the early studies on P2X7R function were carried out on expression systems such as 
human embryonic kidney 293 (HEK293) cells and Xenopus oocytes expressing recombinant 
P2X7Rs. It is also known that immunological and glial cells such as macrophages, microglia 
and astrocytes express P2X7Rs. Therefore, some studies have used macrophage cell lines 
to  investigate  the  functional  properties  of  native  P2X7Rs,  which  would  indeed  be  more 
relevant to physiological conditions. To examine the effects of agonists and antagonists on 
the P2X7R, most studies have used whole-cell patch clamp recordings to measure inward 
currents evoked by P2X7R activation. Furthermore, the permeation properties of the receptor 
were  typically  examined  by  measuring  agonist-induced  calcium  influx  or  YO-PRO-1 
fluorescent  dye  uptake  in  transfected  cells.  Fig.  3.1  summarises  some  pharmacological 
characteristics of mouse P2X7Rs. 
 
3.2.1 Agonists 
3.2.1.1 Activation of membrane currents 
One of the main distinguishing properties of the P2X7R is its relatively low affinity for its 
agonist,  ATP,  compared  to  that  of  other  P2X  receptor  subtypes  (Evans  et  al.,  1996; 
Surprenant et al., 1996; Bianchi et al., 1999). Early studies in macrophages showed that 
ATP-induced  currents  were  a  result  of  a  non-selective  increase  in  permeability  to  both 
cations and anions (Buisman et al., 1988).  However, membrane current recordings from 
HEK293  cells  expressing  recombinant  rat  P2X7Rs  (rP2X7Rs)  have  shown  selectivity  for 
small cations (Surprenant et al., 1996; Virginio et al., 1999). The EC50 value for ATP at the 
P2X7R was 10- to 100-fold higher than that at the other receptor subtypes expressed in 
1321N1  human  astrocytoma  cells  (Bianchi  et  al.,  1999),  and  therefore  less  potent  at 
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activating  P2X7Rs. The effect of repeated ATP applications was examined in the NTW8 
mouse  microglia  cell  line  expressing  native  P2X7Rs  and  HEK293  cells  expressing 
recombinant  mouse,  rat  or  human  P2X7Rs  (Chessell  et  al.,  1998a).  Repeated  ATP 
applications (1mM) resulted in successively larger current amplitudes in NTW8 cells and at 
recombinant  mouse  P2X7Rs  (mP2X7Rs),  so  that  by  the  eighth  application,  the  current 
amplitude had increased by 303% and 74%, respectively. Additionally, rise and decay times 
did not significantly change over repeated agonist applications (Chessell et al., 1998a). This 
property may reflect the opening of a pore permeable to large molecules (North, 2002). 
 
Although  not  P2X7R-selective,  2’,  3’-O-(4-benzoyl-benzoyl)  adenosine  5’-triphosphate 
(BzATP) is the most potent agonist at the P2X7R subtype, exhibiting at least 10- to 30-fold 
potency than ATP, at this receptor (Surprenant et al., 1996). There are some remarkable 
species differences in P2X7R agonist potency. Repeated BzATP (100 µM) applications at 
the  mouse  and  human  P2X7Rs  (hP2X7R)  evoked  successively  potentiating  currents. 
However, this effect was only observed with rP2X7Rs when a much lower dose (1-3 µM) was 
applied  (Chessell  et  al.,  1998a).  Higher  BzATP  doses  (>10  µM)  either  had  no  effect  or 
reduced the current amplitude at rP2X7Rs (Hibell et al., 2000). Furthermore, when using a 
supra-maximal concentration of BzATP (100uM) at rP2X7Rs, the deactivation period for the 
evoked current response had increased by 1259%, following the eighth application (Chessell 
et al., 1998a). Therefore, BzATP is clearly the most potent at rat P2X7Rs, compared to the 
human and mouse orthologues, a notion which has also been confirmed in later studies 
(Donnelly-Roberts  et  al.,  2009a).  This  relatively  high  agonist  potency  and  the  increased 
response decay time on repeated application, both reflect higher agonist dissociation rates 
at rat P2X7Rs, compared to its mouse and human counterparts (Hibell et al., 2001). The 
majority of studies investigating P2X7R function have been carried out using recombinant rat 
receptors. Thus, it is important that these species differences in agonist potency are noted 
when using alternative animal models. P2X1, P2X2 and P2X3 receptor subtypes are also 
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activated by BzATP (Bianchi et al., 1999). The agonist potency order (BzATP>ATP) is also 
valid  at  P2X1Rs.  However,  the  nucleotide  agonists  2-methylthioATP  (2-MeSATP)  and  α, 
βmethyleneATP  (α,  β-meATP)  are  highly  potent  at  the  P2X1Rs  (nM  to  low  µM  range), 
whereas they are relatively weak agonists of P2X7Rs (Bianchi et al., 1999). Thus, these 
differences in agonist profiles would further enable P2X1 and P2X7 receptor subtypes to be 
distinguished. 
 
Other  endogenous nucleotides,  AMP  and  ADP,  normally  show  no  or very  weak  agonist 
activity at P2X7Rs. However, recombinant mouse and rat P2X7Rs expressed in Xenopus 
oocytes, when primed with an initial application of ATP, were dose-dependently activated. 
This  was  also  supported  by  the  activation  of  native  P2X7Rs  in  ATP-primed  mouse  and 
human  microglial  cells,  which  evoked  the  release  of  the  pro-inflammatory  cytokine, 
interleukin-1β (IL-1β) (Chakfe et al., 2002). Thus, pre-exposure to ATP sensitises P2X7Rs, 
whether  recombinant  or  native,  such  that  they  are  susceptible  to  activation  by  weaker 
nucleotide agonists. This may play an important physiological role in vivo where extracellular 
ATP is rapidly hydrolysed by ectoATPases at the surface of the cell membrane (Banerjee, 
1981; Ziganshin et al., 1994). 
 
3.2.1.2 Large pore formation 
It  has  been  shown  that  repeated  or  prolonged  applications  of  ATP  or  BzATP  evoke 
successively larger currents that also display increased deactivation latencies (Chessell et 
al., 1998a), which may reflect the opening of a pore permeable to large molecules. Indeed, it 
was shown that ATP
4- permeabilised J774 macrophages to large fluorescent dyes such as 
Lucifer Yellow (457 Da) and Fura-2 (831 Da), but not larger dyes such as Evans Blue (961 
Da)  (Steinberg  et  al.,  1987).  Following  the  cloning  of  rat  P2X7Rs,  it  was  shown  that 
prolonged agonist application to transfected cells led to sustained currents and a subsequent 
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uptake of the dye YO-PRO-1 (Surprenant et al., 1996), a property also observed in mouse 
and human P2X7Rs (Rassendren et al., 1997b; Chessell et al., 1998a). Prolonged (30 to 40 
sec) BzATP application induced membrane blebbing, YO-PRO-1 uptake and cell death in 
HEK293  cells  expressing  rP2X7Rs  (Virginio  et  al.,  1999),  a  property  attributed  to  the 
activation of apoptotic pathways. The time course of dye uptake was much slower than that 
of the induction of ionic currents. Furthermore, it was shown with short agonist applications 
and YO-PRO-1 uptake, that the pore dilation was reversible (Virginio et al., 1999). Species 
differences have also been observed between rat, human and mouse P2X7Rs in agonist-
evoked YO-PRO-1 uptake in transfected cells (Donnelly-Roberts et al., 2009a). It has been 
shown that BzATP produced a more rapid YO-PRO-1 influx into cells expressing rat and 
human P2X7Rs, compared to mouse P2X7Rs (Hibell et al., 2000).  
 
There  are  at  least  two  possible  mechanisms  to  explain  the  time-dependent  increase  in 
permeability of the P2X7R-activated ion channel, to larger cationic dyes (North, 2002). One 
is that the agonist-evoked membrane currents and dye-uptake are both mediated through a 
common pathway, in which the small non-selective cation channel progressively increases in 
diameter to allow the entry of larger molecules, in a time and dose-dependent manner. The 
alternative is that the P2X7R-activated ion channel and large permeable pore are separate 
entities, and that the large pore is activated through protein recruitment interactions with the 
intracellular P2X7R C-terminus. Both hypotheses are supported by several lines of evidence 
(North, 2002; Pelegrin and Surprenant, 2009). 
 
The  common  pathway  model  was  supported  by  the  findings  that  agonist-evoked  P2X7R 
membrane currents progressively increased as a result of repeated or prolonged application. 
A  short  agonist  application  (1  sec)  led  to  the  activation  of  transient  membrane  currents 
attributed to a cationic conductance. Repeated or prolonged agonist application led to a 
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sustained  increase  in  the  inward  current,  which  reflected  a  progressive  increase  in 
permeability to large cations, such as NMDG
+ (Virginio et al., 1999). Due to the slower time 
course of dye uptake compared to the onset of agonist-evoked membrane currents, it was 
suggested  that  the  small  P2X7R-activated  cation-selective  channel  pore  progressively 
dilated over a period of 10-20s to allow entry to larger cations and dyes  (Virginio et al., 
1999). However, the agonist dose-dependent current growth was thought to be associated 
with a decreased rate of agonist dissociation from the receptor, rather than a progressive 
increase in the pore diameter of the ion channel (Hibell et al., 2000, 2001).  
 
The notion that the ion channel and large pore are separate, is also supported (Pelegrin and 
Surprenant, 2009). It was found that calmidazolium potently blocked agonist-evoked P2X7R-
mediated membrane currents but did not affect YO-PRO-1 uptake (Virginio et al., 1997). 
Additionally, initial studies in macrophage cells revealed that ATP application induced the 
uptake of anionic dyes such as Lucifer Yellow (Steinberg et al., 1987), which differs from the 
property of P2X7R-activated ion channels as displaying cationic conductances. Furthermore, 
a C-terminus mutation of the P2X7R led to a diminished permeability to NMDG
+ but had no 
effect on dye-uptake in HEK293 cells expressing rat P2X7Rs (Jiang et al., 2005). This was 
also  supported  by  the  finding  that  NMDG
+  permeability  did  not  increase  with  prolonged 
BzATP application, in the presence of a normal extracellular sodium concentration (Jiang et 
al., 2005). The conclusions of these studies suggest an alternative mechanism in which dye 
uptake may also occur through a separate large permeable pore.  
 
3.2.2 Extracellular ions 
Extracellular  concentrations  of  divalent  cations  have  been  shown  to  modulate  agonist-
evoked P2X7R responses. BzATP-evoked currents recorded from HEK293 cells expressing 
recombinant  rP2X7Rs,  were  potentiated  in  amplitude,  and  prolonged  on  repeated 
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applications  after  the  removal  of  magnesium  (Mg
2+)  and  calcium  (Ca
2+)  ions  from  the 
external solution (Surprenant et al., 1996). However, there was only a modest increase in 
the agonist potency (Surprenant et al., 1996). The inhibitory effect of responses at rP2X7Rs 
by divalent cations was confirmed by Virginio and colleagues (1997). Currents evoked by 
BzATP were inhibited by the addition of  extracellular Ca
2+, Mg
2+,  zinc (Zn
2+) and copper 
(Cu
2+) ions. BzATP-evoked YO-PRO-1 uptake was also inhibited by divalent cations with 
similar potencies (Virginio et al., 1997). 
 
As with the effect of agonists, there are species differences in the responses of P2X7Rs in 
low divalent solutions. Currents in HEK293 cells expressing recombinant rat and human 
P2X7Rs were evoked by BzATP (Rassendren et al., 1997b). Lowering the extracellular Ca
2+ 
concentration and the removal of extracellular Mg
2+ led to a potentiation in currents at both 
receptor orthologues. Furthermore, the potentiation of the hP2X7R currents was greater than 
that at rP2X7Rs (Rassendren et al., 1997b). This observation reflects the higher potency of 
BzATP at rP2X7Rs, and suggests a possibility that the agonist might be competing with 
Mg
2+, at the extracellular agonist binding site, a concept that has previously been proposed 
(Cockcroft and Gomperts, 1980), but is widely disputed  (Virginio et al., 1997; North and 
Surprenant,  2000).  Additionally,  inhibition  of  agonist-evoked  currents  by  Mg
2+  were  also 
observed in a human macrophage cell line (Rassendren et al., 1997b). In another study, a 
short pre-incubation of hP2X7R-transfected HEK293 cells with copper caused an inhibition of 
BzATP-evoked currents (Chessell et al., 1998b). 
 
Similarly,  mouse  P2X7Rs  expressed  natively  in  the  NTW8  microglial  cell  line  showed  a 
significantly  larger  potentiation  of  BzATP-  and  ATP-evoked  currents  in  low  divalent 
extracellular solution (Chessell et al., 1997). Moreover, the successively larger currents on 
repeated ATP exposure were further potentiated in the absence of divalent cations (Chessell 
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et al., 1997). Another study (Moore and Mackenzie, 2008), examined the effects of zinc and 
copper on mouse and rat P2X7Rs. The influx of the fluorescent dye ethidium bromide (EtBr), 
through the P2X7-activated pore, was used to measure the level of P2X7 activation. Copper 
potently  inhibited  ATP-  and  BzATP-evoked  EtBr  influx  in  native  mouse  RAW264.7 
macrophages and in HEK293 cells expressing recombinant mouse or rat P2X7Rs. However, 
the  effect  of  zinc  was  dependent  on  the  expression  system  and  the  agonist  used.  Zinc 
treatment led to an inhibition of recombinant rP2X7Rs when activated by ATP or BzATP. 
ATP-evoked  recombinant  mP2X7R activation  was  potentiated  by  zinc  but  inhibited  when 
BzATP was used as the agonist. The native receptors in mouse macrophages were not 
affected by zinc on ATP-mediated stimulation. However, when using BzATP as the agonist, 
zinc  inhibited  P2X7R  activation  in  mouse  macrophages  (Moore  and  Mackenzie,  2008). 
These findings suggest that P2X7R function is modulated by zinc and copper, but also stress 
further the species and agonist differences in P2X7R responses.  
 
P2X7R responses have also been shown to be modulated by the extracellular concentrations 
of monovalent ions. Rat P2X7R responses were inhibited by protons when stimulated by 
BzATP (Virginio et al., 1997). Furthermore, the substitution of extracellular Na
+ with NMDG
+, 
led to an enhanced rate of YO-PRO-1 uptake, as well as a potentiated ionic current (Virginio 
et al., 1999). BzATP potency was tested at hP2X7Rs in the presence of different monovalent 
cations while maintaining chloride as the anion in the extracellular solution (Michel et al., 
1999). BzATP was more potent at hP2X7Rs in the presence of choline (pEC50 6.14) when 
compared to K
+ and Na
+ (pEC50 5.87 and 5.19, respectively). It was also observed that using 
glutamate in place of chloride as the monovalent anion enhanced BzATP-evoked hP2X7R 
currents, in a low divalent solution (Michel et al., 1999). These findings suggest that P2X7R 
function is inhibited, to a certain extent, by extracellular sodium chloride (NaCl) and could 
explain the low agonist potency at this receptor compared to other P2XR subtypes. While 
under physiological conditions, it is unlikely that extracellular ion concentrations fluctuate to 
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such a degree, the authors (Michel et al., 1999) have suggested that P2X7R function could 
be  enhanced  under  stress  conditions  such  as  ischemia,  when  extracellular  Na
+  and  Cl
- 
concentrations are reduced in the brain (Xie et al., 1995). 
 
3.2.3 Antagonists 
The  polysulfonated  dye,  Coomassie  Brilliant  Blue  G  (BBG)  is  a  potent,  non-competitive 
antagonist at the P2X7R (Jiang et al., 2000). BBG led to an inhibition of BzATP-evoked 
currents  at  both  rat  and  human  P2X7Rs  in  the  nanomolar  range  (IC50 10  and  200  nM, 
respectively). BBG also has antagonising properties at other P2XR subtypes (IC50 2-30 µM) 
(Jiang et al., 2000). At the P2X4R, BBG inhibited currents with IC50 values of 10 (rat) and 3.2 
(human)  µM.  Thus,  BBG  displayed  a  1000-fold  higher  potency  at  rP2X7RS,  than  at  the 
rP2X4RS. P2X7Rs and P2X4Rs are often co-expressed in the same tissues with overlapping 
roles in inflammation and pain (Dubyak, 2007), although their propensity to form functional 
heteromeric complexes is not completely understood. In another study, recombinant mouse, 
rat  and  human  P2X7  receptors  were  expressed  in  human  astrocytoma  1321N1  cells 
(Donnelly-Roberts  et  al.,  2009a).  BBG  only  potently  blocked  calcium  influx  through  rat 
P2X7Rs,  but  showed  effective  inhibition  of  YO-PRO-1  uptake  at  mouse,  human  and  rat 
P2X7Rs.  In  this  case,  BBG  was  more  potent  at  blocking  mouse  (BALB/c  and  C57BL/6 
strains; pIC50 6.71 and 6.34, respectively) YO-PRO-1 uptake, than at the rat and human 
receptor subtypes (pIC50 6.24 and 5.71, respectively) (Donnelly-Roberts et al., 2009a). 
 
Another  antagonist  of  the  P2X7R  is  the  isoquinoline  derivative  KN-62  (1-[N,  O-bis  (5-
isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine),  which  displays  remarkable 
selectivity  at  the  human  and  mouse  but  not  at  rat  P2X7Rs  (Humphreys  et  al.,  1998; 
Donnelly-Roberts et al., 2009a). KN-62 was first shown to potently inhibit ATP-stimulated 
barium  influx  and  ethidium  dye  uptake  by  human  lymphocytes  thought  to  have  been 
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mediated by P2X7Rs (Gargett and Wiley, 1997). The selectivity of KN-62 to inhibit cation 
currents and dye uptake at the human and mouse, over rat P2X7Rs has been confirmed for 
recombinant P2X7Rs expressed in human astrocytoma 1321N1 cells (Donnelly-Roberts et 
al., 2009a). Although KN-62 has shown to effectively block P2X7Rs function, the antagonist 
is also known to be a CAM-kinase-II inhibitor, which could render its use to be problematic in 
physiological systems, or in vivo.  Therefore, recent developments have led to the synthesis 
of  KN-62  derivatives  that  do  not  inhibit  CAM-kinase-II  but  maintain  P2X7R-blocking 
properties (Baraldi et al., 2004). 
 
Other selective P2X7R antagonists include oxidised ATP (oxATP) and calmidazolium.  The 
calmodulin  antagonist,  calmidazolium,  was  shown  to  effectively  block  currents at  the  rat 
P2X7R at low concentrations, but had no effect on YO-PRO-1 dye uptake (Virginio et al., 
1997). Interestingly, this finding implies that agonist-evoked P2X7R-mediated currents and 
large  dye  uptake  might  essentially  be  attributed  to  differential  pathways,  instead  of  one 
common pore (see below). Other, non-selective P2XR antagonists such as suramin and 
PPADS  (pyridoxal-phosphate-6-azophenyl-2’,  4’-disulphonic  acid)  also  inhibit  P2X7R-
mediated currents and dye uptake, though with relatively less potency than at other P2XR 
subtypes. HEK293 cells expressing recombinant rat P2X7R currents, stimulated with BzATP, 
were  relatively  insensitive  to  suramin  and  PPADS  (IC50  300  and  45  µM,  respectively) 
(Surprenant et al., 1996). Similarly, high concentrations of the antagonists were needed to 
inhibit BzATP–evoked currents at h2X7Rs (Rassendren et al., 1997b). In contrast, PPADS 
was shown to potently antagonise recombinant rat and human P2X7R-mediated YO-PRO-1 
uptake evoked by BzATP, in HEK293 and human astrocytoma 1321N1 cells (Chessell et al., 
1998a; Donnelly-Roberts et al., 2009a). Native (NTW8) and recombinant (HEK293  cells) 
mouse P2X7Rs were also inhibited by PPADS, but less effectively than at the rat or human 
counterparts (Chessell et al., 1998a). A mouse strain-specific response to PPADS inhibition 
was also seen with BzATP-evoked YO-PRO-1 uptake in human astrocytoma 1321N1 cells 
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expressing recombinant BALB/c and C57BL/6 P2X7Rs (pIC50 5.31 and 4.40, respectively) 
(Donnelly-Roberts et al., 2009a). Suramin and PPADS display higher potencies, in the low 
micromolar range, at other P2XR subtypes (P2X1-3 and P2X5), although they are relatively 
insensitive at P2X4Rs (North and Surprenant, 2000; North, 2002).  
 
Intensive  research  into  P2X7R  pharmacology  has  led  to  the  development  of  novel 
antagonists directed at this receptor. Donnelly-Roberts and colleagues have developed two 
novel  series  of  antagonists,  disubstituted  tetrazoles  (A438079)  and  cyanguanidines  (A-
740003), both of which displayed reversible and competitive antagonism with high potencies 
and selectivity at rat and human P2X7Rs (Honore et al., 2006; Nelson et al., 2006; Donnelly-
Roberts and Jarvis, 2007). A438079 (3-((5-(2, 3-dichlorophenyl)-1-H-tetrazole-1-yl) methyl 
pyridine) potently blocked BzATP-evoked calcium influx in human astrocytoma 1321N1 cells 
expressing rat or human P2X7. The antagonist did not have any effect on cells expressing 
other P2XR subtypes. Furthermore, A-438079 inhibited IL-1β release from, and YO-PRO-1 
uptake  by  human  THP-1  macrophages  (Nelson  et  al.,  2006).  A-740003  ((N-(1-
{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl) 
acetamide) was shown to be a more potent blocker at the rat and human P2X7Rs (Honore et 
al.,  2006).  Both  antagonists  were  also  tested  at  recombinant  mouse  P2X7Rs,  inhibiting 
BzATP-evoked changes in intracellular calcium concentrations and YO-PRO-1 dye uptake, 
at low micromolar concentrations (Donnelly-Roberts et al., 2009a).  
 
3.3 P2X7R-mediated molecular mechanisms 
P2X7R-associated functions in neurons and microglia are closely associated with alterations 
in potassium and calcium flow through the activated receptor. Such functions include the 
release of neurotransmitters and cytokines, shown in fig. 3.2. 
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3.3.1 Neurotransmitter release 
The activation of P2X7 receptors with BzATP has been shown to induce calcium influx into 
rat cerebellar granule neurons  (Hervás et al., 2005) and in cerebrocortical and midbrain 
synaptosomal preparations  (Lundy et al., 2002; Alloisio et al., 2008; Marín-García et al., 
2008). BzATP-evoked increases in intracellular calcium concentrations, were blocked by the 
application of the antagonists BBG, A-438079 and Zn
2+, and potentiated in a low divalent 
extracellular solution (Lundy et al., 2002; Hervás et al., 2005; Alloisio et al., 2008; Marín-
García et al., 2008), all hallmarks of P2X7R activation. In cerebellar granule neurons (León 
et al., 2008) and motor neuron terminals at the neuromuscular junction  (Deuchars et al., 
2001), it was found that BzATP-mediated P2X7R activation led to synaptic vesicle release, 
measured by the release of the fluorescent dye FM 1-43 (León et al., 2008). Furthermore, 
vesicle secretion was inhibited by removing extracellular calcium and by the application of 
BBG (Deuchars et al., 2001; León et al., 2008), suggesting that P2X7R-mediated vesicle 
release is dependent on calcium influx. These findings imply that P2X7R activation has a role 
in  neurotransmitter  release.  Indeed,  several  studies  have  shown  that  P2X7R-mediated 
glutamate and GABA release occurs in some regions of the brain (Sperlágh et al., 2002; 
Alloisio et al., 2008; Marín-García et al., 2008; D’Amico et al., 2010). 
 
 
P2X7R-mediated glutamate and subsequent GABA release was shown in rat hippocampal 
slices  (Sperlágh  et  al.,  2002).  Slices  were  incubated  with  [
3H]  GABA  or  [
14C]  glutamate 
before treatment with ATP or other agonists. P2X7R agonist application caused a dose-
dependent  release  of  [
3H]  GABA  and  [
14C]  glutamate  with  a  rank  order  of  potency  of 
BzATP>ATP>ADP. The agonist-evoked neurotransmitter release was inhibited by PPADS, 
BBG  and  Zn
2+.  Furthermore,  [
3H]  GABA  release  by  electrical  field  stimulation  and  ATP 
application were blocked by BBG and kainate receptor antagonists, CNQX and gadolinium, 
respectively. These findings were supported by P2X7R immunoreactivity in area CA1 and 
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CA3  nerve  terminals  targeting  pyramidal  cell  dendrites  and  parvalbumin-immunopositive 
puncta  (Sperlágh  et  al.,  2002).  It  was  suggested  that  P2X7R-activation  at  pre-synaptic 
excitatory terminals modulated the release of glutamate and glutamate-dependent GABA 
release in the hippocampus (Sperlágh et al., 2002). 
 
 
It was also shown that ATP- and BzATP-evoked glutamate and [
3H]D-aspartate release was 
antagonised by the application of P2X7R-selective inhibitors oxATP, BBG (Marín-García et 
al., 2008) and A-438079 (Alloisio et al., 2008) in isolated rat cerebrocortical synaptosomes. 
Rat  caudal  brainstem  synaptosomal  preparations  showed  a  similar  profile  of  P2X7R-
mediated [
3H]D-aspartate release (D’Amico et al., 2010). BzATP application increased both 
the basal and K
+-evoked efflux of [
3H] D-aspartate, which was blocked by A-438079 and 
PPADS. In the same study, the contribution of AMPA receptor function to mediated [
3H] D-
aspartate release was also investigated. Treatment with AMPA did not affect the basal, but 
increased the K
+-evoked efflux of [
3H] D-aspartate. This effect was blocked by the AMPA 
receptor inhibitors NBQX and GYKI52466. The findings of this study suggest that the activity 
of AMPA and P2X7 receptors may be coupled in some way, at the pre-synaptic terminal, to 
modulate the release of glutamate during synaptic transmission. 
 
3.3.2 Cytokine release, the inflammasome complex and TLR4 
Cytokine release from microglia is initiated in the presence of pathogens or cellular stressors 
in  the  extracellular  microenvironment.  The  processing  and  release  of  the  cytokine, 
interleukin-1β  (IL-1β),  is  particularly  prominent  in  the  early  stages  of  inflammation  under 
such conditions, and are believed to require a dual stimulus. Firstly, activation of Toll-like 
receptor 4 (TLR4) by its bacterial ligand lipopolysaccharide (LPS), a pathogen-associated 
molecular pattern (PAMP), induces an intracellular accumulation of pro-IL-1β (31 kDa) and 
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components of the inflammasome enzyme complex, through NFκB signalling (Ferrari et al., 
1997b, 2006; Sanz and Di Virgilio, 2000). Secondly, the activation of P2X7Rs by ATP, a 
damage-associated molecular pattern (DAMP), triggers a large efflux in K
+, inflammasome 
assembly and activation of the enzyme caspase-1. It is unclear how the change in K
+ flux 
stimulates  these  processes,  although  they  are  suppressed  on  inhibition  of  K+  efflux 
(Perregaux and Gabels, 1994; Ferrari et al., 1997b, 2006; Sanz and Di Virgilio, 2000). The 
P2X7R-mediated influx of calcium is suggested to play a key role in triggering the actual 
release of the mature 17 kDa cytokine into the extracellular environment. Release of IL-1β  
may occur through multiple pathways, including microvesicle shedding or through a large 
pore such as the pannexin-1 (panx-1) hemichannel (Mackenzie et al., 2001; Bianco et al., 
2005; Pelegrin et al., 2008; Ferrari et al., 2006).  
 
LPS  stimulation  has  also  shown  to  induce  panx-1  upregulation  in  human  and  mouse 
macrophages, in which the protein was highly expressed and which co-immunoprecipitated 
with  the  P2X7R  subunit  (Pelegrin  and  Surprenant,  2006).  Inhibition  of  panx1  led  to  a 
subsequent inhibition of P2X7R-mediated dye uptake, but did not affect the agonist-evoked 
membrane current or calcium influx. Inhibiting panx1 also blocked caspase-1 activation and 
subsequent  IL-1β  release  from  the  activated  macrophages.  Furthermore,  panx1  over-
expression led to an increased rate of dye uptake  (Pelegrin and Surprenant, 2006). The 
findings of this study  suggest that P2X7R activation may be coupled to the activation of 
panx-1, stimulating the activation of apoptotic pathways and cytokine release (Pelegrin and 
Surprenant, 2006, 2009).  
 
Considering  that  the  upregulation  and  assembly  of  the  inflammasome  complex  requires 
gene transcription (Di Virgilio, 2007), it is likely that this process may occur over a period of 
hours to days following the initial stimulus. It is debated whether preconditioning of microglia 
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with a PAMP such as LPS, is required, although a larger ATP-mediated release of IL-1β is 
seen  upon  preconditioning  (i.e.  with  LPS),  most  probably  due  to  the  upregulation  and 
assembly of the inflammasome complex (Ferrari et al., 1997b, 2006; Sanz and Di Virgilio, 
2000). ATP stimulation of P2X7Rs has shown to trigger the processing and release of TNFα 
without the need for preconditioning, through a calcium-dependent mechanism (Suzuki et 
al., 2004), which may suggest a possible mechanism for non-inflammasome associated IL-
1β release. Interestingly, cytokines have shown remarkable potency in modulating NMDA 
receptor function and synaptic plasticity in the brain (Di Filippo et al., 2008, 2013; Fogal and 
Hewett, 2008), and therefore could also be associated with P2X7R-mediated mechanisms of 
neuromodulation. 
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Figure  3.1  Pharmacological  characteristics  of  mouse  P2X7Rs.  Data  shown  are 
concentration-effect curves for agonist-induced P2X7R-mediated increases in intracellular 
calcium  (A),  and  for  blockade  of  BzATP-induced  effects,  by  various  P2  receptor 
antagonists (B). Data represent mean ± SEM percentage of maximum BzATP-mediated 
response,  in  human  astrocytoma  cells  transfected  with  recombinant  C57BL/6  mouse 
P2X7Rs.  A,  The  curves  illustrate  the higher potency of  BzATP  in  stimulating  P2X7Rs, 
compared to ATP. A similar relationship was observed for agonist-induced YO-PRO-1 dye 
uptake (not shown). B, The competitive antagonists A438079 and A740003 both exhibited 
the  highest  affinity  and  selectivity  for  blocking  P2X7R-mediated  calcium  influx,  in  this 
particular mouse line. The usually potent P2X7R blocker BBG showed similar potency to 
the  broad-spectrum  P2XR  antagonist,  in  blocking  BZATP-induced  calcium  influx. 
However, BBG exhibited comparable potency to A438079 in attenuating agonist-induced 
YO-PRO-1  dye  uptake  (not  shown),  suggesting  that  BBG  may  be  more  selective  for 
P2X7R  large pore activity. P2X7R activation was also blocked by the reported P2X1R 
antagonists,  MRS2159  and  PPNDS.  Figures  extracted  from  Donnelly-Roberts  et  al. 
(2009a). 
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Figure  3.2  Schematic  of  structural  and  functional  properties  of  P2X7Rs.  Functional 
P2X7Rs are comprised of three subunits, forming a homotrimer. Left, Membrane topology 
shows each subunit consists of two hydrophobic transmembrane (TM) domains, a large 
extracellular loop, and both amino (N) and carboxyl (C) termini located intracellularly. The 
ATP binding site is located extracellularly, within a cysteine-rich metal binding domain, 
where it is thought to interact with positively charged lysine residues to induce receptor 
activation.  The  carboxyl  terminus  is  relatively  longer  than  that  of  other  P2XRs,  and 
contains various intracellular protein docking sites such as the TNFR1-like death domain 
and  an  LPS  binding  domain,  which  mediate  further  downstream  signalling  cascades. 
Middle, P2X7Rs form large non-selective cation channels. Large influx of calcium (Ca2+) 
and efflux of potassium (K+) ions are characteristic of P2X7R activation. Brief stimulation 
induces a rapid and reversible  increase in permeability to these cations. Sustained or 
repeated activation of the receptor induces larger fluxes of the ions, stimulating further 
downstream  mechanisms  such  as  neurotransmitter  release  from  neurons  or  cytokine 
release from microglial cells. Right, P2X7Rs are also closely associated with Pannexin-1 
(Panx-1)  hemichannels,  which  have  shown  to  mediate  ATP  release.  It  is  uncertain 
whether the large pore formed by sustained receptor activation is caused by the wider 
opening of P2X7Rs themselves, or through the activation of another pore, such as Panx-1. 
It has been widely reported that P2X7Rs and Panx-1 are required for the activation various 
glial-mediated  inflammatory  cascades  such  as  interleukin-1β  release  (IL-1β),  and  the 
induction of various apoptotic pathways. Overall, P2X7R activation has pleiotropic effects 
and is important for mediating various neuronal and glial cell functions.  
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Chapter 4 
P2X7R-Mediated Neuromodulation in the Retina 
 
4.1 P2X7R immunoreactivity in the retina 
P2X7 mRNA and protein expression has been detected in the rodent, primate and human 
retina on neuronal and glial cells, in both synapse-rich and nuclear layers (Brändle et al., 
1998; Wheeler-Schilling et al., 2001; Innocenti et al., 2004; Ishii et al., 2003; Puthussery and 
Fletcher, 2004; Puthussery et al., 2006; Vessey and Fletcher, 2012) (fig. 4.1).  
 
In the outer retinal layers of the rodent, specific P2X7R immunoreactivity was localised near 
ribbon synapses in rod spherules, as well as on postsynaptic GABAergic puncta identified as 
horizontal cell dendrites (Puthussery and Fletcher, 2004; Puthussery et al., 2006; Vessey 
and Fletcher, 2012). In the human retina, most immunoreactivity was observed in the OPL, 
although  P2X7R  mRNA  did  not  co-localise  with  photoreceptor  molecular  markers 
(Niyadurupola et al., 2013). These studies put into question the specific cellular expression 
of P2X7Rs in photoreceptors, and highlight an important species difference in the  P2X7R 
expression profile, between the mouse and human retina under physiological conditions. In 
the inner retina, P2X7R localisation was detected on processes presynaptic to rod-bipolar 
cell  terminals,  specifically  at  conventional  synapses  immunopositive  for  glycinergic  and 
GABAergic  molecular  markers  (Puthussery  and  Fletcher,  2004).  Receptor  expression on 
bipolar cell dendrites and axon terminals remains elusive.  P2X7R immunopositive puncta 
appeared to co-localise with rod-bipolar cell processes in both outer and inner retinal layers. 
However, it has been proposed that due to the discrete nature of the staining, these puncta 
are most likely those of horizontal or amacrine cells (Vessey and Fletcher, 2012). Indeed, 
mRNA expression for P2X3R, P2X4R and P2X5R, but not P2X7R was detected in isolated rat 
bipolar cells (Wheeler-Schilling et al., 2000), suggesting that direct purinergic modulation of 
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bipolar  cell  activity  may  occur  through  alternative  P2XRs,  whereas  P2X7R-mediated 
modulation  of  bipolar  cell  signalling  most  likely  occurs  through  presynaptic mechanisms. 
Taken together, these findings suggest that P2X7Rs modulate synaptic signalling in the rod-
mediated visual pathway.  
 
P2X7R localisation in the ganglion cell layer has also been determined (Brändle et al., 1998; 
Wheeler-Schilling et al., 2001). P2X7R  immunoreactivity  was observed at early  postnatal 
stages, in the ganglion cell  and neuroblastic layers (Innocenti et al., 2004), also suggesting 
that P2X7R activity could be important in early retinal function during development. Positive 
staining was detected in ganglion cell somata of the mouse (Kaneda et al., 2004; Franke et 
al., 2005; Vessey and Fletcher, 2012) and monkey retinae (Ishii et al., 2003), although it was 
not clear if the receptors were also localised at ganglion cell dendrites. Intracellular P2X7R 
localisation has also been observed in the cytoplasm and nuclear membrane of monkey 
retinal  ganglion  cells  (Ishii  et  al.,  2003).  In  the  rabbit,  P2X7R  immunoreactivity  was 
predominantly observed in the  inner retinal  layers, particularly  in  the ganglion  cell  layer, 
whereas most staining was observed in the OPL of the human retina (Sugiyama et al., 2006; 
Niyadurupola et al., 2013). Furthermore, in the human retina, high P2X7R mRNA expression 
detected in the inner retinal layers (Niyadurupola et al., 2013).P2X7R expression in Müller 
cells is disputed, as receptor immunoreactivity was not detected in some studies (Jabs et al., 
2000; Innocenti et al., 2004; Vessey and Fletcher, 2012), but others have provided both 
immunohistochemical and functional evidence of Müller cell P2X7Rs (Pannicke et al., 2000; 
Bringmann et al., 2001). These differences could reflect the upregulation of P2X7Rs in Müller 
cell  dysfunction,  for  example  in  proliferative  vitreoretinopathy  (Bringmann  et  al.,  2001). 
Similarly, P2X7R expression in astrocytes remains uncertain. In the mouse retina, P2X7R 
immunoreactivity co-localised with astrocytes in the C57BL/6 strain, although no astrocytic 
expression  of  the  receptor  was  found  in  the  BALBc  strain,  suggesting  a  strain-specific 
expression profile (Franke, 2005; Vessey and Fletcher, 2012). Furthermore, microglia in the 
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rodent retina are known to express P2X7Rs (Innocenti et al., 2004; Vessey and Fletcher, 
2012). Thus, microglial P2X7Rs are likely to play a significant role in the orchestration of 
neuroinflammatory responses in the retina. 
 
In addition to P2X7Rs, other P2R subtypes have been found in the rodent, cat and monkey 
retinae. The P2X2R, P2X3R and P2X5R subtypes were strongly expressed in the dendrites 
and somata of cholinergic amacrine cells, in the mouse (Kaneda et al., 2004; Shigematsu et 
al.,  2007).  Furthermore,  P2X3Rs  and  P2X4Rs  were  detected  in  the  inner  nuclear  and 
ganglion cell layers of the rat (Wheeler-Schilling et al., 2001). P2X3R immunoreactivity was 
localised to GABAergic amacrine cell bodies, and processes associated with rod and cone 
bipolar  cell  terminals  in  the  rat  inner  plexiform  layer  (Puthussery  and  Fletcher,  2007). 
P2X1Rs were also localised to neuronal processes in the inner plexiform layer, and to retinal 
ganglion cell bodies in the cat and monkey retinae (Yazulla and Studholme, 2004). P2Y1R 
immunolabelling was observed in the ganglion cell layer, and on Müller cell processes and 
end feet (Ward and Fletcher, 2009). P2Y4Rs were localised to presynaptic rod bipolar cell 
terminals in the inner plexiform layer, and to processes postsynaptic to cone bipolar cells 
(Ward et al., 2008).  
 
4.2 P2X7R neuromodulation in retina 
The  specific  localisation  of  P2X7Rs  on  neurons  of  the  vertical  rod-mediated  pathway 
suggests that these receptors may have an  important role  in modulating scotopic visual 
responses under physiological conditions, as proposed by the extensive studies of Fletcher 
and  colleagues  (Puthussery  et  al.,  2006;  Vessey  and  Fletcher,  2012).  A  large  body  of 
evidence suggests a role for neuronal P2X7Rs in the modulation of neurotransmitter release 
and  subsequent  regulation  of  synaptic  function  (Sperlágh  et  al.,  2006).  It  would  be 
interesting to clarify the neuronal role of this receptor in mediating synaptic efficacy within 
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the retinal circuitry. Furthermore, the expression of  P2X7Rs on Müller glia and  microglia 
implicates a non-neuronal, modulatory contribution by the activation of these receptors, to 
visual responses in the retina. The following discussion highlights the current knowledge of 
the  role  of  P2X7Rs  in  modulating  neuronal  and  glial  function  in  the  healthy  mammalian 
retina. 
 
 
Administration of an intravitreal injection of BzATP (4mM) led to a sustained potentiation in 
the  photoreceptor-derived  a-wave  amplitude  and  a  transient  reduction  in  the  post-
photoreceptor b-wave component of the rat rod- and cone-mediated electroretinogram. This 
indicates  the  P2X7R-mediated  alteration  of  both  rod  and  cone  photoreceptors,  and  the 
concomitant  modulation  of  a  post-photoreceptor,  ON-bipolar  cell-mediated  component 
(Puthussery et al., 2006).  
 
In line with this notion, mixed rod and cone ERG responses were altered across all light 
intensities in a P2X7R knockout mouse (Vessey and Fletcher, 2012). There was no change 
in the kinetics of the P2X7R knockout rod PIII (a-wave), compared to the wild-type mouse. 
However, the dissected rod and cone PII (b-wave) components were larger in amplitude, 
along  with  a  decreased  latency  to  reach  the  maximum  rod  PII  response  (Vessey  and 
Fletcher, 2012). The findings of this study provide compelling evidence that P2X7 receptors 
contribute to overall retinal function by modulating both rod and cone pathways in the normal 
retina.  Supported  by  immunohistochemical  evidence  of  P2X7R  localisation  on  inhibitory 
horizontal and amacrine cells in the retina, the authors have suggested a role for P2X7Rs at 
GABAergic synaptic terminals, in the regulation of synaptic transmission in the outer and 
inner plexiform layers (Vessey and Fletcher, 2012). However, horizontal cell contribution to 
the  rod  pathway  remains  controversial  (Bloomfield  and  Dacheux,  2001),  and  P2X7R 
activation in the goldfish retina does not evoke non-vesicular GABA release  (Jones and 
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Palmer, 2009). Therefore, it would be of much interest and relevance to identify whether this 
P2X7R-mediated  alteration  of  the  vertical  rod  pathway  occurs  in  the  absence  of  lateral 
inhibitory inputs. 
 
The  relative  contribution  of  other  P2-purinoceptors  to  retinal  function  has  also  been 
observed. P2X2R-mediated currents sensitive to PPADS, were recorded from mouse OFF 
cholinergic amacrine cells, potentiating the frequency of IPSCs these cells, but not of ON 
cholinergic amacrine cells. Furthermore, PPADS application led to an increase in OFF- but a 
reduction in ON- ganglion cell firing rate. Thus, it was suggested that P2X2Rs are selectively 
expressed by cells of the OFF vertical pathway (Kaneda et al., 2008, 2010). It would be 
interesting to investigate whether there is a selective pathway dominance of the P2X7R in 
the mammalian retina. Thus, immunohistochemical and functional evidence have highlighted 
the presence of an array of P2 purinoceptor subtypes in the mammalian retina, adding to the 
complexity  of  dissecting  a  specific  P2  purinoceptor  component  of  ATP-gated  synaptic 
modulation in the mammalian retina. 
 
 
4.3 P2X7R modulation of Müller cell and astrocyte function 
 
Müller cells express an array of P2X and P2Y receptors, and release ATP upon mGluR 
activation or osmotic membrane stretching. Autocrine, purinergic signalling is involved in the 
induction of intracellular glial calcium waves, and in the  regulation of a variety of Müller cell 
functions, particularly in the uptake and metabolism of amino acid neurotransmitters (Wurm 
et al., 2011; Bringmann et al., 2013). Many studies have provided functional evidence for 
P2X7R modulation of Müller cell inflammatory processes in retinal disease. In mammalian 
species, in the absence of inflammation, functional P2X7Rs have only been found on human 
Müller  cells  (Wurm  et  al.,  2011).  ATP-induced  P2X7R-mediated  large  inward  membrane 
53 
currents were potentiated in the absence of divalent cations, and were associated with the 
influx  of  calcium  (Pannicke  et  al.,  2000).  However,  prolonged  P2X7R  activation  did  not 
induce large pore formation (Pannicke et al., 2000), which is often characteristic of these 
receptors  under  conditions  of  inflammation.  Thus,  it  has  been  proposed  that  under 
physiological conditions, P2X7Rs on Müller cells may be associated with the increase in glial 
intracellular calcium, which occurs during light illumination (Pannicke et al., 2000; Wurm et 
al., 2011; Newman, 2005). 
 
 
The close anatomical proximity between Müller cell and neuronal processes in the retinal 
plexiform layers suggests a role for bi-directional purinergic signalling between Müller cells 
and neurons. Indeed, it has been demonstrated that ATP released by retinal ganglion and/or 
amacrine cells upon light stimulation, induces a reduction in Müller cell intracellular calcium 
waves, through the activation of glial P2 receptors  (Newman, 2005).  Furthermore, Müller 
cell-derived  ATP,  which  is  rapidly  degraded  to  adenosine,  has  shown  to  inhibit  retinal 
ganglion cell firing rate through the activation of A1 adenosine receptors and the opening of 
potassium channels  (Newman, 2003; 2004). Although this latter finding does not directly 
involve the activation of P2 receptors, it highlights a neuronal target of Müller cell-released 
ATP. It would be interesting to investigate whether ATP from Müller cells can be released at 
a sufficiently high concentration to evoke P2X7R activation on neighbouring neurons in the 
retina, under physiological conditions. 
 
 
Retinal astrocytes are largely restricted to the RGC axon-containing nerve fibre layer and are 
closely associated with retinal vasculature (see section 4.5.2.1) across the retinal surface 
and in the inner retinal layers (Newman, 2004). Although astrocytes are not thought to play a 
direct role in retinal neuromodulation, gap junctional coupling with Müller cells along with 
their role in controlling vascular tone in the retina may indirectly contribute to overall visual 
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function. Furthermore, the presence of P2X7Rs on retinal astrocytes is disputed, although 
modulation of Müller cell function may occur through the release of ATP or the propagation 
of  intracellular  calcium  waves  (Newman,  2004;  2005).  In  other  areas  of  the  CNS,  brain 
astrocytes have shown to release glutamate and other neurotransmitters on stimulation of 
P2X7Rs  (Sperlágh  et  al.,  2006),  and  thus  further  investigation  may  provide  clues  as  to 
whether the same may occur in the retina.  
 
 
4.4 P2X7R modulation of microglia in the retina 
P2X7Rs have been located on microglia in the mammalian retina, although they have been 
most extensively associated with inflammatory conditions and retinal disease (Innocenti et 
al., 2004; Franke et al., 2005). In recent years, much research has been conducted on the 
role  of  microglia  in  the  healthy  CNS.  Microglial  processes  are  highly  motile  and  the 
movement of their processes is tightly regulated by extracellular ATP/ADP balance (Davalos 
et al., 2005; Nimmerjahn et al., 2005; Gyoneva and Traynelis, 2013). Microglia express other 
P2Rs which are known to play an essential role in process  extension / retraction. Under 
conditions  of  high  neuronal  activity  within  the  visual  pathway,  microglial  processes  form 
close  contacts  with  synaptic  elements.  In  some  cases,  these  contacts  result  in  the 
modulation of neuronal activity (Wake et al., 2009; Tremblay et al., 2010; Li et al., 2012).  
 
The mechanism by which this modulation occurs is uncertain, but it has been suggested that 
microglia  may  release  various  neuroactive  substances  such  as  glycine  (Hayashi  et  al., 
2006).  Furthermore,  P2X7R-mediated  microvesicle  release  from  microglia  has  been 
characterised, and is thought to play a role in modulating synaptic efficacy under normal 
physiological conditions  (Turola et al., 2012). Most studies have been carried out  in the 
brain.  Retinal  microglia  have  shown  to  be  influenced  by  the  activation  and  blockade  of 
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various neurotransmitter receptors (Fontainhas et al., 2011), and thus are capable of being 
themselves, modulated  by  neuron-released  transmitters,  including  ATP.  The  evidence  of 
microglial-induced  fine-tuning  and  modulation  of  neuronal  synaptic  activity  in  the  brain 
strongly  supports  the  notion  that  this  may  also  occur  within  the  retina.  Microglia  are 
exclusively localised to the inner and outer plexiform layers within the normal adult mouse 
retina  (Santos  et  al.,  2008).  Thus,  microglial  processes  are  in  close  proximity  to  retinal 
synaptic  elements,  pointing  to  the  possibility  of  playing  a  genuine  role  in  retinal  visual 
processing by shaping and fine-tuning neuronal signalling. 
 
4.5 P2X7R in retinal pathology 
P2X7R  expression  is  known  to  be  significantly  upregulated  in  many  CNS  pathologies  in 
which microglial activation and proliferation are characteristic features (Monif et al., 2010). 
Although the function of P2X7Rs in pathology is heavily associated with the orchestration of 
the early microglial inflammatory response, these receptors are also known to directly co-
ordinate neuronal dysfunction and cell death. The following section highlights the current 
knowledge  of  the  role  of  P2X7R  in  neuronal  degeneration,  Müller  cell  dysfunction  and 
microglial activation under pathological  conditions in the mammalian retina. Furthermore, 
P2X7R-associated molecular mechanisms of inflammation in the retina are also discussed. 
 
4.5.1 Photoreceptor degeneration 
The enhancement of P2X7R expression and activation by extracellular ATP is associated 
with the elevation of intracellular calcium and subsequent photoreceptor and retinal ganglion  
cell  death,  thus  implicating  a  role  for  P2X7R  in  retinal  degenerations  such  as  retinitis 
pigmentosa, glaucoma, age-related macular degeneration (AMD) and retinopathies (Mitchell 
et al., 2009; Fletcher, 2010).  
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In the BALBCrds (retinal degeneration slow) mouse model of retinitis pigmentosa, P2X7R 
mRNA  and  protein  expression  were  enhanced  exclusively  on  neuronal  populations,  and 
absent  on  glial  cells.  Furthermore,  P2X7R  expression  peaked  during  the  stage  at  which 
photoreceptor degeneration was most pronounced, with P2X7R expression levels declining 
following neuronal loss (Franke et al., 2005). In line with this finding, intravitreal injection of 
high  extracellular  ATP  into  the  normal  adult  rat  eye  induced  extensive  apoptosis  of 
photoreceptors  with  severe  degeneration  of  the  outer  nuclear  layer  (Puthussery  and 
Fletcher,  2009).  These  morphological  changes  were  accompanied  by  an  irreversible 
reduction in the ERG a-wave amplitude, suggesting impairment in photoreceptor function. A 
follow-up study by the same group found that ATP had induced total photoreceptor loss by 
six  months  post-injection,  with  a  subsequent  remodelling  of  retinal  circuitry  through  the 
formation of new synapses, which is characteristic of various retinal degenerations including 
AMD (Vessey et al., 2014).  
 
Administration of the broad spectrum P2X antagonist, PPADS appeared to protect against 
the  ATP-induced  morphological  changes  in  the  normal  rat  retina,  and  also  augmented 
photoreceptor survival in the rd1 mouse model of retinitis pigmentosa, within the first week 
post-injection (Puthussery and Fletcher, 2009). However, it is still to be determined whether 
the administration of the P2XR antagonist also reverses the ATP-induced functional changes 
in  the  ERG  responses.  It  has  been  proposed  that  ATP  release  from  degenerating 
photoreceptors may exacerbate neuronal apoptosis through the activation of P2X7Rs and 
the subsequent elevation in intracellular calcium (Puthussery and Fletcher, 2009; Fletcher, 
2010; Vessey et al., 2012). Interestingly, within 3-min of intravitreal BzATP (a more potent 
P2X7R  agonist  than  ATP)  injection  into  the  rat  eye,  a  potentiation  in  the  ERG  a-wave 
amplitude was observed, an effect which is contrary to the ATP-induced functional changes 
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in the ERG a-wave (Puthussery et al., 2006; Puthussery and Fletcher, 2009), and thus puts 
into question the specific involvement of P2X7R in the latter model of retinal degeneration. 
However, this disparity may be due to the different intervals at which the ERG recordings 
were tested post-injection (BzATP: 3, 15 and 45 min; ATP: 1 and 5 days). Therefore, these 
findings reveal the possibility of differential time-dependant effects of P2X7R activation on 
retinal processing. It would be of much therapeutic interest to establish whether a selective 
P2X7R  antagonist  can  reverse  the  ATP-mediated  neurodegeneration  and  dysfunction  in 
such models  of  retinal  dystrophies,  as  well  as  the  early  functional  changes  seen  in  the 
BzATP-treated retina. 
 
Subretinal  haemorrhage  and  choroidal  neovascularisation  are  associated  with  severe 
photoreceptor degeneration in AMD. Extracellular ATP was found to be elevated in vitreous 
samples of AMD patients with subretinal haemorrhage, implicating a role for ATP-mediated 
retinal pathology (Notomi et al., 2013). In line with this notion, BzATP-mediated and BBG-
sensitive  P2X7R  activation  induced  significant  photoreceptor  cell  death  associated  with 
caspase-8 and -9 activation, in primary retinal cultures (Notomi et al., 2011). In an in vivo 
model of subretinal haemorrhage, extravascular blood injected into the subretinal space of 
the  mouse  eye  induced  photoreceptor  apoptosis,  which  was  markedly  reduced  in  the 
presence of BBG (Notomi et al., 2013). Retinal pigment epithelial cells are known to release 
ATP  into  the  subretinal  space,  and  therefore  may  contribute  to  the  ATP-mediated 
photoreceptor  degeneration  seen  in  several  pathologies  (Mitchell  and  Reigada,  2008). 
Additionally,  dysregulation  of  lysosomal  pH,  lipid  oxidation  and  impaired  phagosome 
clearance were triggered by P2X7R activation in cultured human RPE cells  (Guha et al., 
2013).  Furthermore,  cell  death  in  retinal  microvascular  cells  mediated  by  ATP-induced 
P2X7R activation, was associated with the concomitant activation of voltage-gated calcium 
channels  and  the  subsequent  lethal  elevation  of  intracellular  calcium  (Sugiyama  et  al., 
2005). Therefore, the activation of P2X7Rs in RPE cells and on retinal microvasculature may 
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also exacerbate the pathological microenvironment in the retina and lead to neuronal cell 
death. 
 
4.5.2 Retinal ganglion cell degeneration 
Retinal  ganglion  cells  are  distinctly  vulnerable  to  metabolic  disruptions,  often  leading  to 
selective and severe neuronal loss by apoptosis in diseases such as glaucoma and diabetic 
retinopathy (Križaj et al., 2013). The presence and activation of P2X7Rs on retinal ganglion 
cells  are  well  established  and  suggested  to  play  an  important  role  in  ganglion  cell 
degeneration. Several P2X7R-mediated mechanisms of ganglion cell dysfunction have been 
characterised  in  response  to  distinct  primary  triggers,  including  ATP-stimulated  lethal 
elevation  of  intracellular  calcium,  mechanical/pressure-induced  damage  and 
hypoxia/ischemia-associated cytokine release. 
 
 
ATP-induced increase in calcium permeability of retinal ganglion cell P2XRs was first shown 
in cultured rat RGCs (Taschenberger et al., 1999). Subsequently, it was shown that BzATP- 
and ATP-mediated P2X7R activation in isolated RGCs produced a large, sustained increase 
in calcium levels, which were blocked by BBG treatment (Zhang et al., 2005). Furthermore, 
treatment with either BBG or oxATP, but not suramin, inhibited the BzATP-induced, dose-
dependent increase in retinal ganglion cell death in vitro and in vivo (Zhang et al., 2005; Hu 
et al., 2010). The RGCs were impermeable to YO-PRO-1, suggesting that these cells were 
not associated with large pore formation, which is often seen in P2X7R-mediated apoptosis 
(Mitchell  et  al.,  2009).  These  findings  indicate  that  through  direct  ATP-mediated  P2X7R 
activation, retinal ganglion cells are readily permeable to calcium, which can rapidly lead to 
neuronal death through a large and sustained elevation in intracellular calcium. 
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Elevated  intraocular  pressure,  a  hallmark  of  glaucoma-associated  ganglion  cell 
degeneration, is known to induce a pathological increase in extracellular ATP in the aqueous 
humour of human patients with acute and chronic glaucoma (Zhang et al., 2007; Li et al., 
2011).  In  a  rat  model  of  experimentally  induced  pressure  damage,  degradation  of 
extracellular ATP or selective blockade of P2X7Rs with BBG, prevented pressure-induced 
ganglion cell membrane blebbing-associated damage (Resta et al., 2007). Furthermore, a 
rapid rise in IOP caused significant damage to these cells in vitro and in vivo, which was 
otherwise not seen in slow IOP elevation, suggesting that mechanisms of acute ganglion cell 
injury could differ from slow-developing chronic states of pathology (Resta et al., 2007). A 
pressure-dependent rise in extracellular ATP in the bovine retina was reduced by pannexin-1 
inhibitors, carbenoxolone and NPPB, suggesting that ATP release may be driven through 
pannexin-1 channels (Reigada et al., 2008). Indeed, mechanical deformation of isolated rat 
RGCs led to the release of ATP, which was sensitive to probenicid,  carbenoxolone and 
inhibitory peptide 
10Panx (Xia et al., 2012). Additionally, mechanical stretch and subsequent 
swelling of RGCs led to the activation of cationic membrane currents that were sensitive to 
the P2X7R antagonists A-438079, AZ-10606120 and zinc, and to inhibitors of panx-1. Thus, 
it was suggested that ATP released via pannexin hemichannels on damaged RGCs acts 
cell-autonomously  to  activate  P2X7  receptor-mediated  currents  in  an  autostimulatory 
feedback loop (Xia et al., 2012).  
 
 
P2X7R activation has also been linked to the release of pro-inflammatory mediators in retinal 
ganglion cell degeneration (Sugiyama et al., 2013). Following experimental IOP elevation in 
rats, retinal ganglion cell loss was ameliorated in the presence of the P2X7R antagonists 
OxATP and BBG. In addition, simultaneous upregulation of P2X7R and the cytokines IL-1β, 
TNFα and IL-6 were markedly suppressed in the presence of the antagonists (Sugiyama et 
al., 2013). Taken together, the results  of these studies suggest that under conditions  of 
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acute mechanical injury due to elevated IOP, panx-1-induced ATP release from damaged 
ganglion  cells  themselves  is  sufficiently  high  to  activate  P2X7Rs  and  drive  cell  damage, 
possibly  through  lethal  calcium  influx.  Furthermore,  the  exceptionally  close  link  between 
P2X7Rs  and  enhanced  cytokine  release  in  glaucoma  pathology  supports  the  notion  that 
P2X7R activation likely drives the upregulation of these mediators from surrounding glia, 
leading to a secondary inflammatory response that may exacerbate the condition. 
 
 
In addition to their involvement in acute mechanical stress, P2X7Rs have also been linked to 
dysregulation in retinal blood flow and subsequent ischemia, mechanisms associated with 
the pathogenesis of glaucoma. RGC loss due to simulated ischemia has shown to involve 
P2X7R activation in human organotypic retinal cultures (Niyadurupola et al., 2013). Selective 
P2X7R  blockade  by  BBG  attenuated  the  effect  of  RGC  degeneration  in  retinae  that 
underwent BzATP treatment or oxygen-glucose deprivation. P2X7Rs are expressed by glial 
cells and may have contributed to RGC loss in  this model. However, it was determined 
under normal conditions that the P2X7R expression pattern correlated with that of INL and 
GCL  molecular  markers  (Niyadurupola  et  al.,  2013).  Therefore,  although  the  indirect 
contribution of glial activation cannot be ruled out, a direct role of P2X7Rs in RGC death is 
also probable under ischemic conditions, in line with a mechanism demonstrated in other 
models of RGC damage and degeneration (Zhang et al., 2005; Xia et al., 2012). 
 
 
Hyperglycaemia and alterations in retinal vascular functions are major contributory factors to 
the development and progression of diabetic retinopathy-associated neuronal damage. High 
glucose conditions are known to enhance the release of extracellular ATP, which causes 
retinal neuronal death through P2XR-mediated lethal elevation of intracellular calcium (Costa 
et al., 2009; Oliveira Simões Pereira et al., 2010). Further to this, P2X7R activation induced 
pore formation and apoptosis of retinovascular cells, which was associated with an increase 
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in  intracellular  calcium,  in  hyperglycaemic  rat  retinae  (Sugiyama  et  al.,  2004,  2005). 
Intravitreal  injection  of  BzATP  into  the  healthy  rabbit  eye  caused  a marked  reduction  in 
retinal blood velocity. This effect was significantly enhanced in diabetic rabbits, and was 
accompanied by a considerable attenuation in the amplitudes of the ERG a- and b-waves 
(Sugiyama et al., 2006). It is clear from these findings that P2X7R-associated changes in 
retinal vascular function are key mechanisms involved in the disruption of visual processing 
in the retina. 
 
 
The release of ATP from glial cells and the subsequent purinergic control of vascular tone in 
the retina through the activation of P2X1 and P2Y4 receptors has also been demonstrated in 
the rodent (Kawamura et. al, 2003; Kur and Newman, 2014). This phenomenon, and those 
discussed above (Sugiyama et al., 2004, 2005), highlight the intimate relationship between 
the retinal microvasculature and cells of the retinal parenchyma. Control of vascular tone 
and maintenance of the blood-retinal barrier is mediated by the ‘neurovascular unit’ (NVU) – 
a  functional  unit  consisting  of  close  interactions  between  various  cell-types  including 
neuronal,  glial  and  vascular  endothelial  components  (Metea  and  Newman,  2007; 
Stanimirovic and Friedman, 2012). A change in vascular tone can significantly modulate the 
diameter of the blood vessels, and is therefore important in influencing the velocity of blood 
flow through the vasculature (Metea and Newman, 2007). As described above, changes in 
retinal blood velocity can contribute significantly to the disruption of neuronal function within 
the retina (Sugiyama et al., 2006). Furthermore, under pathological conditions, the loss of 
structural integrity of the NVU and resultant uncoupling of the cells are major contributory 
factors in the disruption of the blood retinal barrier, and can lead to a large increase in the 
permeability to serum proteins and fluid, initiating an inflammatory response within the retina 
(Stanimirovic  and  Friedman,  2012).  The  upregulation  and  recruitment  of  inflammatory 
mediators may lead to a secondary injury and therefore contribute to retinal ganglion cell 
death. Thus, P2X7R may also modulate neuronal function and viability through the indirect 
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control of retinal blood flow, by facilitating local ATP release, and subsequent purinergic 
control of vascular tone.  
 
4.5.3 Müller cell P2X7R 
Functional changes in Müller cells are characteristic of P2X7R-associated mechanisms in 
glaucoma,  retinal  ischemia  and diabetic  retinopathy  (Bringmann  and Wiedemann,  2012). 
Under  pathological  conditions,  reactive  Müller  cells  are  pivotal  in  the  generation  of 
neuroprotective  adenosine  from  extracellular  ATP,  by  upregulating  the  release  of 
ectonucleotidases  (Iandiev  et  al.,  2007).  Accordingly,  high  extracellular  ATP  and  P2X7R 
activation  are  known  to  play  a  significant  role  the  proliferation  of  Müller  cells.  BzATP-
stimulation  of  isolated  human  Müller  cells  evoked  a  P2X7R-mediated  rise  in  intracellular 
calcium,  which  was  coupled  with  the  activation  of  large  conductance  Ca
2+  -activated  K
+ 
channel  (BK)  currents.  Furthermore,  Müller  cells  from  patients  with  proliferative 
vitreoretinopathy  demonstrated  significantly  larger  BK  and  P2X7R    cation  currents 
(Bringmann  et  al.,  2001).  These  findings  support  the  notion  that  an  increase  in  P2X7R 
expression in proliferative disease elevates intracellular calcium and subsequently promotes 
larger  BK  conductances,  which  drive  Müller  cell  proliferation  (Bringmann  et  al.,  2001; 
Bringmann  and  Wiedemann,  2012).  In  line  with  this,  an  upregulation  of  P2X7R  cation 
currents is correlated with the downregulation of inwardly rectifying potassium channel (Kir) 
currents in Müller cells from patients with proliferative diabetic retinopathy (Bringmann et al., 
2002). Thus, a shift in potassium homeostasis triggered by  P2X7Rs promotes Müller cell 
activation and proliferation under pathological conditions, and the promotion of inflammation 
(Pannicke  et  al.,  2005).  Furthermore,  glutamate  uptake  currents  were  diminished  in  the 
presence  of  BzATP,  an  effect  which  was  suppressed  by  KN-62,  in  human  Müller  cells 
(Pannicke et al., 2000; Bringmann et al., 2013). Therefore, P2X7R activation also disrupts 
Müller  cell  glutamate  uptake,  which  likely  contributes  to  excitotoxicity,  cell  swelling  and 
63 
apoptosis under pathological conditions in the retina. In cultured rat  Müller cells, elevated 
glucose conditions increased P2X7R mRNA, although the receptor protein or function were 
not detected in these cells (Trueblood et al., 2011).  
 
4.5.4 Microglial P2X7R 
Microglia act as crucial sensors for pathological disturbances within the neural parenchyma 
(Kreutzberg, 1996). The activation and proliferation of microglia are characteristic features of 
almost all forms of trauma, stress and neurodegenerative conditions in the CNS (Monif et al., 
2010). Furthermore, the concurrent upregulation of P2X7Rs on microglia under pathological 
conditions  has  led  to  the  widely  held  notion  that  early  immune  responses generated  by 
activated microglia are primarily driven through P2X7R activation (Ferrari et al., 2006; Monif 
et al., 2010). Extracellular ATP, released by surrounding stressed or injured neurons acts as 
a ‘danger’ signal to induce the activation and proliferation of these cells, which undergo rapid 
morphological and functional changes in graded responses (Raivich et al., 1999; Streit et al., 
1999). Thus, delineating the morphological features of these cells can provide compelling 
insight  into  their  functional  behaviour.  Microglia  are  highly  ramified  in  structure,  with 
numerous  processes  when  in  their  ‘resting’  state,  but  are  far  from  quiescent  as  they 
constantly monitor neuronal synapses in their locality. Activated microglia typically take on 
an amoeboid appearance, with few or no processes, and have the capacity to secrete a vast 
array  of  molecular  signals,  including  cytokines,  chemokines,  ATP  and  reactive  oxygen 
species,  all  of  which  trigger  further  inflammatory  cascades.  These  activated  microglia 
proliferate and migrate to the site of cellular stress, and provide imperative trophic support to 
the  injured  neuron,  in  addition  to  phagocytosing  surrounding  cellular  debris.  Activated 
microglia  are  notoriously  associated  with  the  secretion  of  ATP  and  pro-inflammatory 
cytokines  such  as  interleukin-1β  (IL-1β),  tumour  necrosis  factor-α  (TNFα)  and  colony-
stimulating  factors  (CSF),  which  in  turn  are  linked  with  mediating  cell  death  through 
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apoptosis. Depending on the extent of cellular stress within the microenvironment, these 
inflammatory phenomena may eventually lead to either the recovery of neuronal integrity, or 
drive the progression towards the onset of secondary injury responses (Raivich et al., 1999; 
Streit et al., 1999). 
 
Selective  blockade  of  P2X7Rs  and  subsequent  suppression  of  microglial  activation,  has 
proven  effective  in  reducing  the  severity  of  neuronal  dysfunction,  degeneration  and 
promoting recovery in in vivo models of spinal cord injury (Wang et al., 2004; Peng et al., 
2009), mechanical injury in the nucleus accumbens (Franke et al., 2007), amyotrophic lateral 
sclerosis (D’Ambrosi et al., 2009), epilepsy (Vianna et al., 2002; Avignone et al., 2008) and 
Parkinson’s  disease  (Marcellino  et  al.,  2010).  P2X7R-mediated  microglial  release  of 
inflammatory  molecules  and  reactive  oxygen  species  has  also  been  implicated  in  the 
pathogenesis of Alzheimer’s disease (Parvathenani et al., 2003; Mclarnon et al., 2006; Sanz 
et al., 2009), neuropathic pain and hyperalgesia (Chessell et al., 2005; Honore et al., 2006; 
McGaraughty et al., 2007; Clark et al., 2010; Teixeira et al., 2010). 
 
As  in  other  areas  of  the  CNS,  microglial  activation  and  inflammation  are  concurrent 
phenomena in many retinal and ocular pathologies including photoreceptor dystrophy, AMD, 
acute  retinal  trauma,  optic  nerve  transection,  glaucoma,  uveitis,  diabetic  retinopathy  and 
proliferative vitreoretinopathy (Chen et al., 2002; Langmann, 2007). Although a significant 
body of evidence suggests a pathological role for P2X7R activation in microglia of the brain 
and spinal cord,  investigations into the role of P2X7R in retinal microglia are still in their 
infancy, and thus it remains poorly understood. 
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In  the  rat  retina,  P2X7R  activation  induced  pore  formation  exclusively  in  microglia.  High 
extracellular ATP or BzATP concentrations led to YO-PRO-1 accumulation in these cells, but 
not in retinal ganglion or Müller cells in the ganglion cell and nerve fibre layers, an effect 
which was attenuated with selective P2X7R blockade (Innocenti et al., 2004). This finding 
suggests  that  P2X7R-induced  pore  formation  is  microglia-specific,  and  likely  plays  an 
important  role  in  the  microglial  inflammatory  response.  Additionally,    under  hypoxic 
conditions, BzATP enhanced the release of the pro-inflammatory cytokines IL-1β and TNFα 
in cultured rat retinal microglia (Morigiwa et al., 2000). Under hyperglycaemic conditions, 
high ATP or BzATP concentrations induced calcium influx through unspecified P2XRs in 
cultured  microglia  (Oliveira  Simões  Pereira  et  al.,  2010).  Selective  inhibition  of  P2X7Rs 
suppressed the release of IL-1β, IL-6 and TNFα, and subsequently reduced retinal ganglion 
cell neurodegeneration in a rat model of elevated IOP (Sugiyama et al., 2013). It was not 
clear in this study whether these neuroprotective effects were exerted through the direct 
blockade of P2X7Rs on retinal ganglion cells, or indirectly through inhibition of microglial 
activation. 
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Figure  4.1  Distribution  of  P2X7Rs  in  the  mouse  retina.  Transverse  retinal  section 
immunolabelled  for  the  P2X7R  N-terminal,  in  the  wild  type  mouse.  P2X7R 
immunoreactivity is most prominent in the outer and inner plexiform layers, inner nuclear 
layer and ganglion cell layer. The punctate structures indicate that P2X7Rs are present at 
synapses and may therefore regulate synaptic function. The ganglion cell layer and the 
proximal  region  of  the  inner  nuclear  layer  show  P2X7R  immunolabelling  in  soma-like 
structures, suggestive of their expression on neuronal cell bodies, as well as on neurites. 
ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform  layer;  GCL,  ganglion  cell  layer.  Figure  adapted  from  Vessey  and  Fletcher 
(2012).  
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Chapter 5 
Project Hypothesis 
 
ATP-gated P2X7Rs have been specifically localised to synapses within the rod pathway of 
the mammalian retina. In the healthy rodent, in vivo electroretinogram (ERG) studies have 
shown  alterations  to  both  outer  and  inner  retinal  function,  in  response  to  short-term 
administration of the P2XR agonist, BzATP (Puthussery and Fletcher, 2004; Puthussery et 
al., 2006; Vessey and Fletcher, 2012). However, the specific contribution of P2X7Rs to the 
BzATP-mediated modulation of retinal function remains elusive. A further complexity that 
P2X7Rs are distributed throughout all layers of the retina, adds to the uncertainty of the 
specific  site(s)  of  action  for  these  receptors  in  modulating  neurotransmission  within  the 
retina. In line with this notion, it is unclear from the sole use of ERG recordings, whether 
P2X7Rs also directly modulate retinal ganglion cell synaptic function.  
 
Using a dark-adapted ex vivo mouse retinal wholemount preparation to record extracellular, 
light-evoked  transretinal  ERG  responses,  and  ON  and  OFF  RGC  excitatory  synaptic 
responses,  and  with  the  use  of  selective  P2X7R  antagonists,  the  present  investigation 
sought to address the following questions: 
 
  Do  P2X7Rs  modulate  signal  transmission  at  the  photoreceptor-ON  bipolar  cell 
synapse? 
 
  Is retinal ganglion cell function within both the ON and OFF pathways modulated by 
P2X7R activation? 
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  Are the effects of P2X7R activation in the inner retina driven by their action in the 
outer  retina,  or  do  these  receptors  have  cell-specific  and  distinct  mechanisms  of 
action? 
 
P2X7Rs are also expressed on retinal microglia (Innocenti et al., 2004; Franke et al., 2005), 
and  are  known  to  drive  microglial  activation  and  the  release  of  inflammatory  mediators 
associated with the early host-response to stressors in the microenvironment (Monif et al., 
2010). Growing evidence supports the notion that purinergic signalling coordinates resting 
microglia  to  play  a  genuine  role  in  fine-tuning  synapses  and  modulating  neuronal 
transmission in the healthy central nervous system (Nimmerjahn et al., 2005; Tremblay et 
al., 2010; Pascual et al., 2011). In the adult mouse retina, microglia are exclusively localised 
to the synapse-rich outer and inner plexiform layers, under physiological conditions (Santos 
et al., 2008). Retinal microglia have shown to undergo rapid morphological and functional 
alterations in response to various neurotransmitters (Fontainhas et al., 2011). However, their 
specific contribution to synaptic signalling in the healthy retina remains elusive. In light of 
this, the present investigation sought to explore the following questions:  
 
  Does early microglial activation modulate signal transmission at the photoreceptor-
ON bipolar cell synapse? 
 
  Is retinal ganglion cell function within both the ON and OFF pathways modulated by 
early microglial activation? 
 
  Does  the  microglial-mediated  mechanism  of  neuromodulation  specifically  involve 
P2X7Rs? 
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Chapter 6 
Materials and Methods 
 
To  investigate  effects  on  outer  and  inner  retinal  synaptic  function,  transretinal 
electroretinogram (ERG) or ON and OFF field excitatory postsynaptic potentials (fEPSPs) 
were recorded from dark-adapted ex vivo mouse retinae, in response to a single flash of light 
repeated  at  regular  intervals.  Pharmacological  compounds  were  applied  to  the  bathing 
medium, which continuously superfused the slice preparation through the course of each 
experiment.  The  effect  of  pharmacological  compounds  on  microglial  morphology  was 
assessed  using  a  combination  of  immunofluorescence  staining,  laser  scanning  confocal 
microscopy and morphometric analysis. Unless otherwise stated, all procedures during the 
pharmacological experiments were carried out in low-light conditions and red light was used 
for illumination. 
 
The use of the acutely  isolated (ex vivo) retinal preparation of the mouse, employed for 
these investigations provides many advantages over experimentation in vivo. The laminar 
structure  of  the  retinal  circuitry  remains  relatively  intact  with  minimal  effect  to  its  overall 
structural integrity, in the isolated retina. Therefore, its full repertoire of afferent inputs from 
the outer to  inner retinal  layers remains unaltered, enabling the use of relatively natural 
photostimulation  of  neuronal  responses.  The  isolated  retina  facilitates  pharmacological 
isolation and investigation of specific retinal circuitry, and also obviates the requirement for 
anaesthesia  of  the  animal,  which  may  otherwise  confound  observations.  Further 
considerations which favour this preparation include the relative ease of control over drug 
application and modification of the extracellular milieu, as well as the viability of the tissue, 
rendering stable responses to be recorded over duration of up to 6 hours.  
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The  investigation  of  RGC  responses  in  vivo  is  usually  limited  to  the  recording  of  signal 
transduction  to  the  brain,  along  the  optic  tract.  The  isolated  retina  enables  deeper 
exploration of mechanisms associated with the generation of RGC responses in the inner 
retina. The main disadvantage in using the ex vivo preparation is that the observations are 
limited to, and may reflect the artificial conditions of the experiment. In this respect, the use 
of in vivo recordings may instead provide a better understanding of physiological function in 
the intact animal. Additionally, the isolated retina lacks the natural optics of the intact eye, 
which could obscure the response properties of neurons when compared to those in vivo. 
However, there is a high degree of similarity in the response properties between transretinal 
ex vivo and corneal in vivo ERGs, which supports the use of the isolated retinal preparation 
as a valuable tool for the present investigation. 
 
Purinergic signalling and other mediators released as a result of microglial activation are 
important for the recruitment of blood-borne monocytesand leukocytes, under inflammatory 
conditions. Thus, the isolated nature of this retinal preparation is particularly advantageous 
for  this  study,  as  it  would  enable  the  investigation  of  purinergic  modulation  of  retinal 
microglia and neuronal activity, in the absence of possible systemic influences.  
 
For both electrophysiological and microglial investigations, the protocols for preparation of 
the  retinal  wholemount  and  setup  of  the  perfusion  chamber  were  the  same.  The 
experimental procedures for all experiments are as follows. 
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6.1 Animals 
Adult (4-12 weeks) male and female C57BL/6 mice (Harlan Laboratories) were housed on a 
12-hour  light/dark  cycle,  in  the  Biological  Resources  Unit,  Institute  of  Ophthalmology, 
University College London. The animals were given unlimited access to food and water. All 
procedures were in accordance with the UK Animals (Scientific Procedures) Act 1986, and 
approved by the UK Home Office and the University College London local ethics committee. 
 
6.2 Preparation of the ex vivo mouse retinal wholemount 
Animals were killed by cervical dislocation and decapitation. The eyes were rapidly removed 
and  placed  into  an  ice-cold,  oxygenated  high-sucrose  Krebs’  medium  devoid  of  sodium 
chloride, containing (mM): sucrose 202, KCl 2, KH2PO4 1.25, MgSO4 10, CaCl2 0.5, NaHCO3 
26, glucose 10. The eyes were placed in a Petri dish containing sucrose Krebs’ medium, 
under  a  dissection  microscope  and  red  light  was  used  for  illumination.  In  order  for  the 
wholemount to lie flat, the optic nerve and extra-ocular muscle tissue were removed from the 
sclera. Using forceps and a small needle, a cut was made at the ora serrata, and the cornea 
and iris were removed with micro-scissors. This was followed by the removal of the lens and 
vitreous, by gently but swiftly pulling them away from the retina, leaving the open eye-cup, 
consisting of the intact retina, retinal pigment epithelium and sclera. The eye-cup was cut 
into quadrants to allow it to lie flat, as a wholemount preparation, with the integrity of the 
retinal circuitry maintained. 
 
During  the  isolation  of  the  eye-cup,  every  effort  was  made  to  ensure  minimal  contact 
between  the  dissection  instruments  and  the  retina.  It  was  extremely  important  to  limit 
mechanical  trauma  to  the  retina  in  order  to  avoid  any  potential  microglial  activation  or 
inflammation which may have otherwise arisen. Furthermore, the intact RPE layer ensured 
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that  regeneration  of  the  photopigment  was  sustained  throughout  the  course  of  the 
experiments, which helped to maintain stability of the responses. 
 
6.3 Perfusion / recording chamber 
The  retinal  wholemount,  ganglion  cell  layer  side  up,  was  transferred  to  a  blacked-out, 
oxygenated (95% O2, 5% CO2; BOC) interface recording chamber within a Faraday cage, 
set  on  top  of  an  air-filled  anti-vibration  table.  The  retina  was  held  partially  submerged 
between tissue paper and a nylon liner placed over the top, to direct the flow of fluid, with the 
gas flowing over the top. The slice was superfused with O2/CO2 Krebs’ medium containing 
(mM): NaCl 124, KCl 2, KH2PO4 1.25, MgSO4 1, CaCl2 2, NaHCO3 26, glucose 10. The 
perfusion was carried out using a Minipuls3 Gilson pump at a flow rate of 0.4ml/min. A 
constant temperature of 36±0.2°C was maintained using a water bath (Grant Instruments) to 
heat the perfusion medium, and a heating mat contained within the recording chamber. The 
retina was allowed to recover for approximately 60 minutes prior to experimentation. 
 
The particular conditions employed for these experiments were chosen and optimised to 
ensure the maintenance of a relatively homeostatic environment for the retinal preparation. 
Previous studies on isolated retinal wholemounts have shown that temperature changes, or 
any deviation in  ionic and metabolite composition, and pH of the extracellular  perfusate, 
induces alterations in retinal function, as assessed by transretinal ERG recordings (Winkler, 
1972, 1973). Thus, the composition of the Krebs’ medium ensured the proper function of the 
isolated retinal tissue. Furthermore, microglia in isolated retinal wholemount preparations are 
temperature-sensitive (Opie et al., 2012). Thus, the temperature was optimised to maintain 
proper function of all retinal cell-types.  
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6.4 Electrophysiology 
The  same  protocols  were  followed  for  acquisition  and  pharmacological  investigations  of 
transretinal ERG and RGC fEPSP responses, unless otherwise stated. Differences in the 
recording electrodes and sensory stimulation protocols are highlighted where appropriate.  
 
6.4.1 Recording electrode and response acquisition 
Extracellular  recording  electrodes  were  pulled  from  borosilicate  glass  capillaries 
(1.2x0.69mm,  Clark  Electromedical  Instruments)  using  a  horizontal  P97  Flaming/Brown 
micropipette  puller  (Sutter  Instruments).  The  electrodes  were  filled  with  normal  Krebs’ 
medium (see above for composition), with an impedance of 2 - 8 MΩ for both ERG and RGC 
fEPSP recordings. An Ag - AgCl pellet submerged in a well and connected to the recording 
chamber was used as a reference electrode. The recording electrode was fitted into an 
electrode holder, filled with 1M NaCl, and attached to an HS2 headstage (Axon Instruments). 
Responses were amplified and low pass filtered (1 kHz) with an Axoprobe-1A multipurpose 
microelectrode amplifier (Axon Instruments), digitised (5 kHz) via a CED1401 interface, and 
stored on a computer with Spike2 software (Cambridge Electronic Design Ltd., Cambridge, 
UK). Mains-related noise was eliminated (50/60 Hz) with a Humbug noise reduction system 
(Quest Scientific). 
 
The  headstage  was  connected  to  an  electronic  micromanipulator  (MS314,  Marzhauser-
Wetzier), allowing the recording electrode to be moved in the x-, y- and z-axis planes. To 
obtain transretinal ERG responses, the recording electrode was manually lowered onto the 
surface  of  the  retinal  wholemount,  without  breaking  into  the  retinal  layers.  For  retinal 
ganglion cell fEPSP acquisition, the electronic micromanipulator was used to further lower 
the electrode vertically (along the z-axis), from the surface of the wholemount in 5 – 10 μm 
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steps, at a rate of 1μm/step, every 10-15s until break-through to the ganglion cell layer, 
where recordings were obtained. Fig. 6.1 illustrates the positions of the recording electrodes 
for acquisition of ERG and fEPSP responses.  
 
6.4.2 Visual stimulation of responses 
The  retinal  wholemount  was  stimulated  with  a  full-field,  green  light-emitting  diode  (LED; 
λ=562nm) set approximately 2 cm above the preparation, and co-ordinated by a Master-8 
pulse generator. ERG responses were stimulated with a 10 ms - duration flash, repeated 
every 3 sec. RGC fEPSPs were stimulated with a 1 sec - duration flash, repeated every 3 
sec.  
 
Upon stimulation, the transretinal ERG exhibited a characteristic waveform, composed of the 
negative  a-wave,  a  prominent,  and  large-amplitude  positive  b-wave,  and  oscillatory 
potentials  superimposed  on  the  leading  edge  of  the  b-wave.  For  the  RGC  fEPSP 
experiments, the onset and termination of the light stimulus produced negative ON- and 
OFF-  RGC  fEPSPs,  respectively.  Depending  on  the  nature  of  the  recordings  (ERG  or 
fEPSPs),  the  presence  of  the  characteristic  components  of  the  waveforms  was  used  to 
determine  the  viability  of  the  retinal  wholemount  preparation.  Light  intensity-response 
functions were investigated for both ERG and fEPSP responses, and were used to establish 
the light intensity at which a sub-maximal response was induced. At the beginning of each 
experiment, the flash intensity was set to -2.32 log cd.s/m
2, and was increased with 15 sec-
duration  intervals,  until  the  maximum  intensity  (-0.54  log  cd.s/m
2)  was  reached.  Light 
intensity-response functions were carried out at least twice more on one preparation, prior to 
the application of an investigative pharmacological compound, in order to test the viability of 
the retinal wholemount. The preparation was considered viable if  sub-maximal responses 
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were observed between the typical stimulus range of -1.47 and -0.96 log cd.s/m
2 (see figs. 
7.2 and 7.6). 
 
6.4.3 Application of drugs 
In  all  experiments,  the  retinal  preparation  was  allowed  to  recover  in  Krebs’  medium  for 
approximately 60 min. Some ERG experiments were carried out in this medium. For some 
ERG and all RGC fEPSP experiments, consistency in recording conditions was maintained 
using a Krebs’ medium, which was modified to isolate and enhance the NMDA-mediated 
component of the ON and OFF RGC fEPSPs. The solution (hereafter referred to as PMSTN) 
was composed of (mM): NaCl 124, KCl 2, KH2PO4 1.25, CaCl2 2, NaHCO3 26, glucose 10, 
NBQX 0.01, picrotoxin 0.1, strychnine 0.005, tetrodotoxin 0.0001. Magnesium ions were not 
present in the PMSTN medium to remove blockade of NMDA receptors, and thus enhance 
the  NMDA  receptor-mediated  component.  AMPA,  GABAA/C  and  glycine  receptors,  and 
sodium  channels  were  blocked  with  NBQX,  picrotoxin,  strychnine  and  tetrodotoxin, 
respectively.  
 
For  all  experiments,  the  stimulus  was  set  at  a  light  intensity  that  elicited  sub-maximal 
responses. All test compounds were prepared in dH2O (unless otherwise stated), and added 
to  the  bathing  medium  at  known  concentrations.  Table  6.1  shows  all  pharmacological 
compounds used in this study. The protocols for order and duration of drug application in 
specific  investigations  are  as  follow.  Differences  in  protocols  for  ERG  and  RGC  fEPSP 
experiments are highlighted where necessary. 
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6.4.3.1 L-AP4 
The group III metabotropic glutamate receptor agonist, L-2-amino-4-phosphonobutyric acid 
(L-AP4) was tested on both ERG and RGC fEPSP responses. All L-AP4 experiments were 
carried out in PMSTN bathing medium. For ERG experiments, L-AP4 (50 μM) was applied 
for  5  min.  For  the  RGC  fEPSP  dose-response  investigation,  L-AP4  was  tested  at 
concentrations of 10, 20, and 50 μM, applied cumulatively. In some experiments, 5 and 100 
μM doses were also tested. Each application was 10 min in duration. At the beginning or end 
of some experiments, L-AP4 (50 μM) was applied for 5 min, to verify retinal function and 
assess drug access to the wholemount.  
 
6.4.3.2 Purinergic agonists, P2X7R antagonists and LPS 
The effect of BzATP on the ERG was tested in normal Krebs’ perfusate, and in the absence 
of extracellular magnesium ions. In these experiments, BzATP was applied for 10 min. For 
the dose-response investigation of BzATP on ON and OFF RGC fEPSPs, no more than two 
applications of BzATP were used on one preparation, regardless of concentration. The same 
protocol  was  followed  for  the  dose-response  investigation  of  adenosine  on  RGC  fEPSP 
responses. 
 
The protocol for investigating the effect of BzATP in the presence of the P2X7R antagonist 
A438079  was  the  same  for  ERG  and  RGC  fEPSP  experiments.  BzATP  (300  μM)  was 
applied to PMSTN medium for 10 min, followed by a 30 – 40 min washout period. A438079 
was then added to the medium and allowed to superfuse the retina until a stable response 
was reached (~ 20 – 30 min). BzATP was then co-applied with the antagonist-containing 
medium.  In  separate  experiments,  the  effect  of  the  P2X7R  antagonists  A804598  and 
AF27139 (both prepared in DMSO) on the BzATP-mediated effect on RGC fEPSPs, were 
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tested using the same protocol as for A438079. As a control, DMSO (0.1%) was added to 
the PMSTN medium, in these experiments.  
 
For both ERG and RGC fEPSP experiments, LPS (10 μg/ml) was applied for 15 min to the 
perfusate. To investigate the involvement of P2X7Rs, A438079 was applied for ~20 – 30 min 
prior to a 15 min LPS application, in separate experiments. 
 
6.4.3.3 D-AP5 and P2XR antagonists 
The effect of the NMDA receptor antagonist, D-2-amino-5-phosphonopentanoic acid (D-AP5) 
was  tested  on  the  ON  and  OFF  RGC  fEPSPs.  D-AP5  was  applied  for  10  min  at  a 
concentration of 100 μM, which isolated a small residual fraction of the excitatory response. 
In separate experiments, D-AP5 (100 μM) was applied 10 min before the addition of suramin 
(100 μM), PPADS (100 μM) or A438079 (10 μM). Each P2XR antagonist was superfused for 
approximately 10 min, in the presence of D-AP5, prior to washout. 
 
6.4.4 Digital filtering and analysis of ERG components 
The ERG traces were analysed offline using Spike2 software (Cambridge Electronic Design, 
UK). Waveforms were initially low-pass filtered (< 250 Hz) to reduce contamination of the 
signal by high frequency noise. A secondary low-pass filter (< 15 Hz) was applied to isolate 
a smoothed ERG and eliminate the oscillatory potentials. Fig. 6.2 shows no overall distortion 
in the power spectra or waveforms of the low-frequency ERG components (a-wave and b-
wave), following two orders of low-pass filtering. The smoothed waveform ensured accurate 
measurement of the a-wave slope and b-wave amplitude without contamination from the 
oscillatory potentials.  
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The slope of the a-wave, which reflects photoreceptor activity (Hood and Birch, 1990), was 
measured between the onset and peak of the a-wave. The b-wave peak amplitude, was 
measured from the peak of the a-wave to half the recovery phase of the b-wave, and is 
known to reflect ON-bipolar cell function (Stockton and Slaughter, 1989) (fig. 6.3). Sweeps 
were analysed by averaging these parameters over 60 sec, throughout the time-course of 
the experiment. Drug effects on both response components were measured by calculating 
the mean±SEM percentage change in the measured parameters (slope / amplitude), relative 
to control values. The implicit time of the b-wave, in particular, can provide a measure of 
photoreceptor sensitivity, whereas possible contamination of the a-wave by the onset of the 
b-wave must also be considered during analysis of the kinetics of these ERG components 
(Hood and Birch,  1992).  The  latencies were  calculated  from  stimulus  onset  to the  peak 
amplitudes of the a-wave or b-wave, and values are shown as mean±SEM implicit time (fig. 
6.3).  For  light  intensity-response  experiments,  sweeps  were  analysed  over  15  sec,  and 
mean±SEM a-wave slope, b-wave amplitude values, or implicit times were calculated and 
plotted as a function of stimulus intensity. 
 
Oscillatory  potentials  were  analysed  in  the  frequency  domain.  These  high-frequency 
wavelets  are  believed  to  reflect  inner  retinal  network  function,  particularly  the  activity  of 
amacrine and ganglion cells (Wachtmeister, 1998). A secondary high pass filter (> 60 Hz) 
was applied to isolate the oscillatory potentials from the first filtered waveform, as shown in 
fig. 6.2 The oscillatory potentials exhibited a peak frequency of ~ 90  – 110 Hz, which is 
comparable to that of dark-adapted mouse ERGs, in vivo (Zhang et al., 2007). A fast Fourier 
transform was used to derive the power spectrum of the oscillatory potentials, from stimulus 
onset to the half-width of the b-wave recovery phase (~ 240 ms) (fig. 6.3). To analyse drug 
effects, average spectra were generated 120 sec before, during and after drug application, 
and the mean±SEM percentage change in peak power was compared with control values. 
For light intensity-response experiments, averaged (15 sec) power spectra were generated 
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for  each  flash  intensity  tested,  and  the peak  power  was measured.  Data  are plotted  as 
mean±SEM peak power as a function of stimulus intensity. 
 
6.4.5 Analysis of ON and OFF RGC fEPSPs 
ON  and  OFF  RGC  fEPSP  traces  were  also  analysed  offline  using  Spike2  software 
(Cambridge Electronic Design, UK). Responses were visualised as 3-second ‘sweeps’, each 
of which consisted of an ON and an OFF response. Sweeps were analysed by measuring 
the average amplitude of ON and OFF fEPSPs over 60 sec, throughout the time-course of 
the  experiment  (fig.  6.4).  The  effect  of  pharmacological  agents  on  the  ON  and  OFF 
responses  was  measured  by  calculating  the  mean±SEM  percentage  change  in  fEPSP 
amplitude, compared with control values. For light intensity-response experiments, sweeps 
were  analysed  over  15  sec, and  mean±SEM  ON  or  OFF  fEPSP  amplitude values  were 
calculated and plotted as a function of stimulus intensity. 
 
6.4.6 Statistical analysis 
Data  were  imported  from  Spike2  to  Excel  (Microsoft,  USA)  for  analysis  and  generating 
graphs.  Statistical  testing  was  carried  out  using  GraphPad  Prism  (v.6  for Windows,  CA, 
USA). A two-way analysis of variance (ANOVA) was used to analyse light intensity-response 
curves  by  comparing  values  at  each  flash  intensity,  between  conditions.  This  particular 
statistical test was selected as it was considered the most appropriate to evaluate the effect 
of two independent variables on the given waveform parameter (dependent variable). For 
comparisons between baseline and drug effect on the responses, statistical significance was 
established  using  the Wilcoxon’s matched-pairs  test.  In  these comparisons, values  were 
expressed  as  percentages  of  control  and  were  therefore  paired  samples.  This  non-
parametric test was used in this case as it does not require assumptions to be made of the 
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distribution of the data, and was the most appropriate to handle paired values. Comparisons 
between treatment groups were carried out using the non-parametric Mann-Whitney test, 
which was considered the most useful test to compare independent samples, in this study. 
For all tests, statistical significance was observed if P < 0.05. 
 
6.5 Microglia investigations 
Alterations in retinal microglial morphology as a result of specific pharmacological conditions 
were analysed. The experimental protocols are as follow.  
 
6.5.1 Pharmacological investigation protocols 
Retinal wholemounts were prepared and transferred to the perfusion chamber following the 
protocols as described above (section 6.4.3). Recording electrodes were not used in these 
investigations. For each experiment, two retinae were placed adjacently in the bath, leaving 
~ 5 mm gap between them to ensure they did not come into contact with each other during 
the course of the experiment. The nylon liner placed over the top of the retinae was adjusted 
to direct fluid flow over both preparations.  
 
6.5.2 Immunofluorescence staining protocol 
At  the  end  of  each  experiment,  the  nylon  liner  was  removed  using  forceps,  swiftly  and 
carefully. To prevent movement or displacement of the retinal preparation during transfer, 
the top quarter of the tissue paper was cut and divided into two sections, each holding one 
retina. Each section (tissue paper and retina) was  then placed in 4% paraformaldehyde 
(PFA) / 1 X phosphate buffer saline (PBS) in a 48-well plate. The tissue paper was removed 
from the wells, and the plate was covered in foil to ensure maintenance of dark-adapted 
82 
conditions  during  a  30  min  fixing  period,  at  room  temperature.  Under  a  dissecting 
microscope and in 1XPBS, the sclera was removed from each preparation. Any remaining 
RPE cells and debris were brushed off. The isolated retina was then re-fixed in the well plate 
for 10 min. The retina was then transferred to a vial. The following wash and incubation 
steps were carried out using a rotator to evoke gentle agitation, unless otherwise stated. The 
retina  underwent  3  X  15  min  washes  in  1XPBS.  This  was  followed  by  incubation  with 
blocking buffer (1% bovine serum albumin, 5% goat serum, 0.3% Triton X-100, made up in 
1XPBS), for 60 min at room temperature.  
 
To stain for microglia, the retinal wholemount was incubated in anti-mouse IBA1 antibody 
(1/800; rabbit monoclonal, WAKO, Germany) diluted in blocking buffer for 48 hr, at 4°C. For 
immunofluorescence labelling of microglial cells, the retina was first rinsed in 1xPBS for 3 X 
15  min,  and  then  incubated  in  Alexa488-conjugated  anti-rabbit  IgG  (1/400;  goat,  Vector 
Labs, UK) diluted in 1xPBS, at room temperature. The retina was then rinsed in 1xPBS for 3 
X 15 min, incubated in DAPI (300 nM, in 1XPBS, 5 min; Life Technologies, UK), followed by 
a  final  3  X  15  min  wash  in  1XPBS.  After  labelling,  retinae  were  flattened  and  mounted 
ganglion  cell  side  up,  on  wholemount  glass  microscope  sides  in  fluorescence  mounting 
medium (Vectashield, Vector Labs, UK), and coverslipped.  
 
An  antibody  against  the  IBA-1  (ionised  calcium  binding  adaptor  molecule-1)  molecular 
marker  was  chosen  for  this  study,  as  it  is  specifically  and  constitutively  expressed  in 
microglia, independently of their activation state (Ito et al., 1998). DAPI (4’, 6-diamidno-2-
phenulindole) was selected to stain for cell nuclei. The concentrations of anti-IBA-1 antibody, 
Alexafluor488-conjugated IgG and DAPI were optimised for this protocol to ensure effective 
staining  with  minimal  background  noise.  This  was  further  optimised  with  the  use  of  the 
blocking  buffer  constituents  to  minimise  non-specific  binding  of  the  antibodies.  The 
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differential  excitation-emission  spectra  for  DAPI  and  Alexafluor488  ensured  that  during 
visualisation  with  the  laser  scanning  confocal  microscope,  there  was  negligible 
contamination of one fluorophore by the other. 
 
6.5.3 Image acquisition and microglial morphometric analysis 
Visualisation and image acquisition of retinae were performed with a laser scanning confocal 
microscope (Zeiss LSM 710, Germany) using ZEN 2011 software (Zeiss, Germany). For 
each retina, two confocal images were taken, each from a separate quadrant and from a 
mid-peripheral  area.  This  ensured  a  comparable  region  of  analysis  between  treatment 
groups. A Zeiss 10W X / 0.45 water objective was used to observe the microglia and localise 
the specific position for image acquisition, and then the same objective was set at 20W X 
magnification  for  acquisition.  For  each  location,  a  Z-stack  was  taken,  consisting  of 
approximately 17-35 slices (2.65 µm) per stack. Fig. 6.5 summarises the image acquisition 
parameters used for these experiments 
 
Microglial morphology was assessed using Fiji (Image J, NIH, USA) software. The protocols 
for analysis were adapted from previous studies of retinal microglial morphology (Fontainhas 
et al., 2011; Vessey et al., 2011; Opie et al., 2012), and further developed for the purposes 
of the present study. Each image stack was split into two separate fluorescent channels to 
isolate the IBA-1
+ microglia images from the DAPI
+ images. The stack of microglia images 
was then flattened to produce a maximum  intensity projection image for further analysis. 
Morphological changes in ramified microglia were quantified via measurement of the area 
covered by the microglial processes using the polygon tool function in the software (fig. 6.5). 
The criteria for identifying ramified cells were adapted from those described by Tanaka and 
Maeda  (1996),  and  further  refined  for  the  purposes  of  the  present  study.  A  ramified 
microglial  cell  was  defined  as  follows:  The  cell  has  a  distinct  soma  with  two  or  more 
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processes extending from the soma, and which both must be longer than half the diameter 
of  the  soma.  The  original  image  stack was  used  alongside  the  analysis,  to  identify  and 
distinguish cell bodies (with DAPI), as well as the processes of a particular cell, in the case 
of overlap. Cells were excluded from analysis if they extended processes outside of the 
image (i.e. if the full cell expanse was limited by image cut-off). Amoeboid shaped-cells were 
rarely observed, but were excluded from analysis  if encountered, as they did  not fit the 
criteria of ramified cells. 
 
Data were imported into Excel and analysed. Statistical testing was performed in GraphPad 
Prism. The effect of pharmacological compounds was compared to a vehicle control group 
using  an  unpaired,  two-tailed  Student’s  t-test.  Values  were  expressed  as  mean  ±  SEM 
process area (µm
2) and were considered significantly different if P < 0.05. 
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Chapter 6 Figures and Tables 
 
    Page 
     
Table 6.1  Pharmacological compounds used in this study. 
 
87 
Figure 6.1  Placement of recording electrodes for acquisition of transretinal 
electroretinogram and retinal ganglion cell fEPSP responses. 
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Figure 6.2 
 
Digital filtering of transretinal electroretinogram responses.  89 
Figure 6.3 
 
Analysis parameters for the electroretinogram components.  90 
Figure 6.4 
 
Analysis parameters for the ON and OFF retinal ganglion cell 
fEPSPs. 
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Figure 6.5 
 
Image  acquisition  parameters  and  morphometric  analysis  of 
microglia. 
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Figure  6.1  Placement  of  recording  electrodes  for  acquisition  of  transretinal 
electroretinogram and retinal ganglion cell fEPSP responses. Schematic illustrates retinal 
circuitry and the respective positions of the recording electrode for the electrophysiological 
experiments. The retinal wholemount was placed in the bath, ganglion cell layer side up. 
The full-field light flash stimulus was placed above the slice, and the arrow shows the 
direction  in  which  the  light  travelled.  Top  trace,  Typical  transretinal  electroretinogram 
response recorded by lowering the electrode onto the surface of the retinal wholemount, 
without breaking into the layers. The response was repeatedly elicited by a single 10 ms-
duration flash (green arrow), with a 3-sec interval. Bottom trace, Retinal ganglion cell 
fEPSPs were recorded by placing the electrode in the ganglion cell layer. The green bar 
represents the duration of the stimulus (1 sec), which was repeated at 3-sec intervals. 
Upon stimulus onset, an ON retinal ganglion cell fEPSP was generated. Stimulus offset 
produced  an  OFF  retinal  ganglion  cell  fEPSP.  ONL,  outer  nuclear  layer;  OPL,  outer 
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell 
layer. 
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Figure 6.2 Digital filtering of transretinal electroretinogram responses. Top, Dark-adapted 
electroretinogram (ERG) power spectra (300 sec averages) under various filter settings. 
The ERG was low pass-filtered (< 250 Hz; red traces), with the prominent a-wave and b-
wave components within the low to mid frequency range. Further low pass filtering (< 15 
Hz; green traces) eliminated the high-frequency component (oscillatory potentials). A high 
pass filter (> 60 Hz; black trace) was applied after the first filter, in order to isolate the high 
frequency oscillatory potentials, which exhibited a peak frequency  of approximately 100 
Hz. Bottom, Waveform averages illustrate the effect of the filter settings on the shape of 
the ERG. Application of two orders of low pass filter did not distort the waveform, keeping 
the a-wave and b-wave intact. Application of the high pass filter eliminated the a-wave and 
b-wave, isolating the oscillatory potentials for further analysis. Green arrows represent 
flash stimulus (10 ms).  
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Figure 6.3 Analysis parameters for the electroretinogram components. A, The ERG a-
wave was measured by calculating its slope from the onset to peak of the a-wave, shown 
by the vertical blue lines (a). The a-wave implicit time was measured from the onset of the 
stimulus (green vertical line) to the peak of the a-wave (ta). The b-wave amplitude was 
measured from the peak of the a-wave to the half-width of the b-wave recovery phase. Its 
amplitude  is  depicted  by  the  vertical  red  line.  The  implicit  time  of  the  b-wave  was 
measured from stimulus onset to the peak of the b-wave (tb). B, Oscillatory potentials were 
analysed in the frequency domain (e.g. black spectrum in figure 6.2). The power density 
spectrum was derived from stimulus onset to the half-width of the b-wave recovery phase. 
This  window  ensured  that  high-frequency  noise  and  non-ERG  components  were  not 
included in the analysis.  
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Figure 6.4 Analysis parameters for the ON and OFF retinal ganglion cell fEPSPs. Green 
bar represents duration of flash stimulus (1 sec). For all experiments, the ON and OFF 
fEPSPs  were  analysed  by  measuring  their  peak  amplitudes.  The  ON  fEPSP  peak 
amplitude (vertical blue line) was measured from flash onset to the recovered phase (~ 
400  ms  post-stimulus  onset).  The  OFF  fEPSP  peak  amplitude  was  measured  from 
stimulus offset to recovery (~ 300 ms post-stimulus offset). 
91Acquisition Parameters for Z-Stack Images 
Objective / Zoom factor  C-Apochromat 10w/0.45 / x 2.0 
No. of slices / Slice interval  17-35 / 2.65 µm 
Image size - Pixels / Scaled  1024 x 1024 px / 425.1 x 425.1 µm 
 
Image format / Averaging  8-bit / Line-averaged x 4 
Lasers  Argon 488 nm / Diode 405 nm  
Pinhole size / Pixel time   16 µm / 1.27 µs 
Figure  6.5  Image  acquisition  parameters  and  morphometric  analysis  of  microglia.  A, 
Table shows the typical acquisition parameters used for all image stacks. For each retina, 
prior to commencing z-stack acquisition, the gain of the lasers were adjusted to reduce 
saturation of the images. B, Highly schematic representation of a microglial cell, showing 
branched  processes  protruding  from  the  rounded  cell  body.  Alterations  to  microglial 
morphology  were  measured  through  analysis  of  the  area  covered  by  the  microglial 
processes of ramified cells, using a polygon tool (Fiji / Image J). The red lines represent 
the measured microglial process area of one cell.  
A 
B 
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Chapter 7 
Results: Characterisation of Visual Responses of the Ex Vivo Mouse Retina 
 
The effects of P2X7R activation and of microglia, in modulating visual signal transmission in 
the outer and inner mouse retina were investigated. All synaptic responses were obtained 
from  acutely  isolated,  ex  vivo  mouse  retinal  wholemount  preparations.  Dark-adapted 
(scotopic to low mesopic) conditions were specifically chosen to isolate the responses of the 
vertical  rod  photoreceptor-mediated  pathway.  Modulation  of  outer  retinal  function  was 
explored  by  recording  transretinal  electroretinogram  (ERG)  responses.  Investigations  of 
changes to retinal ganglion cell (RGC) function were carried out using recordings of ON and 
OFF RGC field excitatory postsynaptic potentials (fEPSPs) from the ganglion cell layer. The 
following results demonstrate typical response characteristics of the dark-adapted ERG, and 
ON and OFF RGC fEPSPs of the isolated mouse retina. Additionally, this section highlights 
the  specific  experimental  conditions  and  pharmacological  approaches  employed  for  the 
primary study. 
 
7.1 Characterisation of dark-adapted electroretinogram response components  
In physiological perfusion medium (normal Krebs’), the transretinal electroretinogram (ERG) 
typically consisted of three major components: the a-wave, b-wave and oscillatory potentials 
(see methods). Fig. 7.1 shows responses evoked by a 10 ms-duration full-field, dim flash 
stimulus  (-0.96  log  cd.s/m
2),  under  various  pharmacological  conditions  during  the  same 
experiment.  The  initial  negative  a-wave  was  followed  by  a  larger,  positive  b-wave,  with 
smaller-amplitude oscillatory potentials superimposed on the leading edge of the b-wave.  
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7.1.1 Properties of the ERG a-wave and b-wave  
Light  intensity-response  properties  of  the  a-  and  b-waves  in  normal  Krebs’  medium  are 
presented  in  fig.  7.2A  and  B,  respectively  (blue  values),  with  representative  traces  also 
shown (fig. 7.2C, left). The values for the a- and b-waves were measured using the digitally, 
low-pass filtered (< 15 Hz) waveform (section 6.4.4).  For each experiment, a flash intensity 
that gave sub-maximal ERG responses was used. With a typically used stimulus intensity of 
-0.96 log cd.s/m
2, in normal Krebs’ medium, the slope of the a-wave was -0.34 ± 0.07 µV/ms 
(mean ± SEM, n = 6) with an implicit time (time to peak from stimulus onset to a-wave 
maximum amplitude) of 29.4 ± 2ms (fig. 7.2Aa and Ab). The b-wave maximum amplitude 
was 91.8 ± 14µV, with the response peaking at 81.3 ± 2ms following stimulus onset (fig 
7.2Ba and Bb). Both the a-wave slope and b-wave amplitude potentiated as a function of 
flash  intensity,  each  reaching  their  maximum  responses  at  -0.62  and  -0.54  log  cd.s/m
2, 
respectively.  No  marked  changes  were  seen  in  the  implicit  time  of  the  a-wave  peak 
amplitude  with  increasing  stimulus  intensity  (fig.  7.2Ab).  However,  the  b-wave amplitude 
appeared to peak earlier,  with  increasing luminance from  -1.47 to -0.54 log cd.s/m
2 (fig. 
7.2Bb). 
 
Most  experiments  within  the  primary  investigation  were  carried  out  in  the  absence  of 
extracellular magnesium ions (Mg
2+) from the Krebs’ medium for two reasons. Firstly, Mg
2+ 
removal is known to enhance the effects of P2X7R activation, and was therefore used as a 
condition  to  characterise  P2X7R  involvement  in  the  ERG  experiments.  Secondly,  the 
absence  of  Mg
2+  also  enhances  the  NMDA  receptor-mediated  component  of  excitatory 
synaptic responses of retinal ganglion cells (see section 7.2). The removal of extracellular 
Mg
2+  appeared  to  enhance  both  a-  and  b-waves.  Fig.  7.1  shows  that  the  addition  of 
tetrodotoxin (TTX; 100 nM), picrotoxin (100 µM), strychnine (5 µM) and NBQX (10 µM) to the 
bathing medium (hereafter referred to as PMSTN medium), further potentiated the a- and b-
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waves. These pharmacological agents were used to isolate and enhance NMDA receptor-
mediated retinal ganglion cell ON and OFF fEPSPs (section 7.2).  
 
The scotopic ERG a- and b-waves are generally considered to be independent of  inner 
retinal  activity.  However,  with  the  scope  of  characterising  specific  P2X7R-mediated 
modulation  of  synaptic  transmission  in  both  the  outer  and  inner  retina  under  the  same 
conditions, some ERG experiments were also carried out using the PMSTN medium. In the 
modified bathing medium, the basic form of the ERG a- and b-waves remained essentially 
unaltered.  Conversely,  there  were  marked  changes  in  the  implicit  times  of  both  waves, 
shown in fig. 7.2Ab and Bb (red values). The time to peak of the a- and b-waves were 
significantly potentiated in the PMSTN perfusate, compared to responses in normal Krebs’ 
medium. In the modified extracellular solution, the a- and b-waves showed similar stimulus-
intensity response properties as in normal Krebs’ (fig. 7.2A and B, respectively). The a-wave 
slope reached its maximum response between -0.82 and -0.71 log cd.s/m
2, a lower stimulus 
intensity than in normal Krebs’. The maximum response of the b-wave was achieved at the 
highest stimulus intensity tested (-0.54 log cd.s/m
2). There was no statistically significant 
difference in the a-wave slope or b-wave amplitude between ERG responses recorded in 
normal and modified perfusate, across all  light  intensities tested (P > 0.05). The implicit 
times of both a- and b-waves were reduced with increasing flash intensity (P < 0.05 for 
both). Overall, the general response properties of the ERG a- and b-waves were preserved 
in the presence of the pharmacologically altered perfusion medium.  
 
7.1.2 The effect of the group III metabotropic glutamate receptor agonist, L-AP4 on the 
ERG b-wave 
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The mGluR6 glutamate receptor subtype is expressed on the tips of ON bipolar cell dendritic 
processes, directly postsynaptic to the  photoreceptor terminals. It  is established that the 
agonist  L-AP4  selectively  and  reversibly  eliminates  the  ERG  b-wave,  due  to  the 
hyperpolarisation of ON bipolar cells and subsequent blockade of synaptic transmission from 
the photoreceptors to second-order neurons. Indeed, a short (5 min) application of L-AP4 
(50 µM) significantly reduced the b-wave amplitude to 6.9 ± 4% of control (P < 0.05, n = 6). 
This effect was fully reversible, as the b-wave amplitude recovered to 100.3 ± 2% of pre-
treatment  control  (P  >  0.05)  (fig.  7.3A).  The  representative  traces  in  fig.  7.3B  show  the 
selective nature of this interaction, as the negative photoreceptor-derived a-wave remained 
in the presence of L-AP4. These results confirmed the functionality of the photoreceptor-ON 
bipolar cell synapse in transmitting visual signals, under these conditions. 
 
7.1.3 Properties of the ERG oscillatory potentials 
The ERG recorded in normal Krebs’ medium consisted of a series of wavelets embedded in 
the leading edge of the large-amplitude b-wave (fig. 7.1). These high-frequency oscillatory 
potentials were digitally extracted from the raw waveform (high-pass filtered, > 60 Hz), as 
discussed  in  section  6.4.4.  Analysis  of  the  frequency  spectra  of  the  scotopic  oscillatory 
potentials revealed that their power output potentiated with increased light intensity. This 
effect was similar  to the flash intensity-response relationship observed for the a- and b-
waves.  The  representative  traces  in  fig.  7.4B  demonstrate  that  the  amplitude  of  the 
oscillatory potentials became more prominent at higher flash intensities.  
 
Shown in fig. 7.1, the oscillatory potentials were abolished in the presence of the modified 
PMSTN  perfusion  medium.  This  is  consistent  with  the  notion  that  these  wavelets  are 
generated from inner retinal network activity. 
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7.2 Characterisation of ON and OFF retinal ganglion cell fEPSPs 
Photostimulation of the retina (1 sec-duration, full-field flash) generated a characteristic ON 
RGC fEPSP, followed by an OFF RGC fEPSP at termination of the stimulus (fig. 6). In some 
experiments in normal Krebs’ medium, spiking action potentials were apparent in the ON 
and OFF fEPSPs. This feature is typical of inner retinal activity, particularly that of retinal 
ganglion cells. Application of the voltage-gated sodium channel blocker, tetrodotoxin (TTX; 
100 nM) to the perfusion medium abolished the spikes (fig. 7.5), confirming that responses 
were recorded from the ganglion cell layer. The NMDA receptor-mediated component of the 
ON  and  OFF  fEPSPs  was  enhanced  with  the  removal  of  extracellular  Mg
2+  from  the 
perfusate.  Blockade  of  AMPA/KA,  GABAA/B  and  glycine  receptors,  with  NBQX  (10  µM), 
picrotoxin (100 µM) and strychnine (5 µM), respectively, and the presence of TTX, ensured 
the pharmacological isolation of the NMDA-R component. The traces in fig. 7.5 illustrate the 
considerable potentiation of both ON and OFF fEPSPs in the PMSTN medium, indicating the 
enhancement of ON and OFF RGC receptive fields due to the diminished inhibitory surround 
input. 
 
Fig. 7.6 shows that at any given flash intensity, the ON fEPSP was larger in amplitude than 
the OFF fEPSP, indicating a dominant ON pathway-mediated response. This is consistent 
with  the  suppression  of  transmission  through  the  OFF  pathway  due  to  the  presence  of 
NBQX, as OFF bipolar cells are depolarised by the activation of AMPA/KA receptors. The 
ON fEPSP potentiated with increasing flash intensity, reaching its maximum response at -
0.62  log  cd.s/m
2.  The  OFF  fEPSP  displayed  a  similar  stimulus  intensity-response 
relationship, saturating at a lower intensity (-0.96 log cd.s/m
2). As the ON fEPSP was the 
dominant response in all experiments, a flash intensity that gave a sub-maximal ON fEPSP 
was used, typically ranging from -2.00 to -1.00 log cd.s/m
2. 
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7.2.1 The effect of the selective NMDA receptor antagonist, D-AP5 on ON and OFF 
retinal ganglion cell fEPSPs 
The competitive NMDA receptor antagonist, D-AP5 was used to confirm the nature of the 
ON and OFF fEPSPs. D-AP5 (100 µM, 10 min application) significantly reduced the ON and 
OFF fEPSPs to 37 ± 6% and 50 ± 14% of control, respectively (P < 0.05 for both, n = 7 and 
6) (fig. 7.7). On washout, both responses recovered to 91 ± 4% and 99 ± 7% of control (P > 
0.05 for both). Fig.  7.8A illustrates that across almost all  light  intensities tested, the ON 
fEPSP was significantly suppressed in the presence of D-AP5 (P < 0.05, two-way ANOVA). 
Although the OFF fEPSP was reduced with D-AP5, its suppression across all light intensities 
was not statistically significant (P > 0.05, two-way ANOVA) (fig. 7.8B). The representative 
traces in fig. 7.8C illustrate that across all light intensities tested, a residual fraction of the 
ON fEPSP remained in the presence of D-AP5. These results suggest that the ON and OFF 
fEPSPs are primarily mediated by NMDA receptor activation.  
 
7.2.2 The effect of the group III metabotropic glutamate receptor agonist, L-AP4 on the 
ON and OFF retinal ganglion cell fEPSPs 
It is established that mGluR6 activation selectively abolishes the ON RGC response. Indeed, 
it was observed that application of L-AP4 resulted in a concentration-related reduction of the 
ON fEPSP, with no overall effect on the OFF fEPSP (fig. 7.9). Significant reduction of the ON 
fEPSP was achieved with L-AP4 tested at 20 µM and 50 µM, suppressing the response to 
51.2 ± 8% and 17.1 ± 3% of control, respectively (P < 0.05, n = 6 and 26) (fig. 7.9A). Further 
reduction of the ON fEPSP was observed with 100 µM, but which was only tested in two 
experiments.  Following  washout,  the  ON  fEPSP  was  fully  recoverable  to  98.4  ±  2%  of 
control (P > 0.05). Across all concentrations tested, the OFF fEPSP remained essentially 
unaltered (99.8 ± 10% of control, P > 0.05, n = 26). The effect of L-AP4 on the ON fEPSP is 
demonstrated in fig.7.9B, which shows representative traces in the presence of L-AP4 at 10, 
98 
20 and 50 µM, applied in succession. The selective suppression of the ON fEPSP confirmed 
that the overall segregation of the ON and OFF visual pathways were maintained in the ex 
vivo mouse retinal wholemount preparation.  
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Chapter 7 Figures 
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Figure 7.1  Dark-adapted ERG responses under various pharmacological 
conditions. 
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Figure 7.2 
 
Stimulus-intensity  response  functions  of  the  a-wave  and  b-
wave components of the dark-adapted transretinal ERG. 
 
102 
Figure 7.3 
 
The effect of the mGluR6 agonist, L-AP4 on the ERG b-wave 
component. 
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Figure 7.4 
 
Stimulus-intensity  response  relationship  of  oscillatory 
potentials of the dark-adapted transretinal ERG. 
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Figure 7.5 
 
Isolation of the NMDA receptor-mediated component of dark-
adapted,  light-evoked  ON  and  OFF  retinal  ganglion  cell 
fEPSPs. 
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Figure 7.6 
 
Stimulus intensity-response functions of light-evoked ON and 
OFF RGC fEPSPs. 
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Figure 7.7 
 
The  effect  of  the  competitive  and  selective  NMDA  receptor 
antagonist D-AP5 on the ON and OFF RGC fEPSPs. 
 
108 
Figure 7.8 
 
Light  intensity  response  functions  of  dark-adapted,  light-
evoked NMDA receptor-mediated ON and OFF RGC fEPSPs, 
in  the  presence  of  the  competitive  and  selective  NMDA 
receptor antagonist D-AP5. 
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Figure 7.9 
 
The effect of the mGluR6 agonist, L-AP4 on the ON and OFF 
RGC fEPSPs. 
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Normal Krebs’  0 Mg2+  0 Mg2+ + TTX  
0 Mg2+ + TTX + PIC 
+ STY + NBQX  
LPF 250 Hz 
LPF 15 Hz 
HPF 60 Hz 
Figure  7.1  Dark-adapted  ERG  responses  under  various  pharmacological  conditions. 
Representative  traces  show  the  alterations  in  the  ERG  responses  in  the  presence  of 
different  perfusion  solutions.  Each  row  depicts  the  waveform  with  differential  filter 
frequencies (see Fig. 6.2). LPF, low pass filter; HPF, high pass filter. In physiological 
Krebs’  medium,  the  ERG  exhibited  typical  a-wave,  b-wave  and  oscillatory  potential 
components. With the addition of tetrodotoxin (100 nM; TTX), the oscillatory potentials 
were markedly reduced, indicating their inner retinal origin. TTX also appeared to delay 
the peak of the b-wave amplitude. The addition of the picrotoxin (PIC; 100 µM), strychnine 
(STY; 5 µM), NBQX (10 µM), and the removal of extracellular magnesium ions (Mg2+) 
appeared  to  enhance  both  a-wave  and  b-wave  components,  and  almost  completely 
eliminated  the  oscillatory  potentials.  Thus,  for  experiments  undertaken  in  the 
pharmacologically  modified  perfusate  (PMSTN),  the  oscillatory  potentials  were  not 
analysed.  Overall,  the  shape  of  the  ERG  was  not  altered  in  the  modified  perfusate, 
indicating that the cellular generators of the a-wave and b-wave were on the whole, were 
functional under these conditions. 
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102Figure 7.2 Stimulus-intensity response functions of the a-wave and b-wave components 
of the dark-adapted transretinal ERG. Aa and Ab, Values are mean ± SEM a-wave slope 
and implicit time, respectively (n = 8). In normal physiological Krebs’ medium, the a-wave 
slope potentiated with increasing luminance, and was not significantly different from the 
a-wave  slope  in  PMSTN  medium,  across  all  intensities  tested  (P  > 0.05,  for  all).  The 
a-wave implicit time (defined as the time to peak of the a-wave amplitude, from stimulus 
onset),  was  significantly  different  between  normal  physiological  Krebs’  and  PMSTN 
medium, at the lowest intensities tested (*, P < 0.05). Ba and Bb, Values are mean ± SEM 
b-wave amplitude and implicit time, respectively. In both physiological Krebs’ and PMSTN 
medium, the b-wave amplitude potentiated with increasing stimulus intensities. There was 
no significant difference between the two conditions, across all luminances tested (P > 
0.05, for all). The peak of the b-wave amplitude was significantly more delayed in PMSTN 
medium, compared to that in normal physiological medium, across all intensities (*, P < 
0.05). C, Representative traces (15 sec averages) illustrate the enhanced a-wave and 
b-wave at higher luminances. There was no overall alteration in the shape of the ERG 
waveforms in the presence of PMSTN medium, indicating that the function of the retinal 
circuitry was intact.  
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Figure 7.3 The effect of the mGluR6 agonist, L-AP4 on the ERG b-wave component. 
Values  are  mean  ±  SEM  percentage  of  control  b-wave  amplitude.  A,  L-AP4  (50  µM) 
significantly  and  selectively  reduced  the  b-wave amplitude,  compared  to  pre-treatment 
control  (P  <  0.05,  n  =  6).  The  suppression  of  the  b-wave  was  readily  reversible  on 
washout (P > 0.05). ns, not significant; *, P < 0.05. B, Representative traces (120 sec 
averages) illustrate the marked and recoverable elimination of the b-wave in the presence 
of  L-AP4,  leaving  the  a-wave  intact.  The  selective  effect  of  L-AP4  on  the  b-wave 
confirmed the function of mGluR6 activity at the photoreceptor – ON bipolar cell synapse. 
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Figure 7.4 Stimulus-intensity response relationship of oscillatory potentials of the dark-
adapted transretinal ERG. A, Values are mean ± SEM peak power density derived from 
power spectra (n = 8) for each light intensity tested. Oscillatory potentials were extracted 
from the raw ERG waveform, with a high-pass filter (> 60 Hz, see section 6.4.4). The 
power output of the oscillatory potentials was enhanced with increased flash intensity. A 
steeper increase in the peak power was observed at higher light intensities, within the 
range tested. This is consistent with in vivo observations of the dark-adapted oscillatory 
potentials. B, Characteristic traces of extracted oscillatory potentials (15 sec averages) 
illustrate their prominence at higher luminances.  
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Figure 7.5 Isolation of the NMDA receptor-mediated component of dark-adapted, light-
evoked ON and OFF retinal ganglion cell fEPSPs. Responses were recorded from the 
ganglion  cell  layer,  in  response  to  a  1  sec-duration  light  stimulus  (green  bar).  Upon 
stimulus onset, an ON fEPSP was generated, and stimulus offset induced an OFF fEPSP. 
Representative  traces  are  10  sec  averages.  In  the  presence  of  physiological  Krebs’ 
medium  (top  trace),  high-frequency  spiking  action  potentials  were  apparent,  but  were 
diminished with the addition of the tetrodotoxin (TTX; 100 nM), a blocker of voltage-gated 
sodium channels (middle trace). This confirmed that responses were recorded from the 
inner retinal layers, as spiking activity is predominantly attributed to retinal ganglion cells. 
The bottom trace illustrates the changes to the ON and OFF fEPSPs with the addition of 
picrotoxin (PIC; 100 µM), strychnine (STY; 5 µM), NBQX (10 µM), and the removal of 
extracellular  magnesium  ions  (Mg2+).  Superfusion  of  this  pharmacologically  modified 
Krebs’ medium (referred to as PMSTN), considerably enhanced the amplitudes of both the 
ON and OFF fEPSPs, which exhibited characteristic waveforms of dark-adapted, isolated 
NMDA receptor-mediated RGC responses.   
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107Figure  7.6  Stimulus  intensity-response  functions  of  light-evoked  ON  and  OFF  RGC 
fEPSPs. A, Values are mean ± SEM fEPSP amplitudes (mV); n = 4. Flash intensities 
tested were in the scotopic to mesopic range (dim light). The ON fEPSP (blue) potentiated 
with increasing light intensity, typically saturating at approx. -0.62 log cd.s/m2. The OFF 
fEPSP (green) also exhibited a potentiation in response to increasing flash intensity, but 
saturated  at  a  much  dimmer  luminance  (approx.  -1  log  cd.s/m2).  Across  all  stimulus 
intensities tested, the ON fEPSP persisted as the dominant response and thus, for all 
pharmacological investigations, a stimulus that induced a sub-maximal ON fEPSP was 
selected  (typically  between  -2  and  -1  log  cd.s/m2).  B,  Representative  traces  (15  sec 
averages), show the dominance of the ON fEPSP, and its stimulus intensity-dependent 
potentiation. The OFF fEPSP seemed more apparent towards the lower end of the flash 
intensity range used.  
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Figure 7.7 The effect of the competitive and selective NMDA receptor antagonist D-AP5 
on the ON and OFF RGC fEPSPs. A, Values are mean ± SEM percentage control fEPSP 
amplitude. ns, not significant; *, P < 0.05, compared to pre-treatment control. D-AP5 (100 
µM) significantly reduced both the ON (n = 7) and OFF (n = 6) fEPSPs, compared to pre-
treatment  control  (P  <  0.05).  The  D-AP5-mediated  effect  on  both  components  was 
reversible on washout (P > 0.05). B, Representative traces illustrate a marked reduction in 
both ON and OFF responses, which then recover on washout. Note the persistence of a 
residual fraction of the excitatory responses in the presence of D-AP5, suggesting a non-
ionotropic glutamate receptor contribution to the fast responses.  
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Figure  7.8  Light  intensity  response  functions  of  dark-adapted,  light-evoked  NMDA 
receptor-mediated ON and OFF RGC fEPSPs, in the presence of the competitive and 
selective NMDA receptor antagonist D-AP5. Values are mean ± SEM fEPSP amplitude. A, 
In  the  presence  of  D-AP5  (100  µM;  pale  blue),  the  amplitude  of  the  ON  fEPSP  was 
significantly suppressed, across nearly  all flash  intensities tested, compared to control 
(dark blue; * P < 0.05, n = 4 each). B, There was no significant difference between the 
OFF fEPSP in the presence of D-AP5, compared to control, across the light intensities 
tested. C, Representative waveform averages revealed that a residual component of the 
ON fEPSP remained, in the presence of D-AP5, across all stimulus intensities tested, 
suggesting a non-ionotropic glutamate receptor contribution to the fast responses.  
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Figure 7.9 The effect of the mGluR6 agonist, L-AP4 on the ON and OFF RGC fEPSPs. 
Values are mean ± SEM % control fEPSP amplitude. A, L-AP4 selectively reduced the 
NMDA receptor-mediated ON RGC fEPSP,  in a concentration-related manner. ns, not 
significant; *, P < 0.05, compared to pre-treatment control. For 5, 10 and 20 µM, n = 6 
each; 50 µM, n = 26; 100 µM, n = 2.The effect was fully reversible on washout (50 µM 
values). The OFF fEPSP was not affected by L-AP4, compared to control (P > 0.05; n = 
17).  B,  Representative  waveform  averages  of  light-evoked  ON  and  OFF  fEPSPs  in 
response to varying doses of L-AP4.  
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Chapter 8 
Results: The Effects of P2X7R Activation on Dark-Adapted Visual Responses 
 
In this series of experiments, the short-term effects of P2X7R activation on the dark-adapted 
ERG, and ON and OFF fEPSPs were investigated and characterised, in the isolated mouse 
retina. BzATP was used as the P2X7R agonist, as it is currently established as the most 
potent  activator  of  P2X7Rs.  The  agonist-induced  changes  in  the  kinetics  of  the  ERG 
components and RGC fEPSPs were assessed over an application period of 10 minutes, and 
during the recovery phase approximately 10 to 15 min post-wash. Unless otherwise stated, 
all effect values were taken from the final 120 sec of application, and are expressed as mean 
± SEM. The selective, competitive P2X7R antagonist, A438079 was used as the primary 
antagonist  to  characterise  P2X7R  involvement.  A438079  is  well  established  as  a  potent 
inhibitor of P2X7R activation in vivo and in vitro. As described in the previous chapter, some 
ERG and all fEPSP experiments were carried out using a modified physiological perfusion 
medium containing NBQX (10 µM), picrotoxin (100 µM), strychnine (5 µM) and tetrodotoxin 
(100 nM). This ensured that consistency was maintained between investigations of outer and 
inner retinal function. 
 
8.1  The  effects  of  BzATP  on  dark-adapted  electroretinogram  a-wave  and  b-wave 
components in the presence and absence of extracellular magnesium  
In  physiological  Krebs’  medium,  a  10-min  application  of  BzATP  induced  a  marked 
potentiation of the a-wave slope to 130.5 ± 12% of control (P < 0.05, n = 7) (fig. 8.1A). The 
BzATP-mediated changes in the a-wave were relatively rapid in onset, reaching a sustained 
maximum effect within approximately 5-6 min after the start of drug application (fig. 8.1A). 
Following washout of BzATP, the a-wave slope recovered to 109.1 ± 5% of control (P > 
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0.05)  (fig.  8.1A).  BzATP  also  significantly  potentiated  the  implicit  time  of  the  a-wave 
maximum amplitude compared to pre-treatment control (P < 0.05) (fig. 8.1D and table 8.1). 
 
A concomitant reduction of the ERG b-wave to 87.9 ± 4% of control (P < 0.05, n = 7) was 
also measured in the presence of BzATP (fig. 8.1B). The changes in the b-wave within 1-2 
min of application appeared to reach maximum reduction in amplitude immediately prior to 
washout (Fig 8.1B). Thus, a different temporal profile of the BzATP-mediated effect was 
apparent  between  the  a-wave  and  b-wave.  Considering  the  direct  output  of  the 
photoreceptors onto the ON-bipolar cells along the vertical pathway, it would be expected 
that a potentiation in the a-wave slope would lead to a subsequent increase in the b-wave 
amplitude. However, this does not seem to be the case here, and is consistent with the in 
vivo findings of the effect of BzATP on the rat ERG (Puthussery et al., 2006). The b-wave 
amplitude recovered to baseline within  approximately 5 min following washout of BzATP 
(103.3 ± 2% of control, P > 0.05) (Fig. 8.1B). There was no significant effect on the implicit 
time of the b-wave during BzATP application, although a lasting effect on the implicit time 
remained following washout (Fig. 8.1D).  
 
These results have identified that BzATP caused marked changes in the response profiles of 
the ERG a- and b-waves. As has been previously suggested (Puthussery et al., 2006), the 
differing effects on the kinetics of the a-wave and b-waves indicated that BzATP elicited 
independent  alterations  in  the  photoreceptor  and  post-photoreceptor  components. 
Furthermore, the consistency of these results with the findings in the rodent in vivo confirms 
that  the  structural  integrity  and  physiological  function  of  the  retinal  preparation  were 
maintained in vitro. 
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The  effect  of  BzATP-mediated  activation  of  P2X7Rs  is  considerably  enhanced  in  the 
absence of extracellular divalent cations, particularly magnesium ions (Mg
2+) (Surprenant et 
al., 1996; Virginio et al., 1997). To further characterise the BzATP-mediated effect on the 
ERG response components, the P2X7R agonist was applied in normal physiological medium 
in the absence of magnesium. Under these conditions, BzATP induced a reduction in the a-
wave slope to 90.7 ± 3% of control (P < 0.05, n = 6), which was typically recoverable 5 min 
post-wash to 97.2 ± 3% of control (P > 0.05) (fig 8.2A). The effect peaked approximately 8 
min after the start of drug application (fig 8.2A); although the mean value was taken at the 
final 2 min, in order to reliably compare the effect of BzATP across the different conditions 
(table  8.1).  Furthermore,  BzATP  increased  the  implicit  time  of  the  a-wave  maximum 
amplitude,  which  did  not  seem  to  fully  recover  following  washout.  The  BzATP-mediated 
reduction in the a-wave slope was contrary to that seen in the presence of extracellular 
magnesium, suggesting that the effect of P2X7R activation is reversed (P < 0.05; see table 
8.1). 
 
In  the  absence  of  extracellular  magnesium,  BzATP  significantly  reduced  the  b-wave 
amplitude to 89.5 ± 1% of control (P < 0.05, n = 6), an effect which did not recover on 
washout (fig 8.2B). The temporal profile of the b-wave amplitude was comparable to that of 
the  a-wave  slope  during  the  early  phase  of  BzATP  application,  where  an  exponential 
reduction in both components was apparent. However, the differing recovery periods of the 
a- and b-waves strongly supports the notion that BzATP elicited  independent effects on 
photoreceptor  and  post-photoreceptor  components.  Additionally,  BzATP  did  not  elicit  a 
significant effect on the implicit time of the b-wave maximum amplitude. The suppressive 
effect  of  BzATP  on  the  b-wave  amplitude  in  the  presence  and  absence  of  extracellular 
magnesium were similar (P > 0.05, see table 8.1). The differences in the changes to the b-
wave amplitude during the post-wash phase, under both conditions imply that magnesium 
was required for full recovery following BzATP application.  
114 
8.2  The  effects  of  BzATP  on  dark-adapted  electroretinogram  a-wave  and  b-wave 
components, in the presence of  the  antagonists  NBQX,  picrotoxin, strychnine and 
tetrodotoxin 
The following experiments were carried out in PMSTN perfusion medium. As shown in fig. 
8.3A, there was a transient potentiation in the a-wave slope within the first 2-3 min of BzATP 
application. However, this effect reversed from 5 min, with a significant reduction in the a-
wave slope to 70.1 ± 8% of pre-treatment control (P < 0.05, n = 7), and did not appear to 
recover  fully  following  washout  (76.3  ±  9%  of  control,  P  <  0.05).  The  a-wave  was  also 
significantly delayed in the presence of BzATP, recovering on washout (fig. 8.3D and table 
8.1). 
 
The effect of BzATP on the b-wave amplitude followed a similar temporal profile to that of 
the a-wave slope. An initial and transient potentiation in the b-wave amplitude was observed, 
followed by a significant reduction to 66.6 ± 10% of control (P < 0.05, n = 7). As with the a-
wave slope, the b-wave amplitude did not appear to recover following washout of BzATP. 
The  b-wave  implicit  time  was  also  significantly  increased  with  BzATP.  Under  these 
conditions, BzATP induced effects on the a-wave slope and b-wave amplitude which were 
comparable to those seen in the absence of magnesium alone, as shown in table 8.1. 
 
8.3  The  effect  of  the  selective  P2X7  receptor  antagonist  A438079  on  the  BzATP-
mediated  changes  in  the  dark-adapted  electroretinogram  a-wave  and  b-wave 
components 
In  order  to  further  delineate  P2X7R  involvement,  the  effect  of  BzATP  on  the  ERG 
components was assessed in the presence of the selective, competitive P2X7R antagonist, 
A438079 (10 µM). Experiments were carried out in PMSTN medium. The effect of A438079 
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on  the  BzATP-induced  changes  in  the  a-  and  b-waves  was  directly  compared  to  the 
preceding application of BzATP in the same experiment.  
 
As shown in fig. 8.4, A438079 abolished the BzATP-mediated reduction of the a-wave slope 
to 4 ± 16% of the effect of BzATP when applied alone (P < 0.05, n = 7). In the presence of 
A438079, the BzATP-induced increase in the implicit time of the a-wave maximum amplitude 
remained. The P2X7R antagonist reduced the effect of BzATP on the b-wave amplitude to 
58.3 ± 16% of control (maximum BzATP effect; P < 0.05). Contrary to BzATP alone, the 
agonist did not significantly affect the implicit time of the b-wave amplitude in the presence of 
A438079.  Thus,  the  A438079-mediated  attenuation  in  the  effect  of  BzATP  on  these 
components of the ERG confirms the involvement of P2X7R activation. 
 
As illustrated in fig. 8.5, the a-wave slope was significantly potentiated in the presence of 
A438079  (10  µM)  alone,  to  125.7  ±  12%  of  pre-treatment  control  (P  <  0.05,  n  =  10). 
A438079 also markedly reduced the b-wave amplitude to 79.1 ± 15% of control (P < 0.05, n 
= 10). The implicit times for both a- and b-waves were increased in the presence of the 
antagonist. These results suggest that P2X7R activation may modulate retinal function under 
baseline conditions.  
 
8.4  The  effect  of  BzATP  on  the  oscillatory  potentials  of  the  dark-adapted 
electroretinogram 
The  effect  of  BzATP  on  the  oscillatory  potentials  was  also  explored.  As  shown  in  the 
Methods section 6.4.4, the high-frequency oscillatory potentials were digitally extracted from 
the raw ERG waveform. Changes in the peak power output of the oscillatory potentials were 
assessed with their frequency spectra before, during and after agonist application. BzATP 
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significantly reduced the peak power to 63.9 ± 11% of control (P < 0.05) (fig. 8.6). Following 
washout of BzATP, the oscillatory potentials recovered to 99.9 ± 9% of control (P > 0.05). 
These  results  suggest  that  BzATP  considerably  suppressed  the  activity  of  inner  retinal 
networks, and further imply that P2X7R modulation in the inner retina is at least partially 
independent of that in the outer retina. 
 
8.5 The effect of BzATP on NMDA receptor-mediated ON and OFF retinal ganglion cell 
fEPSPs 
The effect of P2X7R activation on synaptic transmission at bipolar-retinal ganglion cell (RGC) 
synapses was investigated. All experiments were carried out in PMSTN medium. As shown 
in fig. 8.7, BzATP was applied to the perfusate for ten minutes, and the agonist-induced 
modulation of the ON and OFF fEPSPs was compared across concentrations ranging from 
10  to  300  µM.  There  was  no  significant  effect  on  the  ON  fEPSP  with  low  micromolar 
concentrations  of  BzATP.  However,  a  dose-related  reduction  in  the  ON  fEPSP  peak 
amplitude  was  measured  at  higher  micromolar  concentrations.  BzATP  at  300  µM,  the 
highest concentration tested, elicited a significant reduction in the ON fEPSP to 78.1 ± 3% of 
control (P < 0.05, n = 21) (Fig. 8.7Aa). BzATP elicited its effect within approximately 2-3 min 
of reaching the retina, and was sustained throughout the duration of application (Fig. 8.7Ab). 
This effect was partially recoverable on washout to 92.4 ± 2% of control (P < 0.05). 
 
BzATP, at all concentrations tested, did not elicit any overall and statistically significant effect 
on the OFF fEPSP (fig. 8.7B). This selective effect of BzATP on the ON fEPSP, but not on 
the OFF fEPSP may suggest a pathway-specific modulation by P2X7Rs. 
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8.6 The effect of the selective and competitive P2X7 receptor antagonists A438079, 
A804598 and AF27139 on the BzATP-mediated modulation of the ON RGC fEPSP 
The effect of BzATP on the ON  fEPSP was assessed in the presence of the  selective, 
competitive P2X7R antagonists A438079, A804598 or AF27139. Experiments were separate 
for each antagonist, and were carried out in PMSTN medium. The effect of each antagonist 
on the BzATP-induced changes in the ON fEPSP was directly compared to the preceding 
application of BzATP in the absence of the antagonist. A438079 (10 µM), A804598 (30 µM) 
and AF27139  (30  µM),  all  partially  attenuated  the BzATP-mediated  reduction of  the  ON 
fEPSP to 68.7 ± 2%, 55.1 ± 11% and 75.2 ± 7% of control, when compared to the maximum 
effect of BzATP (P < 0.05 for all) (fig. 8.8). 
 
These antagonists have previously shown to be potent in blocking  P2X7R activation. The 
potency  of  A438079  in  this  respect  was  further  supported  by  its  inhibitory  effect  on  the 
BzATP-mediated reduction in the ERG a-wave, shown earlier in this study. Therefore, these 
results implicate the involvement of a BzATP-activated release of endogenous agonist (ATP) 
that  may  enhance  P2X7R  activation  and  subsequently  reduce  the  potency  of  the 
antagonists. 
 
Fig. 8.9 illustrates the effect of these antagonists on baseline ON fEPSP responses. The ON 
fEPSP was reduced in the presence of A804598 to 85.0 ± 15% of control (P < 0.05, n = 7), 
but was not significantly affected by A438079 or AF27139 at the concentrations tested. The 
OFF fEPSP was not significantly affected by any of the antagonists. 
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8.7 The effect of adenosine on ON and OFF RGC fEPSPs 
Extracellular ATP is rapidly degraded into its constituent adenosine, by ectonucleotidases. It 
has previously been suggested that the actions of BzATP in the hippocampus are due the 
effect  of  its  breakdown  product  Bz-adenosine  through  the  subsequent  activation  of  A1 
receptors  (Kukley  et  al.,  2004).  Adenosine  receptors  are  known  to  be  expressed  in  the 
retina. Therefore, it was investigated whether the effect of BzATP on the RGC fEPSPs was 
mediated by the activation of adenosine receptors through Bz-adenosine.  
 
The ON fEPSP was significantly potentiated by adenosine, exhibiting a dose-related effect 
(fig.  8.10Aa).  For  the  highest  concentration  tested  (300  µM),  maximum potentiation  was 
achieved within 3 – 5 min of adenosine exposure, to 109.5 ± 2% of control (P < 0.05, n = 8) 
(fig. 8.10Ab). The effect on the ON fEPSP peak amplitude was not sustained, but decayed 
prior  to  washout.  A  transient  reduction  in  the  ON  fEPSP  was  also  observed  before 
recovering fully, to 99.8 ± 2% of control approximately 10 min later (P > 0.05), which is 
illustrated by the representative traces (fig. 8.10Ab and 8.10C). The OFF fEPSP was also 
significantly potentiated with adenosine, with a dose-related profile, similar to that of the ON 
fEPSP. Fig. 8.10Bb shows that the temporal profile of the effect of adenosine on the OFF 
fEPSP was different to that of the ON fEPSP (fig 8.10Ab). At the 5 min time point, ADO (300 
µM) significantly potentiated the OFF fEPSP to 118.8 ± 8% of control (P < 0.05, n = 7), an 
effect that was sustained throughout the duration of application. Following washout, the OFF 
fEPSP showed a transient reduction prior to returning to 95.7 ± 5% of control (P > 0.05). 
Vehicle application had no significant effect on either the ON or OFF fEPSPs (fig 8.10). 
 
These results suggest that the differential effects of BzATP and adenosine on the ON and 
OFF fEPSPs are due to the activation of different purinergic receptors. Furthermore, the 
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OFF fEPSP is markedly modulated by adenosine, but not by BzATP, further implicating ON-
pathway dominance for P2X7Rs. 
 
8.8 The effect of BzATP and of the P2XR antagonists suramin, PPADS and A438079 on 
the ON fEPSP, in the presence of D-AP5  
The addition of the competitive NMDA receptor antagonist, D-AP5 (100 µM) to the PMSTN 
perfusate revealed that a considerable residual fraction of the fEPSPs remained (figs. 7.7 
and 7.8, Chapter 7). The possible contribution of P2XRs and in particular, that of P2X7Rs to 
the residual fraction of the ON fEPSP was investigated. All experiments were carried out in 
PMSTN medium in the presence of D-AP5 (100 µM). Fig. 8.11B shows the marked reduction 
in the ON fEPSP induced by D-AP5, as previously demonstrated in the preceding chapter. 
Co-application of BzATP (300 µM) induced a further reduction of the ON fEPSP to 78.8 ± 
3% of the D-AP5-mediated effect (P < 0.05, n = 7). Following washout of BzATP, the ON 
fEPSP recovered to 94.8 ± 4% of its amplitude pre-BzATP (P > 0.05) (fig. 8.11A and B). 
These  results  suggest  that  the  effect  P2X7R  activation  on  the  ON  RGCs  occurs 
independently of NMDA-R activity. 
 
In  separate  experiments,  A438079  (10  µM)  or  the  broad-spectrum  P2XR  antagonists 
suramin (100 µM) and PPADS (100 µM) were also co-applied with D-AP5 (fig. 8.12A – C). 
All three compounds elicited further reductions in the ON fEPSP. The residual fraction of the 
ON fEPSP was significantly suppressed to 44.9 ± 9%, 74.0 ± 7% and 91.1 ± 3% of control, 
by  suramin,  PPADS  and  A438079,  respectively  (P  <  0.05,  n  =  6,  for  all)  (fig.  8.12D). 
Together, these results suggest that P2X7Rs and other P2XR subtypes contribute to the 
residual component of baseline ON retinal ganglion cell activity, in the absence of NMDA-R 
function.  
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Figure 8.1  The effect of BzATP on the dark-adapted ERG in physiological 
Krebs’ medium. 
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Figure 8.2 
 
The effect of BzATP on the dark-adapted ERG in the absence 
of extracellular magnesium ions. 
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Figure 8.3 
 
The effect of BzATP on the dark-adapted ERG in the absence 
of extracellular magnesium ions, and in the presence of NBQX, 
picrotoxin, strychnine and TTX. 
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Table 8.1 
 
Summary of the actions of BzATP on the ERG a-wave and b-
wave components, under all three conditions tested. 
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Figure 8.4 
 
Actions  of  the  selective  P2X7R  antagonist  A438079  on  the 
BzATP-mediated effects on the ERG components. 
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Figure 8.5 
 
The effect of the selective P2X7R antagonist A438079 on ERG 
components, in normal physiological function. 
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Figure 8.6 
 
The effect of BzATP on ERG oscillatory potentials.  128 
Figure 8.7 
 
The  effect  of  BzATP  on  light-evoked  ON  and  OFF  RGC 
fEPSPs. 
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Figure 8.8 
 
Actions of selective P2X7R antagonists on the BzATP-induced 
suppression of the ON fEPSP. 
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Figure 8.9 
 
Direct  actions  of  selective  P2X7R  antagonists  on  NMDAR-
mediated ON and OFF fEPSPs. 
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Figure 8.10 
 
The effect of adenosine on the NMDAR-mediated ON and OFF 
RGC fEPSPs. 
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Figure 8.11 
 
Actions of BzATP on the ON  fEPSP in the presence of the 
NMDA receptor antagonist D-AP5. 
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Figure 8.12 
 
Actions  of  broad-spectrum  P2XR  antagonists  suramin  and 
PPADS, and the selective P2X7R antagonist A438079 on the 
ON fEPSP, in the presence of the NMDA receptor antagonist 
D-AP5. 
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Figure 8.1 The effect of BzATP on the dark-adapted ERG in physiological Krebs’ medium. 
Time course plots show the effect of BzATP (300 µM; 10 min) on the a-wave slope and b-
wave amplitude. A, BzATP induced a sustained potentiation of the a-wave slope, which 
reached maximal effect within approximately 5 min of application, and was reversible on 
washout.  B,  BzATP  concomitantly  reduced  the  b-wave  amplitude  over  the  course  of 
application,  an  effect  which  was  recoverable  following  washout.  Note  the  differential 
temporal profiles of the effect of BzATP on the ERG components. Values are mean ± SEM 
percentage change (n = 7). C, Representative traces illustrate the effect of BzATP on the 
ERG. a, control; b, BzATP; c, wash; d, merge. D, Summary of the actions of BzATP on 
the  a-wave  and  b-wave  (mean  ±  SEM).  ns,  not  significant;  *,  P  <  0.05,  compared  to 
control. 
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104.6 ± 3 *  
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Figure 8.2 The effect of BzATP on the dark-adapted ERG in the absence of extracellular 
magnesium ions. Time course plots show the effect of BzATP (300 µM; 10 min) on the a-
wave slope and b-wave amplitude. A, BzATP reduced the a-wave slope, an effect which 
was reversible on washout. B, BzATP also caused a reduction in the b-wave amplitude 
over the course of application, which was not fully recoverable following washout. Note 
the  differential  temporal  profiles  of  the  effect  of  BzATP  on  the  ERG  components, 
particularly during the wash phase. Values are mean ± SEM percentage change (n = 6). 
C, Representative traces illustrate the effect of BzATP on the ERG in the absence of 
extracellular magnesium ions. a, control; b, BzATP; c, wash; d, merge. D, Summary of the 
actions of BzATP on the a-wave and b-wave (mean ± SEM). ns, not significant; *, P < 
0.05, compared to control. 
Control  BzATP   Wash 
a-wave 
Slope (% of control)  
Implicit time (ms) 
 
- 
29.7 ± 2 
 
90.7 ± 3 * 
32.5 ± 2 *  
 
97.2 ± 3 ns 
31.0 ± 2 * 
b-wave 
Amplitude (% of control)  
Implicit time (ms) 
 
- 
74.4 ± 2 
 
89.5 ± 1 * 
80.6 ± 3 ns 
 
81.2 ± 4 ns 
77.6 ± 3 ns 
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Figure 8.3 The effect of BzATP on the dark-adapted ERG in the absence of extracellular 
magnesium ions, and in the presence of NBQX, picrotoxin, strychnine and TTX. Time 
course plots show the effect of BzATP (300 µM; 10 min) on the a-wave slope and b-wave 
amplitude. A, BzATP reduced the a-wave slope, an effect which was partially reversible 
on  washout.  B,  The  b-wave  amplitude  was  markedly  suppressed,  and  was  not  fully 
recoverable following washout. Note the relatively similar effect of BzATP on the b-wave, 
compared to that shown in fig. 8.2B. Values are mean ± SEM percentage change (n = 7). 
C,  Representative  traces  illustrate  the  effect  of  BzATP  on  the  ERG  under  these 
conditions. a, control; b, BzATP; c, wash; d, merge. D, Summary of the actions of BzATP 
on the a-wave and b-wave (mean ± SEM). ns, not significant; *, P < 0.05, compared to 
control. 
Control  BzATP   Wash 
a-wave 
Slope (% of control)  
Implicit time (ms) 
 
- 
61.1 ± 7 
 
70.1 ± 8 * 
68.5 ± 7 *  
 
78.9 ± 8 * 
60.8 ± 7 ns 
b-wave 
Amplitude (% of control)  
Implicit time (ms) 
 
- 
104.9 ± 3 
 
66.6 ± 10 * 
109.8 ± 3 * 
 
69.8 ±10 * 
108.3 ± 3 * 
D 
b  c  d  a 
124Physiological 
Krebs’ ( n = 7) 
0 mM Mg2+ 
(n = 6) 
Modified Krebs’ 
(PMSTN)  
(n = 7) 
a-wave 
Slope (% of control) A 
Change in implicit time (ms) 
 
130.5 ± 12  
+ 2.9 ± 1  
 
90.7 ± 3  
+ 2.8 ± 0 
 
70.1 ± 8  
+ 7.4  ± 2 
b-wave 
Amplitude (% of control) B 
Change in implicit time (ms) 
 
87.9 ± 4   
+ 4.3 ± 2  
 
89.5 ± 1  
+ 6.2 ± 3  
 
66.6 ± 10   
+ 5.0  ± 1  
Table  8.1  Summary  of  the  actions  of  BzATP  on  the  ERG  a-wave  and  b-wave 
components,  under  all  three  conditions  tested.  All  values  are  mean  ±  SEM.  A, 
Comparisons of the BzATP-mediated effects between conditions, on the a-wave slope: 
Krebs’ vs. 0 mM Mg+ or PMSTN, P < 0.05 for both; 0 mM Mg+ vs. PMSTN, P < 0.05. For 
the change in a-wave implicit time values, there were no significant differences in the 
effect of BzATP between conditions tested (P > 0.05, for all). B, Comparisons between 
conditions, of the BzATP-induced effect on the b-wave amplitude and implicit time. There 
were no significant differences between conditions tested, for changes to the amplitude (P 
> 0.05, for all comparisons) or implicit time (P > 0.05, for all comparisons).  
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Figure 8.4 Actions of the selective P2X7R antagonist A438079 on the BzATP-mediated 
effects on the ERG components. Values are mean ± SEM percentage of control (max. 
BzATP effect i.e. 100%; n = 7). A, The BzATP-mediated potentiation of the ERG a-wave 
was almost completely suppressed in the presence of A438079 (10 µM), compared to 
control (P < 0.05). B, A438079-induced attenuation of the BzATP-mediated reduction in 
the b-wave was observed (P < 0.05 vs. control). Note the persistent effect of BzATP on 
the  b-wave.  C,  BzATP-mediated  changes  from  baseline  implicit  time  values  in  the 
absence and presence of  A438079 (P > 0.05 for both ERG components). 
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Figure 8.5 The effect of the selective P2X7R antagonist A438079 on ERG components, in 
normal  physiological  function.  All  experiments  were  carried  out  in  PMSTN  perfusion 
medium. Values are mean ± SEM percentage of pre-treatment control; n = 10. A438079 
(10 µM) was superfused for 20 – 30 min, until the response was stable. A, Application of 
A438079 alone induced a marked potentiation in the a-wave, compared to control (P < 
0.05). B, The b-wave was significantly reduced in the presence of A438079 (P < 0.05). C, 
Representative traces reflect the A438079-mediated alterations to ERG components. a, 
control; b, A438079; c, merge. D, Implicit time values (mean ± SEM) before (control) and 
during application of A438079 (P < 0.05 vs. control, for both components). 
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Figure 8.6 The effect of BzATP on ERG oscillatory potentials. Experiments were done in 
physiological Krebs’ medium and were digitally extracted from the same ERG experiments 
shown in fig. 8.1. A, Mean ± SEM percentage of control peak power; n = 7. BzATP (300 
µM; 10 min) caused a reversible and significant reduction in the peak power output of the 
oscillatory potentials, compared to control (P < 0.05), indicating modulation of inner retinal 
function.  B,  Representative  power  spectra  of  oscillatory  potentials,  before,  during  and 
post-BzATP  application.  Black,  control;  green,  BzATP;  grey,  wash.  Under  control 
conditions, the oscillatory potentials exhibited a peak frequency ~ 107 Hz, typical of dark-
adapted ERG responses. In the presence of BzATP, no overall shift in frequency was 
detected. C, Waveform averages (120 sec) illustrate the BzATP-mediated suppression of 
the oscillatory potentials, and recovery on washout. a, control; b, BzATP; c, wash.  
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Figure 8.7 The effect of BzATP on light-evoked ON and OFF RGC fEPSPs. Responses 
are  pharmacologically  isolated,  NMDAR-mediated.  BzATP  was  applied  (10  min)  at 
concentrations of 10 (n = 2), 30 (n = 6), 100 (n = 6) and 300 µM (ON, n = 21; OFF, n = 17). 
Values are mean ± SEM percentage of pre-treatment control fEPSP peak amplitude. Aa, 
BzATP elicited a concentration-related reduction of the ON fEPSP. Washout of BzATP 
(300 µM) induced recovery of the ON fEPSP. Ba, No overall effect on the OFF fEPSP was 
measured, in the presence of BzATP across all concentrations tested. ns, not significant; 
*, P < 0.05, compared to control. Ab and Bb, Time course plots show the effect of BzATP 
(300 µM) on the ON and OFF fEPSPs, respectively. Plotted values are mean ± SEM 
percentage  change  in  fEPSP  peak  amplitude,  relative  to  pre-treatment  control.  C, 
Representative traces (120 sec averages) illustrate the effect of BzATP (300 µM) on the 
ON and OFF fEPSPs. a, control; b, BzATP; c, wash; d, merge.  
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Figure 8.8 Actions of selective P2X7R antagonists on the BzATP-induced suppression of 
the ON fEPSP. Values are mean ± SEM percentage of control relative to the BzATP 
effect. The selective P2X7R antagonists, A438079 (n = 6), A804598 (n = 7) or AF27139 (n 
= 6) significantly attenuated the BzATP (300 µM)-mediated reduction of the ON fEPSP. All 
three  compounds  exhibited  similar  potency  in  blocking  P2X7R  function,  at  the 
concentrations tested. Note that in the presence of all antagonists, a large residual effect 
on  the  ON  fEPSP  persisted  with  BzATP  application.  ns,  not  significant;  *,  P  <  0.05, 
compared to control. 
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Figure 8.9 Direct actions of selective P2X7R antagonists on NMDAR-mediated ON and 
OFF fEPSPs. Values are mean ± SEM percentage of pre-treatment control fEPSP peak 
amplitude. A, The ON fEPSP was significantly reduced in the presence of A804598 (n = 
7), but not by A438079 (n = 6) or AF27139 (n = 6), at the concentrations tested. B, There 
was no overall effect on the OFF fEPSP in the presence of the P2X7R antagonists. ns, not 
significant; *, P < 0.05, compared to control. Representative traces show the effect of 
A438079 (C), A804598 (D) and AF27139 (E) on the ON and OFF fEPSPs. For all: a, 
control; b, respective antagonist, c, merge. All scale bars: vertical, 20 µV; horizontal, 400 
ms. 
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Figure 8.10 The effect of adenosine on the NMDAR-mediated ON and OFF RGC fEPSPs. 
Adenosine (ADO) was applied (10 min) at concentrations of 100 and 300 µM. ON, n = 8; 
OFF  n  =  7,  for  both  concentrations  tested.  Aa  and  Ab,  Values  are  mean  ±  SEM 
percentage of pre-treatment control fEPSP peak amplitude, taken ~5 – 7 min after the 
start  of  adenosine  application.  Both  the  ON  and  OFF  fEPSPs  were  reversibly  and 
significantly  potentiated  by  adenosine,  in  a  concentration-related  manner.  Vehicle 
application elicited no effect on either ON or OFF fEPSPs. ns, not significant; *, P < 0.05, 
compared to control. Ab and Bb, Time course plots show the effect of adenosine (300 µM; 
green) and vehicle (yellow) on the ON and OFF fEPSPs, respectively. Plotted values are 
mean  ±  SEM  percentage  change  in  fEPSP  peak  amplitude,  relative  to  pre-treatment 
control. ns, not significant; *, P < 0.05, compared to control. C, Representative traces (120 
sec averages) illustrate the effect of adenosine (300 µM) on the ON and OFF fEPSPs. a, 
control; b, 5 min; c, 12 min ; d, wash; e, merge.  
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Figure 8.11 Actions of BzATP on the ON fEPSP in the presence of the NMDA receptor 
antagonist D-AP5. Application of D-AP5 (100 µM) significantly reduced the ON fEPSP 
amplitude, although a residual component of the fEPSP remained. A, Co-application of 
BzATP (300 µM) further suppressed the ON fEPSP, an effect which was reversible on 
washout. Values are mean ± SEM percentage of control in the presence of D-AP5. ns, not 
significant; *, P < 0.05, compared to control; n = 7. B, Time course plot shows mean ± 
SEM percentage change in fEPSP peak amplitude, relative to pre-D-AP5 application. The 
time course of the BzATP-mediated effect is comparable to that in the absence of D-AP5, 
as shown in fig. 8.7. C, Waveform averages demonstrate the effect of D-AP5 and BzATP 
co-application on the ON fEPSP. a, control; b, D-AP5; c, + BzATP; d, wash; e, merge. All 
scale bars: vertical, 20 µV; horizontal, 200 ms. iGluR, ionotropic glutamate receptor. 
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134Figure 8.12 Actions of broad-spectrum P2XR antagonists suramin and PPADS, and the 
selective P2X7R antagonist A438079 on the ON fEPSP, in the presence of the NMDA 
receptor antagonist D-AP5. Compounds were applied in the presence of D-AP5 (100 µM). 
The residual component of the ON fEPSP was significantly reduced by suramin (Aa, 100 
µM; n = 6), PPADS (Ba, 100 µM; n = 6) or A438079 (Ca, 10 µM; n = 6). Values are mean 
± SEM percentage of pre-treatment control fEPSP peak amplitude. Representative traces 
show the effects of D-AP5 and P2XR antagonist co-application. For all, b, control; c, D-
AP5; d, respective P2XR antagonist; e, wash; f, merge. All scale bars: vertical, 10 µV; 
horizontal, 400 ms. D, Summary histogram shows the effect of each compound on the 
residual fraction of the ON fEPSP, compared to pre-treatment control in the presence of 
D-AP5. The effects of suramin and PPADS suggest the involvement of other P2XRs in 
mediating  the  residual  component.  The  A438079-induced  reduction  in  the  ON  fEPSP 
indicates  that  P2X7Rs  facilitate  the ON fEPSP  in  the  absence  of  ionotropic  glutamate 
receptor  (iGluR) activity. ns, not significant; *, P < 0.05, compared to control.  
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Chapter 9 
Results: LPS and P2X7R Modulation of Microglia, and Dark-Adapted Visual 
Responses 
 
In this series of experiments, the short-term effects of microglial activation on dark-adapted 
ERG  and  ON  and  OFF  RGC  fEPSP  responses  were  explored  and  characterised.  The 
bacterial endotoxin lipopolysaccharide (LPS) was used as the activator for microglia. LPS is 
a glycolipid, and a characteristic constituent of Gram negative bacterial cell walls (Park et al., 
2009). The ability of LPS to potently stimulate the microglial innate immune response is well-
established  (Ferrari  et  al.,  1997a,  2006;  Sanz  and  Di  Virgilio,  2000).  The  length  and 
composition of the polysaccharide chains of LPS can vary with bacterial strain, although the 
hydrophobic lipid A component, the cytotoxic portion of LPS, is generally conserved (product 
information, LPS E. coli 055:B5, product no. L4524, Sigma-Aldrich, UK). The binding of LPS 
to  its  receptor  TLR4  and  associated  proteins  (Park  et  al.,  2009),  induces  microglial 
activation,  and  the  initiation  of  downstream  intracellular  signalling  cascades,  ultimately 
resulting in the upregulation and release of pro-inflammatory mediators and cytokines (see 
section 3.3.2). LPS is also known to stimulate ATP release from microglia within minutes of 
exposure (Sperlágh et al., 1998; Pascual et al., 2011).  
 
Microglial  morphology  is  closely  related  to  its  functional  state.  Thus,  the  effect  of 
endogenous  signals  on  retinal  microglial  morphology  was  first  investigated,  in  order  to 
determine whether microglial functional changes are plausible within the experimental time 
course. The LPS-induced changes in the kinetics of the ERG components and RGC fEPSPs 
were  assessed  over  an  application  period  of  15  min,  and  during  the  recovery  phase 
approximately 10 to 15 min post-wash. Unless otherwise stated, all effect values were taken 
136 
from  the  final  120  sec  of  application,  and  are  expressed  as  mean  ±  SEM.  In  order  to 
delineate  the  involvement  of  P2X7Rs  or  pannexin-1  hemichannels  in  the  LPS-mediated 
effect on visual responses, the antagonists A438079 and carbenoxolone were also used. 
Unless otherwise stated, all experiments were carried out in PMSTN perfusion medium to 
maintain consistent recording conditions between ERG and fEPSP experiments. 
 
9.1 The effect of lipopolysaccharide and BzATP on retinal microglial morphology 
Under  control  conditions,  in  PMSTN  bathing  medium,  IBA-1
+  microglia  were  dispersed 
across the retinal wholemount, from the central optic nerve head to peripheral regions. The 
cells typically displayed a non-overlapping distribution, indicative of a relatively non-activated 
state, as shown in fig. 9.1. Cells within the mid-peripheral regions of the retina exhibited 
characteristic morphology of ‘resting’ microglia. Overall, cells with  amoeboid morphology, 
which is suggestive of a typically activated microglial cell (Streit, 1999), were not observed. 
They had typically  long, thin processes protruding from a relatively smaller and rounded 
soma, and had an average microglial process area of 2656.6 ± 106 µm (n = 110 cells, 6 
retinae) (fig. 9.2A and 9.3).  
 
Application of BzATP (300 µM; 10 min) induced an observable increase in branching of 
microglial processes, compared to control, as shown in fig. 9.2. The overall morphology of 
the microglia treated with BzATP remained unchanged, with cells maintaining a typically 
ramified state. In the presence of BzATP, microglial process area was on average 3152.8 ± 
98 µm (n = 170 cells, 6 retinae), which was significantly increased, compared to control (P < 
0.05) (fig. 9.3). In the presence of LPS (10 µg/ml; 15 min), microglial processes appeared 
less branched, compared to control, suggesting retraction of processes may have occurred 
(fig. 9.2C). Morphometric analysis of the cells treated with LPS revealed an average process 
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area  of  2112.9  ±  111  µm  (n  =  108  cells,  6  retinae),  which  was  markedly  reduced  in 
comparison  to  control  conditions  (P  <  0.05)  (fig.  9.3).  These  results  demonstrated  that 
microglia  in  the  retina  have  the  capability  to  undergo  rapid  morphological  alterations  in 
response to P2X7R or TLR4 activation. However, BzATP and LPS elicited opposite effects 
on microglia, suggesting transitions to early, but differential states of microglial activation. 
 
9.2 The effect of lipopolysaccharide on the dark-adapted ERG a-wave 
LPS (10 µg/ml) did not seem to modulate the a-wave slope, following a 15 min application of 
the bacterial component (91.2 ± 10% of control;  P > 0.05, n = 7), as shown in fig.  9.4. 
Furthermore, there was no overall effect on the a-wave with vehicle application, compared to 
control (107.4 ± 6% of control, P > 0.05, n = 6), and no significant difference in the a-wave 
slope between LPS and vehicle treatment (P > 0.05) (fig. 9.4A). Neither LPS nor vehicle 
application affected the implicit time of the a-wave maximum amplitude, compared to values 
prior to treatment (P > 0.05 for both). These results suggest that LPS had no overall effect 
on the photoreceptor-derived a-wave, at the given concentration.  
 
9.3 The effect of lipopolysaccharide alone, and in the presence of A438079, on the 
scotopic ERG b-wave 
LPS (10 µg/ml) induced a significant reduction in the b-wave amplitude to 82.2 ± 4% of 
control (P < 0.05, n = 7), as illustrated in fig. 9.5. The suppressive effect of LPS on the b-
wave  amplitude  developed  relatively  slowly  and  progressed  throughout  the  duration  of 
application (fig. 9.5B). Following washout of the bacterial component, the reduction in the b-
wave amplitude was not reversible (87.9 2 ± 4% of control, P > 0.05), although a transient 
period of recovery within 2 to 5 min following washout was observed in some experiments. 
LPS significantly delayed the implicit time of the b-wave amplitude, an effect which remained 
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after washout (fig. 9.5C). Application of vehicle had no effect on the b-wave amplitude or 
implicit time (fig. 9.5A and C). 
 
The effect of LPS on the ERG b-wave in the presence of the P2X7R antagonist A438079 (10 
µM), was also investigated. Co-application of A438079 did not reduce the effect of LPS on 
the b-wave amplitude. In the presence of the antagonist, changes to the b-wave amplitude 
mediated by LPS appeared to follow a similar temporal profile to those observed with LPS 
alone  (fig.  9.5B).  Furthermore,  there  was  no  significant  difference  between  the  LPS-
mediated suppression of the b-wave in the absence and presence of A438079 (P > 0.05). 
The  LPS-induced  delay  in  the  b-wave  amplitude  was  not  apparent  in  the  presence  of 
A438079 during the application of the bacterial component (fig. 9.5C). Overall, these results 
suggest that post-photoreceptor activity  is modulated by LPS-activated glial cells. At this 
stage, the involvement of P2X7Rs  is uncertain, and could implicate a role for third-order 
neurons in modulating b-wave kinetics in the presence of LPS.  
 
9.4  The  effect  of  lipopolysaccharide  alone,  and  in  the  presence  of  A438079  or 
carbenoxolone, on the ON and OFF retinal ganglion cell fEPSPs 
The ON and OFF RGC fEPSPs were significantly reduced with a 15 min application of LPS 
(10 µg/ml), to 85.5 ± 3% of control (P < 0.05, n = 10) and 65.1 ± 6% of control (P < 0.05, n = 
8), respectively (figs. 9.6A and 9.7A). The time courses for both ON and OFF fEPSPs (fig. 
9.6B and 9.7B) show that LPS took effect within 6-8 min, on both responses. Furthermore, 
no effect was elicited by vehicle application, on the ON or OFF fEPSPs (P > 0.05 vs. pre-
treatment control, n = 7; P < 0.05 vs. LPS for both) (fig. 9.6A and 9.7A). In the presence of 
the P2X7R antagonist, A438079 (10 µM), small reductions in both the ON and OFF fEPSPs 
to 96.0 ± 2% and 95.2 ± 2% of control, respectively were observed, although these were not 
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statistically  significant,  compared  to  control  values,  pre-LPS  (P  >  0.05,  n  =  7  and  6, 
respectively).  The  effects  of  LPS  on  both  the  ON  and  OFF  fEPSPs  were  markedly 
attenuated with A438079 (P < 0.05 vs. LPS alone for both). These results suggested the 
LPS-mediated release of endogenous ATP either through P2X7Rs themselves, or through 
an alternative pathway. 
 
To  investigate  whether  endogenous  agonist  was  released  through  pannexin-1 
hemichannels, the panx-1 inhibitor, carbenoxolone (10 µM) was applied. CBX alone caused 
no  significant  effect  on  baseline  ON  and  OFF  fEPSPs  (P  >  0.05,  n  =  6  for  both).  This 
confirmed that CBX had no overall effect on retinal network activity. The suppressive effect 
of LPS on the ON fEPSP in the presence of CBX was comparable to its effect when applied 
alone as shown in fig. 9.6. Conversely, CBX apparently reduced the effect of LPS on the 
OFF fEPSP (fig. 9.7),  indicating that pannexin-1 hemichannel release of ATP  may have 
occurred from a sub-population of neurons within the OFF pathway.  
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Chapter 9 Figures 
 
    Page 
     
Figure 9.1  Distribution of microglia across the mid-peripheral region of the 
mouse retinal wholemount, under control conditions. 
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Figure 9.2 
 
Effects of BzATP or LPS on retinal microglial morphology.  143 
Figure 9.3 
 
Actions of BzATP or LPS on retinal microglial process area.  144 
Figure 9.4 
 
The effect of lipopolysaccharide on the ERG a-wave.  145 
Figure 9.5 
 
The effect of lipopolysaccharide alone, and in the presence of 
the P2X7R antagonist A438079, on the ERG b-wave. 
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Figure 9.6 
 
Actions of lipopolysaccharide alone, and in the presence of the 
P2X7R  antagonist  A438079  or  the  pannexin-1  hemichannel 
blocker carbenoxolone, on the ON RGC fEPSP. 
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Figure 9.7 
 
Actions of lipopolysaccharide alone, and in the presence of the 
P2X7R  antagonist  A438079  or  the  pannexin-1  hemichannel 
blocker carbenoxolone, on the OFF RGC fEPSP. 
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141200 µm 
ONH 
Figure 9.1 Distribution of microglia across the mid-peripheral region of the mouse retinal 
wholemount,  under  control  conditions.  The  maximum  intensity  projection  image  (mag. 
x5w)  illustrates  that  IBA-1+  microglia  were  widely  dispersed  throughout  the  retinal 
quadrants.  Retinae  were  in  the  presence  of  a  modified  Krebs’  medium  containing 
picrotoxin, strychnine, tetrodotoxin, and with extracellular magnesium ions removed from 
the perfusate. Under these control conditions, microglia within the mid-peripheral region 
typically  exhibited  a  non-overlapping  distribution,  characteristic  of  a  ‘resting’  state.  For 
consistency between treatment groups, cells around the optic nerve head (ONH) and far-
peripheral regions (~ 500 µm from the edges) were excluded from further analysis.  
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Figure 9.3 Actions of BzATP or LPS on retinal microglial process area. Values are mean ± 
SEM process area. IBA-1+ microglial process area was measured from maximum intensity 
projection images of z-stacks. Control, n = 110 cells, 6 retinae; BzATP, n = 170, 6 retinae; 
LPS, n = 108, 6 retinae). With a short-term (10 min) application of BzATP (300 µM), 
microglial  process  area  was  significantly  increased,  compared  to  control  (P  <  0.05). 
Conversely,  in  the  presence  of  LPS  (10  µg/ml;  15  min),  microglial  process  area  was 
markedly reduced, compared to control (P < 0.05). Thus, BzATP and LPS induce rapid 
alterations  to  microglial  morphology,  suggesting  that  they  stimulate  a  transition  to 
differential states of ‘alertness’ or early stages of activation. 
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Figure 9.4 The effect of lipopolysaccharide on the ERG a-wave. All values are mean ± 
SEM; n = 7, LPS; n = 6, vehicle. A, The a-wave slope was not significantly affected with 
vehicle application or a 15 min bath-application of LPS (10 µg/ml) (P > 0.05, for both, 
compared to pre-treatment control). Comparison between LPS and vehicle indicates no 
overall difference in their effect on the a-wave, between LPS and vehicle application (P > 
0.05). B, Time course plot shows mean ± SEM percentage change in the a-wave slope. 
No overall effect on the a-wave was observed in the presence of LPS. C, Change from 
baseline implicit time values. Comparison between LPS and vehicle show no significant 
difference (P > 0.05). 
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Figure  9.5  The effect  of  lipopolysaccharide  alone,  and  in  the  presence  of  the P2X7R 
antagonist A438079, on the ERG b-wave. All values are mean ± SEM; n = 7, LPS; n = 6, 
vehicle, n = 6, LPS + A438079. A, The b-wave amplitude was significantly reduced with 
direct application (15 min) of LPS (10 µg/ml) alone, and in the presence of A438079 (P < 
0.05,  for  both,  compared  to  pre-treatment  control).  Furthermore,  there  was  no  overall 
difference in the effect of LPS on the b-wave amplitude in the absence and presence of 
A438079  (P  >  0.05).  Application  of  vehicle  had  no  significant  effect  on  the  b-wave 
amplitude  (P  >  0.05,  compared  to  pre-treatment  control),  but  was  not  considered 
statistically significant from the effect of LPS (P > 0.05). B, Time course plot shows the 
percentage change in b-wave amplitude with LPS alone, and co-applied with A438079. 
The P2X7R antagonist did not affect the LPS-mediated suppression of the b-wave. C, 
Representative traces illustrate the LPS-induced reduction in the b-wave amplitude, and 
no overall effect on the a-wave slope (see Fig. 9.4). a, control; b, LPS; c, wash; d, merge. 
D,  Change  from  baseline  implicit  time  values.  Comparison  between  LPS  and  LPS  + 
A438079  or  vehicle  (P  >  0.05)  suggested  no  significant  differences  in  implicit  time 
alterations across groups. 
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Figure  9.6  Actions  of  lipopolysaccharide  alone,  and  in  the  presence  of  the  P2X7R 
antagonist A438079 or the pannexin-1 hemichannel blocker carbenoxolone, on the ON 
RGC fEPSP. All values are mean ± SEM; vehicle, n = 7; LPS, n = 10; LPS + A438079, n = 
7; LPS + CBX, n = 6. A, ns, not significant; *, P < 0.05, compared to pre-treatment control. 
LPS  (10  µg/ml;  15  min)  induced  a  significant  reduction  in  the  ON  fEPSP  amplitude, 
compared to pre-treatment control. Comparisons between groups suggest that the LPS-
mediated effect was attenuated in the presence of A438079 (10 µM; P < 0.05), but not 
with carbenoxolone (CBX; 10 µM; P > 0.05). Vehicle application had no overall effect on 
the ON fEPSP amplitude. B, Time course plot shows percentage change in the ON fEPSP 
amplitude with LPS alone and in the presence of the antagonists. Although there is no 
overall difference during LPS application, CBX appears to show a slight reduction in the 
effect of LPS during the washout phase. Inhibition of the LPS-mediated suppression of the 
ON fEPSP with A438079 is more apparent following washout. C, Representative traces 
(120 sec averages) illustrate the effect of LPS on the ON and OFF (see Fig. 9.7) RGC 
fEPSPs. a, control; b, LPS; c, wash; d, merge. All scale bars: vertical, 20 µV; Horizontal, 
400 ms. 
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Figure  9.7  Actions  of  lipopolysaccharide  alone,  and  in  the  presence  of  the  P2X7R 
antagonist A438079 or the pannexin-1 hemichannel blocker carbenoxolone, on the OFF 
RGC fEPSP. All values are mean ± SEM; vehicle, n = 7; LPS, n = 7; LPS + A438079, n = 
6; LPS + CBX, n = 6. A, ns, not significant; *, P < 0.05, compared to pre-treatment control. 
LPS (10 µg/ml; 15 min) significantly reduced the OFF fEPSP amplitude, compared to 
pre-treatment control. Comparisons between groups suggest that the LPS-mediated effect 
was attenuated in the presence of A438079 (10 µM; P < 0.05), or carbenoxolone (CBX; 10 
µM; P < 0.05). Vehicle application had no overall effect on the OFF fEPSP amplitude. B, 
Time course plot shows the percentage change in the OFF fEPSP amplitude with LPS 
alone and in the presence of the antagonists. A progressive and marked suppression of 
the OFF fEPSP induced by LPS was considerably attenuated in the presence of either 
antagonist, with comparable potency.  
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Chapter 10 
Discussion 
 
The  investigations  presented  in  this  thesis  sought  to  verify  and  characterise  a  role  for 
P2X7Rs in modulating rod photoreceptor-mediated outer and inner retinal function, using an 
ex vivo mouse retinal wholemount preparation. Furthermore, the involvement of P2X7Rs in 
the putative microglial-mediated modulation of signal  transmission in the retina  was also 
explored.  
 
The dark-adapted, light-evoked electroretinogram (ERG), and excitatory ON retinal ganglion 
cell (RGC) fEPSP responses were identified as predominantly glutamatergic, mediated via 
the  ‘classic’  rod  photoreceptor  –  rod-ON  bipolar  cell  pathway.  It  was  shown  that  P2X7R 
activation directly modulates photoreceptor, ON bipolar cell and ON RGC function, but not 
OFF RGC function. The differential spatiotemporal effects mediated by this receptor indicate 
that P2X7R activation modulates inner retinal function independently of its effects in the outer 
retina. In addition,  it  was demonstrated that acute application of the microglial-activating 
bacterial  component,  lipopolysaccharide  (LPS),  modulates  inner  retinal  function,  possibly 
through a P2X7R-associated mechanism of endogenous ATP release. Furthermore, P2X7Rs 
and other P2XR subtypes were found to contribute to an excitatory residual component of 
the ON RGC fEPSP, which was not mediated through ionotropic glutamate receptors. 
 
10.1 Dark-adapted, extracellular electroretinogram and retinal ganglion cell responses 
are predominantly mediated by the rod photoreceptor – ON bipolar cell pathway 
149 
The mouse retina largely consists of rods, with cones comprising ~3% of the photoreceptor 
mosaic (Jeon et al., 1998). Thus, depending on the state of dark or light adaptation, retinal 
synaptic  responses  can  essentially  be  driven  by  ‘mixed’  rod-  and  cone-mediated  inputs 
(Rosolen et al., 2008). Dark-adapted recording conditions and the use of a dim light stimulus 
ensured that rod-driven pathways were dominant in these experiments (Peachey and Ball, 
2003). 
 
10.1.1 Electroretinogram characterisation 
Changes to photoreceptor function were determined through analysis of the negative ERG 
a-wave, which under dark-adapted conditions, is recognised to be predominantly driven by 
rod photoreceptors (Lamb and Pugh, 2006). The light intensity-response relationship of the 
a-wave (fig. 7.2Aa) shows that in physiological medium, the a-wave saturated at -0.62 log 
cd.s/m
2, an intensity well within the scotopic to mesopic range. The a-wave appeared to be 
enhanced  when  recorded  in  the  pharmacologically  modified  perfusion  medium,  possibly 
reflecting release of inhibition of rods by horizontal cells, due to the addition of the GABAA/C 
receptor  antagonist  picrotoxin.  However,  the  specific  role  of  horizontal  cells  in  providing 
inhibitory inputs to rods is disputed, as receptive field surround properties in the retina are 
diminished  under  dark-adapted  conditions.  In  support  of  this  notion,  mammalian  rod-ON 
bipolar cells have not shown to express surround responses  (Bloomfield and Xin, 2000). 
Alternatively, the observed enhancement of the a-wave could also be due to an increase in 
the Na
+-driven rod dark current, promoted by a reduction in extracellular magnesium in the 
perfusate. Essentially, normal photoreceptor function was not disrupted across the range of 
light  intensities,  when  comparing  responses  between  the  different  bathing  solutions,  as 
supported by the comparable stimulus intensity-response data. 
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The  relatively  large-amplitude,  positive  ERG  b-wave  is  classically  known  to  reflect  ON 
bipolar cell activity (Massey et al., 1983; Stockton and Slaughter, 1989). Connected directly 
in series with its photoreceptor input (Boycott and Kolb, 1973), this relationship is supported 
by its stimulus intensity-response function, where the b-wave amplitude exhibits potentiation 
with  increasing light  intensity. Considering that in the outer retina, the  rod photoreceptor 
signal is exclusively transduced to rod-ON bipolar cells, it is reasonable to conclude that this 
is the dominant pathway driving the ERG responses. Although the b-wave appears delayed 
with  the change in perfusion medium, overall function  of the rod-ON bipolar cells  is not 
affected, as supported by the stimulus intensity-response data and the preservation of the 
waveform. The increase in the implicit time of the b-wave is probably due to the addition of 
TTX, picrotoxin and strychnine, which are likely to block regulation of presynaptic bipolar cell 
terminals in the inner retina, by third order neurons (Dong and Hare, 2000, 2002). The ON 
pathway  dominance  of  the  b-wave  is  further  ensured  with  the  addition  of  NBQX  in  the 
modified perfusion medium, which blocks any possible contribution to the b-wave from OFF 
bipolar cells, as they are normally depolarised by AMPA/KA receptors (Euler et al., 1996). 
This is confirmed by the substantial sensitivity of the b-wave to the mGluR6 agonist L-AP4, 
which selectively and potently abolished post-photoreceptor responses of the ON pathway, 
previously demonstrated in classic studies (Massey et al., 1983; Slaughter and Miller, 1983; 
Stockton and Slaughter, 1989). 
 
Although  a  selective  agonist  for  group  III  mGluRs  (mGluR4/6/7/8),  L-AP4  does  not  show 
selectivity at any particular subtype within the group, all of which have been localised within 
the retina (Brandstätter et al., 1998). Therefore, it is possible that the agonist may bind to an 
alternative  group  III  subtype.  In  particular,  mGluR8  has  been  shown  to  act  as  an 
autoreceptor at photoreceptor terminals. Its activation leads to the closure of L-type calcium 
channels, decreasing intracellular calcium within photoreceptors and subsequently reducing 
glutamate release (Koulen, 1999). This would result in a sign-conserving effect on the ON-
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bipolar cell, rather than the hyperpolarisation seen with mGluR6 activation (a sign-inverting 
effect).  The  mGluR4  and  mGluR7  subtypes,  which  are  primarily  expressed  in  the  inner 
retinal layers, are unlikely to have a direct and such a pronounced effect on the outer retinal, 
ON-bipolar cell response (Brandstätter et al., 1998). Therefore, in the present study, it is 
most probable that L-AP4 exerts its effects through the activation of postsynaptic mGluR6 in 
ON-bipolar cells.All experiments were carried out using stimulus intensities that elicited sub-
maximal responses, typically within the range of -2 to -1 log cd.s/m
2. Additional evidence for 
rod pathway dominance of the ERG responses recorded within this luminance range comes 
from  the  characterisation  of  the  oscillatory  potentials.  Digital  filtering  of  the  ERG  and 
corresponding analysis of the frequency spectrum identified that the dominant frequency of 
the  oscillatory  potentials  peaked  at  approximately  100  Hz  (fig.  6.2)  when  evoked  by  a 
stimulus intensity within the given range. This frequency is characteristic of rod-driven inputs 
under  dark-adapted  conditions,  which  is  higher  than  that  of  cone-derived  oscillatory 
potentials in the mouse ERG (~ 75 Hz) (Asi and Perlman, 1992; Lei et al., 2006; Zhang et 
al.,  2007).  Thus,  several  lines  of  evidence  support  the  notion  that  the  ERG  responses 
recorded during the course of this study were predominantly driven by the rod photoreceptor 
– ON-bipolar cell pathway. 
 
10.1.2 Retinal ganglion cell fEPSP characterisation 
The ON and OFF retinal ganglion cell fEPSPs recorded in this study displayed characteristic 
properties of dark-adapted retinal ganglion cells. Dark-adapted RGC fEPSP responses are 
typically enhanced with the isolation of the NMDA-R component of the excitatory responses 
(fig. 7.5). Across all light intensities tested, the ON fEPSP was consistently larger, indicating 
ON  pathway  dominance  of  the  responses.  Furthermore,  the  ON  fEPSP  amplitude 
potentiated with increasing luminance, exhibiting similar properties to the ERG a- and b-
waves, whereas the OFF fEPSP was more prominent at lower luminances.  
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The removal of extracellular magnesium  ions from the perfusion medium as well as the 
addition of a combination of compounds enhanced NMDA-R activity (Yu and Miller, 1996). 
Voltage-gated sodium channel-mediated spiking activity of RGCs was blocked with TTX, 
whilst  AMPA/KA,  GABAA/C  and  glycine  receptor  functions  were  abolished  with  NBQX, 
picrotoxin and strychnine, respectively. The resultant suppression of amacrine cell-mediated 
GABAergic inhibitory surround ensured the subsequent enlargement of RGC receptive field 
centres. The dominance of the rod – rod-bipolar cell – AII cell pathway in eliciting the ON 
RGC fEPSP was further confirmed with its sensitivity to L-AP4, which suppressed rod-ON 
BC signal transmission. Furthermore, suppression of the ON and OFF RGC fEPSPs with D-
AP5 revealed a predominant NMDA-R component of both responses.  
 
The presence of NBQX and strychnine to the medium did not abolish the OFF pathway, and 
a residual OFF fEPSP persisted. This response was not sensitive to L-AP4 either, altogether 
confirming that it was not mediated via the rod  – rod-ON BC  – AII pathway.  Thus, it  is 
unlikely that the OFF fEPSP is generated directly from outer retinal input. Furthermore, a rod 
pathway  involving  connexin-mediated  coupling  to  cones  and subsequent  transmission  to 
OFF cone BCs is also ruled out due to the blockade of cone – OFF cone BC transmission 
with NBQX. Thus, it is suggested that the OFF fEPSP originates from the inner retina, rather 
than generated from a direct outer retinal drive.  
 
Indeed,  recent  evidence  suggests  that  connexin-mediated  electrical  coupling  between 
ganglion cells coordinate concerted activity between homologous cell types (Bloomfield and 
Völgyi,  2009).  However,  it  is  unclear  whether  ON  and  OFF  cells  are  directly  coupled, 
although  connexin-mediated  modulation  of  ON  and  OFF  pathways  has  shown  to  occur 
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through glycinergic AII amacrine cells (Manookin et al., 2008; Liang and Freed, 2010). Light 
intensity-response data indicate that the OFF fEPSP generated under these conditions is 
maximally responsive with lower intensity stimuli, as the responses appear to saturate when 
approaching the higher end of the tested intensity scale. Thus, it could be suggested that if 
direct coupling between ON and OFF ganglion cells is indeed the case, it may serve to 
extend the operating range of the OFF pathway at lower light intensities. 
 
10.2 P2X7Rs selectively modulate the ON pathway in the outer and inner retina 
The  present  study  has  demonstrated  that  neuronal  function  in  both  the  outer  and  inner 
mouse retina is considerably altered by  P2X7R activation, under dark-adapted conditions. 
Furthermore,  the  actions  of  P2X7Rs  are  apparently  selective  for  the  rod-mediated  ON 
pathway,  as  supported  by  several  lines  of  evidence.  It  is  also  suggested  that  P2X7R-
modulation of visual responses occurs through independent mechanisms, at different levels 
of  the  rod  pathway.  These  findings  are  not  unexpected,  as  P2X7Rs  are  expressed  on 
photoreceptors, horizontal, amacrine and retinal ganglion cells, and on non-neuronal cells 
including microglia and vascular endothelial cells within the retina. As of yet, P2X7Rs have 
not been localised to bipolar cells. 
 
10.2.1 Modulation of outer retinal function 
P2X7R-mediated  alterations  to  synaptic  transmission  from  rod  photoreceptors  to  rod-ON 
bipolar cells were assessed using the dark-adapted ERG. Under physiological conditions, 
P2X7R activation by its agonist, BzATP potentiated the a-wave, with a concomitant reduction 
in the b-wave. This finding is consistent with previous work in the rat, in vivo (Puthussery et 
al.,  2006).  BzATP  also  delayed  the  time  to  peak  of  the  a-wave,  which  could  indicate  a 
reduction in photosensitivity of the rods (Hood and Birch, 1997). However, in the study by 
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Puthussery et al. (2006), computational extraction of the sensitivity parameter of the a-wave 
leading  edge,  indicated  no  change  in  photoreceptor  sensitivity  as  a  result  of  P2X7R 
activation. Thus, the change in implicit time of the a-wave in this investigation could instead 
be attributed to a possible contamination of the BzATP-induced effect on the b-wave. 
 
The  contradictory  effects  of  BzATP  on  the  photoreceptor  and  bipolar  cell  response 
components  could  be  explained  by  a  mechanism  associated  with  a  change  in  the  dark 
current  of  the  photoreceptors.  Depolarisation  of  the  photoreceptor  terminal,  induced  by 
P2X7R activation would subsequently potentiate the a-wave during photostimulation, due to 
a  greater  change  in  the  photoreceptor  dark  current,  as  has  been  suggested  previously 
(Puthussery et al., 2006). Concurrently, facilitation of the photoreceptor dark current would 
increase  the  rate  of  glutamate  release  in  the  dark,  thus  eliciting  a  smaller  light-induced 
depolarisation of the ON-BCs. Stable calcium influx through L-type channels is imperative for 
the sustained release of glutamate from rod terminals, in darkness (Okawa and Sampath, 
2007).  A  P2X7R-dependent  rise  in  intracellular  calcium  has  previously  shown  to  directly 
stimulate vesicular glutamate release from hippocampal and cortical presynaptic terminals 
(Sperlágh et al., 2002; Alloisio et al., 2008; Marín-García et al., 2008). The present findings 
suggest that  P2X7R activation may modulate ERG responses through a similar calcium-
dependent mechanism, although direct P2X7R modulation of ribbon synapses has not yet 
been shown.  
 
P2X7R activity is enhanced in the absence of extracellular magnesium (Surprenant et al., 
1996;  Virginio  et  al.,  1997).  In  the  present  study,  removal  of  magnesium  ions  from  the 
perfusate reversed the effect of P2X7R activation on the a-wave, instead inducing a marked 
reduction  in  the  photoreceptor  response.  This  could  suggest  a  dual  function  for  P2X7R 
modulation  of  photoreceptor  activity,  whereby  an  ionic  imbalance  in  the  extracellular 
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environment  could  promote  the  switch  to  a  detrimental  function  for  P2X7Rs.  Without 
extracellular magnesium, the b-wave was suppressed by BzATP, to a similar magnitude, 
when compared to the effect in the presence of the divalent cation. Contrary to the observed 
effect in physiological perfusate, the BzATP-mediated suppression of the b-wave was not 
reversible in the absence of magnesium. The differential temporal profiles of the effect of 
BzATP on the a- and b-waves highlight independent sites of modulation by P2X7Rs in both 
the inner and outer retina. 
 
In  the  present  study,  the  suppressive  effect  of  P2X7R  activation  on  the  photoreceptor 
response was enhanced in the presence of blockers of GABAA/C, glycine and AMPA/KA 
receptors, and of voltage-gated sodium channels. It has previously been suggested that 
P2X7R-associated modulation of the mouse ERG may be due to alterations in horizontal and 
amacrine cell feedback (Vessey and Fletcher, 2012). However, the underlying mechanism of 
modulation  of  the  photoreceptor  response  may  not  be  associated  with  the  release  of 
inhibitory  inputs to the rod terminals under dark-adapted conditions  (Bloomfield and Xin, 
2000). Indeed, the study by Vessey and Fletcher (2012) found that the ERG a-wave was 
unaltered,  whereas  the  b-wave  was  markedly  potentiated  in  a  P2X7R-knockout  mouse 
model. In the present investigation, there was no overall difference in the BzATP-induced 
reduction in the b-wave, between responses recorded in the absence of magnesium alone, 
and  with  the  addition  of  pharmacological  blockers  of  inhibitory  neurotransmission.  This 
indicates that P2X7R-mediated modulation of the ON BCs is not due to an effect on inhibitory 
feedback at the ON BC terminal in the inner retina. Since BCs do not themselves express 
P2X7Rs, these results could reflect a possible modulation of both ERG components by non-
neuronal cells during P2X7R stimulation. 
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The  involvement  of  P2X7R-mediated  modulation  of  the  a-wave  was  confirmed  with  the 
selective antagonist A438079, which abolished the effect of  P2X7R on the photoreceptor 
response.  However,  a  residual  effect  of  P2X7R  modulation  remained  on  the  bipolar  cell 
response  in  the  presence  of  the  antagonist.  This  supports  the  notion  of  an  additional 
mechanism, whereby a localised release of endogenous ATP in the inner retinal layers could 
act to enhance the P2X7R-mediated effect on the ON BCs, and not at the photoreceptor 
terminals.  P2X7Rs  are  known  to  drive  ATP  release  which  then  acts  cell-autonomously. 
Indeed, P2X7R-mediated, non-vesicular release of ATP has been shown in retinal ganglion 
cells (Xia et al., 2012). 
 
These  results  strongly  suggest a  direct  role  for  P2X7Rs  in  photoreceptors  in  modulating 
outer  retinal  processing,  and  is  supported  by  studies  that  have  shown  P2X7R 
immunoreactivity at ribbon synapses within the rod spherule, in the rodent retina (Puthussery 
and Fletcher, 2004; Puthussery et al., 2006; Vessey and Fletcher, 2012). However, P2X7R 
modulation of photoreceptor function through alternative mechanisms cannot be ruled out. 
The  P2X7R  expression  profile  in  the  human  retina  has  shown  no  evidence  of 
immunoreactivity in photoreceptors (Niyadurupola et al., 2013), and may instead support the 
notion that P2X7Rs may modulate photoreceptor function through its expression in retinal 
pigment epithelial cells. Indeed, RPE cells are sources of ATP, which can be released in 
response to hyperosmotic stress (Eldred et al., 2003), through various mechanisms including 
ATP-triggered secondary ATP release, CFTR-dependent ATP efflux as  well as vesicular 
ATP secretion (Reigada and Mitchell, 2005; Reigada et al., 2005). This autostimulatory ATP 
release, may be driven through P2X7R-associated panx-1 hemichannels  (Reigada et al., 
2008).  Furthermore,  RPE  cells  have  demonstrated  the  presence  of  ectonucleotidases 
(Eldred  et  al.,  2003;  Reigada  et  al.,  2005),  which  may  rapidly  degrade  ATP  into  its 
constituents,  in order to activate other P2 and adenosine receptors in cells of the outer 
retina. 
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10.2.2 Modulation of inner retinal function 
A  selective  effect  of  P2X7R  activation  on  the  ON  pathway  was  apparent,  as  BzATP 
suppressed the ON fEPSP in a concentration-related manner, but had no overall effect on 
the OFF fEPSP. The involvement of P2X7Rs in modulating the ON fEPSP was supported by 
the partially attenuated effect of BzATP in the presence of the selective P2X7R antagonists 
A438079, A804598 or AF27139. With each antagonist, a residual effect of BzATP on the ON 
fEPSP remained, which could be explained by a lack of potency of these compounds for 
blocking P2X7R-mediated effects in the inner retinal layers. This is supported by an almost 
complete attenuation of the BzATP-mediated reduction in the ERG a-wave, but only a partial 
reduction in the agonist-induced effect on the b-wave, in the presence of A438079. 
 
Compared  to  the  more  classically  used  P2X7R  antagonists,  A438079  and  A804598  are 
generally considered amongst the most potent suppressors of mouse  P2X7R function, of 
those commercially available (Donnelly-Roberts et al., 2009a, 2009b). AF27139 is not yet 
commercially available, and A804598 has not been widely tested, but both have shown to 
potently block P2X7R-mediated cytokine release in cell culture preparations, across species  
(Donnelly-Roberts et al., 2009b; Lundbeck, DK). The less novel A438079 was chosen for 
this study as it has demonstrated potent suppression of P2X7R function in models of chronic 
pain, microglial neuroinflammation and neurodegenerative disorders in the spinal cord and 
brain  (Donnelly-Roberts  and  Jarvis,  2007;  McGaraughty  et  al.,  2007;  Clark  et  al.,  2010; 
Marcellino  et  al.,  2010;  Teixeira  et  al.,  2010).  The  use  of  A438079  in  ex  vivo  retinal 
preparations has not previously been reported, although the compound has proved potent in 
suppressing swelling-induced damage to isolated retinal ganglion cells  (Xia et al., 2012).  
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Agonist-induced P2X7R activation is known to elicit further release of ATP, through P2X7Rs 
themselves.  Thus,  the  lack  of  potency  of  these  compounds  in  suppressing  the  BzATP-
mediated  reduction  in  ON  RGC  responses  could  be  due  to  the  stimulated  release  of 
endogenous  ATP  within  the  inner  retinal  layers.  P2X7Rs  are  expressed  on  amacrine, 
ganglion  and  microglial  cells  in  the  inner  mouse  retina,  and  are  all  therefore  potential 
sources of ATP-mediated ATP release. In mammalian species, in the absence of pathology 
or inflammation, functional P2X7Rs have only been found on human Müller cells (Wurm et 
al., 2011). However, it has been shown in the rat retina that light-evoked ATP release from 
ganglion cells increases Müller cell Ca
2+ transients through activation of glial P2YRs. This in 
turn  mediates  release  of  glial  ATP,  which  is  rapidly  hydrolysed  into  adenosine;  in  turn 
hyperpolarising ganglion cells through the activation of A1 receptors (Newman, 2005).  
 
It has been proposed that the BzATP-mediated suppression of excitatory responses in the 
rodent hippocampus and brainstem was attributed to its breakdown product Bz-adenosine 
and subsequent activation of adenosine receptors (Kukley et al., 2004; Tautenhahn et al., 
2012).  However,  in  the  present  study,  the  possible  contribution  of  A1  receptors  to  the 
BzATP-mediated reduction of the ON fEPSP was ruled out. Adenosine produced a dose-
related potentiation in the ON fEPSP, an effect which followed a differential temporal profile 
to that seen for the effect of BzATP. Furthermore, adenosine also elicited a dose-related and 
sustained  effect  on  the  OFF  fEPSP.  This  suggests  that  adenosine  facilitates,  possibly 
through  A3  receptors,  both  the  ON  and  OFF  pathways  whereas  P2X7Rs  appear  to 
selectively reduce neuronal activity within the ON pathway.  
 
Although BzATP is a potent agonist of P2X7Rs, it is not selective for the receptor and can 
bind to P2X1, P2X2 and P2X3 receptors with similar potency (Sperlágh et al., 2006), and 
therefore the possibility remains that these receptor subtypes may also be activated in the 
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presence of the  agonist. P2X1R  immunoreactivity has been localised  to the  inner retinal 
layers of the cat and monkey retina (Yazulla and Studholme, 2004), although its expression 
in the mouse is uncertain. In the rodent, P2X3Rs have been detected in the inner plexiform 
layer  (Puthussery  and  Fletcher,  2007).  On  activation,  both  P2X1Rs  and  P2X3Rs  rapidly 
desensitise (North, 2002), and thus their kinetic profiles do not correlate with the BzATP-
mediated effects observed in the present study. Selective expression of P2X2Rs in starburst 
amacrine cells within the OFF vertical pathway has been demonstrated in the mouse retina 
(Kaneda et al., 2008, 2010). Although P2X2Rs display slowly desensitising properties similar 
to P2X7Rs, it is uncertain whether they would directly affect neuronal responses within the 
ON pathway. Therefore, the major component of the BzATP-mediated effects observed in 
the present investigations is most likely attributed to the activation of P2X7Rs. 
 
10.3  Functional  significance  of  short-term  P2X7R-  and  lipopolysaccharide-induced 
alterations to retinal microglial morphology  
Microglia are highly dynamic and motile, constantly surveying their microenvironment, even 
in  the  absence  of  pathological  stressors  (Nimmerjahn  et  al.,  2005).  Growing  evidence 
suggests  that  microglia  are  genuine  partners  of  neurotransmission,  fine-tuning  neuronal 
responses while also regulating physical synaptic structure (Tremblay et al., 2010; Li et al., 
2012). In the adult mouse retina, resting microglia reside exclusively in the outer and inner 
plexiform  layers  (Santos  et  al.,  2008),  although  their  role  in  modulating  visual  function 
remains unexplored.  
 
Retinal microglia are known to express both P2X7Rs and TLR4, which are stimulated by 
BzATP and LPS, respectively. The present study demonstrated that microglial morphology 
was altered relatively rapidly with short-term application of BzATP or LPS. Under baseline 
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conditions,  the  microglial  cells  exhibited  typically  ramified  morphology,  suggestive  of  a 
‘resting’ state. The presence of NBQX in the bathing medium may have reduced the size 
and complexity of the microglial processes, as shown previously in the isolated mouse retina 
(Fontainhas et al., 2011). BzATP induced an increase in microglial process area, whereas 
the same was decreased in the presence of LPS. These findings support the notion that 
microglia are highly dynamic and responsive to rapid changes in the microenvironment.  
 
The varied effects of BzATP and LPS on retinal microglia suggest the transition to differential 
stages of early microglial activation. Indeed, microglial activation is a graded response, and 
the stage of activation is highly dependent upon the levels of potential stressors in their 
external surroundings. The increase in microglial expanse with BzATP treatment indicates 
an  ‘alerted’  state  whereby  cells  become  hyper-ramified,  with  an  increased  capacity  for 
process extension and retraction. ATP is a strong chemoattractant of microglia and is known 
to regulate rapid changes in microglial motility through P2Y12Rs (Haynes et al., 2006). ATP 
in  the  extracellular  space  is  readily  hydrolysed  into  adenosine,  which  is  also  known  to 
regulate  microglial  process  retraction  and  extension  at  later  stages  of  the  microglial 
response (hours to days) (Gyoneva et al., 2009). BzATP is unlikely to activate these P2Rs at 
the concentration tested. However, release of endogenous ATP, through BzATP-activated 
P2X7Rs themselves, is highly plausible. Although, it is unclear whether BzATP acts directly 
on microglia, nearby neurons or both cell types, to elicit ATP release.  
 
LPS is a highly potent activator of microglia, and is typically used to simulate inflammation 
and  cytokine-rich  conditions.  The  present  findings  demonstrate  that  short-term  LPS 
application elicits a rapid transition to a more classically ‘activated’ microglial phenotype, 
which is not surprising. An important observation in this study is that the change in microglial 
morphology occurs within minutes in situ. This could suggest that microglial mediators such 
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as IL-1β and ATP, which have classically been associated with longer periods (hours to 
days)  of  LPS  treatment,  could  in  effect  be  released  at  detectable  concentrations,  much 
earlier.  
 
10.4 Lipopolysaccharide-induced microglial activation modulates retinal ganglion cell 
function through P2X7R- and Pannexin-1- mediated release of ATP 
P2X7Rs have classically been associated with ATP and cytokine release from microglia, 
when these cells are primed with lipopolysaccharide (LPS) for a few hours. A recent study 
has  demonstrated  that  direct  bath-application  of  LPS  modulates  excitatory 
neurotransmission through an initial release of endogenous ATP from microglia, in mouse 
hippocampal slices (Pascual et al., 2011). Furthermore, LPS has previously shown to inhibit 
long-term potentiation in the rat hippocampus, when applied directly to the slice preparation 
(Cunningham et al., 1996).  
 
The data reported in this investigation indicate that an acute inflammatory response induced 
by bath-application of lipopolysaccharide (LPS), induces a rapid modulation of excitatory 
responses  in  the  retina.  LPS  acts  through  binding  its  toll-like  receptor  TLR4,  which  is 
predominantly expressed by microglia and RPE cells in the retina (Ko et al., 2011; Kohno et 
al., 2013). TLR4 has also been localised to photoreceptors and Müller cells (Tu et al., 2011; 
Lin et al., 2013). The results of the present study showed that LPS had no overall effect on 
the a-wave, but induced a marked reduction in the b-wave. Furthermore, LPS suppressed 
both the ON and OFF RGC fEPSPs. This suggests that, at least in this investigation, the site 
of  action  of  LPS  was  primarily  within  the  inner  layers  of  the  retina,  and  rules  out  any 
modulation  of  the  photoreceptors.  In  the  mouse  retina,  TLR4  was  co-localised  almost 
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exclusively to microglia within the inner retinal layers, in the absence of inflammation (Halder 
et al., 2013), further supporting an inner retinal site of action for LPS. 
 
The LPS-induced suppression of both ON and OFF fEPSPs was attenuated in the presence 
of the P2X7R antagonist, A438079. This strongly suggests the involvement of  P2X7Rs in 
mediating the effect of LPS. Contrary to the action of BzATP, the effect of LPS was extended 
to modulate the OFF pathway, which indicates the involvement of non-neuronal, presynaptic 
P2X7Rs. Indeed, cultured microglia treated with LPS have shown to elicit a rapid release of 
ATP at nanomolar concentrations after only 15 min of endotoxin exposure (Sperlágh et al., 
1998). Furthermore, bath-applied LPS has shown to trigger microglial ATP, which in turn 
mediates  further  release  from  astrocytes,  subsequently  modulating  excitatory  synaptic 
responses in the mouse hippocampus (Pascual et al., 2011). After the initial release of ATP 
from microglia, possibly through P2X7R-mediated vesicular exocytosis (Imura et al., 2013; 
Kato et al., 2013), the amplification of  the ATP signal via a secondary source could be 
attributed  to  Müller  glia  through  P2YR  activation  (as  considered  above).  However,  the 
present  investigation  implicates  a  mechanism  by  which  further  ATP  release  occurs  via 
pannexin-1 (panx-1) hemichannels, which are predominantly expressed on retinal ganglion 
cells in the adult mouse retina (Dvoriantchikova et al., 2006), and are found abundantly co-
localised with P2X7Rs in rat ganglion cells (Xia et al., 2012).  
 
It  was  found  that  the  panx-1  inhibitor,  carbenoxolone,  markedly  attenuated  the  LPS-
mediated effect on the OFF fEPSP. A small reduction in the LPS-mediated effect on the ON 
fEPSP was observed in the presence of carbenoxolone although this was not statistically 
significant, possibly suggesting the persistence of a panx-1-independent mechanism of ATP 
release.  Indeed,  P2X7Rs  can  act  as  conduits  for  ATP  release  either  through  their  own 
transmembrane channel, as well as via associated panx-1 hemichannels (Praetorius and 
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Leipziger, 2009; Fields, 2011; Xia et al., 2012). The present investigation has demonstrated 
that  OFF  RGC  fEPSPs  are  not  modulated  by  P2X7Rs,  thus  an  OFF-pathway  specific 
mechanism of action of panx-1 is considered unlikely as ATP release via panx-1 normally 
requires P2X7R activation. A438079 is also known to inhibit panx-1 activity. It is proposed 
that the attenuated LPS-mediated effect of both ON and OFF RGC fEPSPs in the presence 
of A438079 may be due to the inhibition of microglial  P2X7Rs, as well as the combined 
blockade of P2X7Rs and panx-1 on the ON RGCs. In the absence of panx-1 activity, P2X7Rs 
may still mediate localised ATP release (through microglia or RGCs) and subsequent cell-
autonomous P2X7R activation in ON RGCs, resulting in a persistent reduction of the ON 
fEPSP with LPS. It is possible that panx-1 blockade prevents a large spillover of ATP, which 
could  otherwise  suppress  OFF  RGC  responses  through  the  activation  of  alternative 
purinergic receptors. 
 
Following washout of LPS, its effect on the ON fEPSP was not reversible, whereas the OFF 
fEPSP showed partial recovery. This further supports the notion of a localised and sustained 
release  of  ATP  near  synapses  within  the  ON  pathway,  which  is  likely  to  initiate  further 
inflammatory responses. At this point, it would not be unreasonable to consider the role of 
multiple  ATP-mediated  mechanisms  as  the  signal  is  rapidly  and  effectively  amplified  in 
response to acute stressors. 
 
As well as ATP release, LPS and P2X7R stimulation of microglia induces the release of 
cytokines,  such  as  Il-1β  and  TNFα,  which  have  shown  to  specifically  modulate  NMDA 
receptor-mediated neuronal function and hippocampal long-term potentiation in vitro and in 
vivo  (Katsuki  et  al.,  1990;  Plata-Salamán  and  Ffrench-Mullen,  1992;  Zeise  et  al.,  1992; 
Bellinger  et  al.,  1993;  Cunningham  et  al.,  1996;  Schneider  et  al.,  1998;  Coogan  and 
O’Connor,  1999;  Vereker  et  al.,  2001).  Under  pathological  conditions,  cytokine  release 
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stimulated  through  this  pathway  is  believed  to  involve  the  inflammasome  complex  (see 
section 3.3.2). However, upregulation and assembly of the associated proteins would be on 
a time scale of hours upon LPS stimulation, due to the requirement for gene transcription, 
therefore ruling out inflammasome involvement in the present investigation. P2X7R activation 
has been shown to induce IL-1β release via alternative mechanisms such as microvesicle 
shedding, from microglia (Dubyak, 2012). 
 
10.5 P2X7Rs contribute an excitatory non-iGluR residual component of the ON RGC 
fEPSP  
When  applied  alone,  A438079  induced  a  marked  potentiation  in  the  ERG  a-wave  while 
suppressing the b-wave, suggesting that in the absence of a high extracellular concentration 
of ATP, P2X7Rs modulate normal neuronal function in the retina. A438079 or AF27139 had 
no effect on the ON fEPSP, whereas the response was reduced by A804598. Overall, the 
OFF fEPSP was not affected by A438079, A804598 or AF27139, further suggesting ON 
pathway dominance for P2X7R modulation in the retina.  
 
Exclusion of the fast responses to glutamate and GABA with their respective antagonists 
identified a small residual component of the ON and OFF RGC fEPSPs persisted. A438079, 
as well as the broad-spectrum P2XR antagonists suramin and PPADS were used to further 
characterise  the  ON  RGC  fEPSP  residual  fraction,  and  to  investigate  whether  this  was 
mediated via a purinergic receptor. In the presence of D-AP5, suramin and PPADS induced 
relatively large suppressive effects on the ON fEPSP. This strongly suggests a contribution 
of  P2XRs  in  mediating  this  residual  component.  Furthermore,  A438079  induced  a  small 
reduction in the ON fEPSP in the presence of D-AP5, contrary to its effect in the absence of 
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the NMDA-R antagonist. This could suggest that P2X7Rs could compensate for a loss of 
ionotropic glutamate receptor activity by facilitating the excitatory drive.  
 
The co-application of BzATP in the presence of D-AP5 induced a reversible reduction in the 
ON fEPSP, comparable to the BzATP-mediated effect in the absence of the antagonist. This 
demonstrates that a high extracellular concentration of agonist switches the P2X7R function 
from facilitatory to inhibitory, and thus supports the notion that P2X7Rs may exemplify a dual 
function depending on the conditions of the extracellular environment.  
 
10.6 Conclusions 
The findings of the present study verify the previously reported notion that acute activation of 
P2X7Rs with the agonist, BzATP markedly alters outer and inner retinal function (Puthussery 
et al., 2006). P2X7Rs have been specifically localised to synapses within the rod pathway of 
the mammalian retina (Puthussery and Fletcher, 2004; Puthussery et al., 2006; Vessey and 
Fletcher,  2012).  With  the  use  of  a  dark-adapted,  ex  vivo  mouse  retinal  wholemount 
preparation, it was possible to investigate and dissect P2X7R involvement in the purinergic 
modulation of predominantly rod-mediated responses, in the outer and inner retina. 
 
Photoreceptor and rod ON bipolar cell responses were investigated using transretinal ERG 
recordings. In physiological perfusion medium, the photoreceptor response was facilitated 
with BzATP, whereas the same was suppressed on removal of magnesium. This suggests 
that  a  detrimental  P2X7R  function  could  be  activated  under  unfavourable  or  stressed 
conditions within the extracellular environment. Such an effect was not seen on the ON 
bipolar cell-mediated ERG b-wave response, which was markedly reduced with BzATP in all 
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perfusates  tested.  The  presence  of  the  P2X7R  antagonist,  A438079  almost  completely 
suppressed  the  effect  of  BzATP  on  the  photoreceptor  response,  whereas  the  agonist-
induced  effect  on  the  ON  bipolar  cell-derived  b-wave  was  only  partially  reduced  with 
A438079. Thus, it is proposed that P2X7R activation occurs at differential sites in the outer 
and inner retina. 
 
ON and OFF retinal ganglion cell function were explored by recording light-evoked NMDA 
receptor-mediated  extracellular  fEPSPs  from  the  ganglion  cell  layer  of  the  retinal 
wholemount.  P2X7R  activation  significantly  attenuated  ON  RGC  fEPSPs,  with  no  overall 
effect on the OFF RGC fEPSPs, indicating a selective modulation of the ON pathway, by 
P2X7Rs. In the presence of selective P2X7R antagonists, a residual BzATP-mediated effect 
on the ON fEPSP remained, suggesting that potential endogenous ATP release in the inner 
retinal layers may reduce the potency of these antagonists.  
 
P2X7Rs are also present on microglia, which reside in the outer and inner plexiform layers in 
the  adult  retina.  Investigation  of  retinal  microglia  revealed  that  BzATP  and  LPS  rapidly 
modulate microglial morphology, under similar conditions, and within the same time course 
as  for  the  electrophysiological  experiments.  Such  morphological  changes  indicate  that 
microglial function is also altered, and may effectively modulate neuronal responses. Indeed, 
LPS-mediated acute microglial activation revealed a novel mechanism by which an initial 
P2X7R-mediated  ATP  release  from  LPS-activated  microglia  resulted  in  suppression  of 
neuronal responses in the inner retina, through rapid amplification of the extracellular ATP 
signal.  Such  amplification  is  suggested  to  involve  P2X7R-associated  pannexin-1 
hemichannels,  which  are  known  to  localise  predominantly  on  retinal  ganglion  cells  and 
mediate neuronal ATP release (Xia et  al., 2012), which subsequently activates neuronal 
P2X7Rs,  suppressing  retinal  ganglion  cell  function.  Fig.  10.1  illustrates  a  possible 
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mechanism  by  which  LPS  and  subsequent  P2X7R  activation  may modulate  inner  retinal 
synapses within the rod-mediate ON pathway. 
 
Release of extracellular ATP and the activation of P2X7Rs, along with the initiation of various 
inflammatory  cascades  are  phenomena  common  to  many  retinal  diseases  that  lead  to 
reduced,  or  loss  of  vision,  such  as  neuronal  degeneration  in  retinitis  pigmentosa  and 
glaucoma. Furthermore, P2X7Rs are heavily associated with diabetic retinopathy and retinal 
ischemia. Thus, P2X7Rs are highly plausible therapeutic targets for alleviation of various 
retinal  degenerative  conditions.  The  role  of  microglia  as  genuine  partners  in  retinal 
neurotransmission  has  also  been  highlighted.  This  study  provides  evidence  that  through 
purinergic signalling, early changes in the immunological state of the central nervous system 
can have detrimental effects on neuronal function, and offers a wider understanding of local 
neural-immune interactions, which may precede more prominent, symptomatic changes in 
disease. 
 
10.7 Future Directions  
A novel finding of this thesis, that an early stage of microglial activation can modulate visual 
responses in the retina through purinergic signalling, offers an exciting avenue for extending 
this work. Under physiological conditions, microglia are highly dynamic and motile in their 
resting state (Davalos et al., 2005; Nimmerjahn et al., 2005).  In the mouse visual cortex, 
resting microglia have shown to contact dendritic spines with their processes, modifying or 
eliminating  synapses  in  vivo  (Wake  et  al.,  2009;  Tremblay  et  al.,  2010).  Further,  in  the 
zebrafish optic tectum, high neuronal activity has been demonstrated to attract microglial 
processes through purinergic signalling, which then reduce spontaneous and visually evoked 
responses, thereby regulating normal neuronal function (Li et al., 2012). It would be possible 
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to  explore  such  putative,  dynamic  microglial-neuronal  contacts  in  the  ex  vivo  retinal 
wholemount  preparation,  through  the  use  of  time-lapse  confocal  imaging  and  green 
fluorescent  protein-labelled  microglia.  Employing  the  wholemount  preparation  for  further 
study  would  also  enable  the  recording  of  neuronal  responses,  simultaneously  with 
visualising microglia, under physiological conditions.  
 
Other mediators of inflammation released through P2X7R activation, such as the cytokine IL-
1β,  have  previously  shown  to  modulate  neuronal  activity  in  the  hippocampus.  Microglial 
activation, ATP release, P2X7R activation and IL-1β release are phenomena which occur in 
the  presence  of  various  acute  stressors  in  the  microenvironment.  Extending  the  current 
work, to explore the possible neuromodulatory function of IL-1β and other cytokines in retinal 
visual processing, would provide a better understanding of neural-immune interactions at the 
very early stages of inflammation and disease, not only in the retina, but across the central 
nervous system.  
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Chapter 10 Figures 
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Figure 10.1 
 
Schematic  of  the  possible  mechanism  by  which  early 
lipopolysaccharide-induced  microglial  activation  and  P2X7Rs 
could modulate the rod ON pathway through extracellular ATP 
release in the inner retina. 
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Figure  10.1 Schematic  of  the possible  mechanism  by  which  early  lipopolysaccharide-
induced microglial activation and P2X7Rs could modulate the rod ON pathway through 
extracellular ATP release in the inner retina. 1, In the inner plexiform layer, the ON rod 
bipolar cell (ON rBC) signal is transduced to the ON retinal ganglion cell (ON RGC) via the 
AII amacrine cell (AII) pathway. Glutamate is released from ON rBC ribbon synapses, 
activating postsynaptic ionotropic glutamate receptors (iGluRs) on the AII cell. In turn, the 
AII cell transmits the rod signal to the ON cone bipolar cell (ON cBC) terminal, through 
gap  junctions.  2,  Activation  of  postsynaptic  iGluRs  on  the  ON  RGC  results  in 
depolarisation. 3, Lipopolysaccharide (LPS) binds to toll-like receptor-4 (TLR4; purple) on 
the  microglial  cell  (MIC),  inducing  the  release  of  ATP,  possibly  through  P2X7Rs 
themselves (4). TLR4 activation is known to enhance P2X7R activity, although the exact 
mechanism by which this occurs is uncertain. The C-terminus of the P2X7R contains an 
LPS binding domain, which could be modulated by an internalised LPS-TLR4 complex. 5, 
The presence of high levels of extracellular ATP in the local microcircuit may stimulate 
postsynaptic P2X7Rs on the ON RGC, resulting  in an overall attenuation of ON RGC 
function.  In  turn,  further  ATP  release  occurs  through  P2X7R-associated  Pannexin-1 
hemichannels,  ultimately  amplifying  extracellular  ATP  release,  and  activating  further 
downstream  mechanisms.  6,  It  is  uncertain  whether  Pannexin-1  hemichannels  are 
functional on resting microglia in the retina. However, these channels are known to be 
important in mediating cytokine release from microglia under inflammatory conditions, in 
other areas of the central nervous system. ATP release may also occur through microglial 
Pannexin-1 channels. 7, Potentially, the large, amplified release of ATP may spillover to 
cellular targets within the OFF pathway, to modulate OFF RGC function. ATP is rapidly 
hydrolysed in the extracellular space, and could therefore alter neuronal and Müller glial 
activity  through  the  activation  of  alternative  purinergic  receptors.  8,  TLR4  and  P2X7R 
activation  are  also  associated  with  the  release  of  other  inflammatory  mediators  from 
microglia, such as the cytokine interleukin-1β (IL-1β). In the brain, IL-1β has shown to 
potently modulate NMDA-R-mediated neuronal function, and therefore, may also play a 
role in regulating synaptic function in the inner retina.  
171 
References 
 
Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in 
the nervous system: an overview. Trends Neurosci 32:19–29. 
Adinolfi E, Kim M, Young MT, Di Virgilio F, Surprenant A (2003) Tyrosine phosphorylation of 
HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol 
Chem 278:37344–37351. 
Adriouch  S,  Dox  C, Welge  V,  Seman M,  Koch-Nolte  F,  Haag  F  (2002)  Cutting  edge:  a 
natural P451L mutation in the cytoplasmic domain impairs the function of the mouse 
P2X7 receptor. J Immunol 169:4108–4112. 
Alloisio S, Cervetto C, Passalacqua M, Barbieri R, Maura G, Nobile M, Marcoli M (2008) 
Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve 
terminals. FEBS Lett 582:3948–3953. 
Ashwell  KW,  Holländer  H,  Streit  W,  Stone  J  (1989)  The  appearance  and  distribution  of 
microglia in the developing retina of the rat. Vis Neurosci 2:437–448. 
Asi H, Perlman I (1992) Relationships between the electroretinogram a-wave , b-wave and 
oscillatory potentials and their application to clinical diagnosis. Doc Ophthalmol 79:125–
139. 
Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E (2008) Status epilepticus 
induces a particular microglial activation state characterized by enhanced purinergic 
signaling. J Neurosci 28:9133–9144. 
Balasubramanian V, Sterling P (2009) Receptive fields and functional architecture in the 
retina. J Physiol 587:2753–2767. 
Ballerini P, Di Iorio P, Ciccarelli R, Nargi E, D’Alimonte I, Traversa U, Rathbone MP, Caciagli 
F (2002) Glial cells express multiple ATP binding cassette proteins which are involved 
in ATP release. Neuroreport 13:1789–1792. 
Banerjee RK (1981) Ecto-ATPase. Mol Cell Biochem 37:91–99. 
Baraldi  PG,  Di  Virgilio  F,  Romagnoli  R  (2004)  Agonists  and  antagonists  acting  at  P2X7 
receptor. Curr Top Med Chem 4:1707–1717. 
Béchade C, Cantaut-Belarif Y, Bessis A (2013) Microglial control of neuronal activity. Front 
Cell Neurosci 7:32. 
Bellinger FP, Madamba S, Siggins R (1993) Interleukin 1-beta inhibits synaptic strength and 
long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227–234. 
Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, Park HS, Yu H, 
Metzger  R,  Kowaluk  E,  Jarvis  MF,  van  Biesen  T  (1999)  Pharmacological 
characterization  of  recombinant  human  and  rat  P2X  receptor  subtypes.  Eur  J 
Pharmacol 376:127–138. 
172 
Bianco F, Pravettoni E, Colombo A, Schenk U, Moller  T,  Matteoli  M, Verderio  C (2005) 
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1  Release from Microglia. J 
Immunol 174:7268–7277. 
Bloomfield S, Dacheux R (2001) Rod vision: pathways and processing in the mammalian 
retina. Prog Retin Eye Res 20:351–384. 
Bloomfield S, Xin D (2000) Surround inhibition of mammalian AII amacrine cells is generated 
in the proximal retina. J Physiol 523 Pt 3:771–783. 
Bloomfield SA, Völgyi B (2009) The diverse functional roles and regulation of neuronal gap 
junctions in the retina. Nat Rev Neurosci 10:495–506. 
Boos R, Muller F, Wassle H (1990) Actions of excitatory amino acids on brisk ganglion cells 
in the cat retina. J Neurophysiol 65:1368–1379. 
Boumechache M, Masin M, Edwardson JM, Górecki DC, Murrell-Lagnado R (2009) Analysis 
of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent 
immune cells. J Biol Chem 284:13446–13454. 
Boycott BB (1988) Horizontal cells of mammalian retinae. Neurosci Res 8:S97–S111. 
Boycott BB, Kolb H (1973) The connections between bipolar cells and photoreceptors in the 
retina of the domestic cat. J Comp Neurol 148:91–114. 
Brändle U, Kohler K, Wheeler-Schilling TH (1998) Expression of the P2X7-receptor subunit 
in neurons of the rat retina. Mol brain Res 62:106–109. 
Brandstätter  JH,  Koulen  P,  Wässle  H  (1998)  Diversity  of  glutamate  receptors  in  the 
mammalian retina. Vision Res 38:1385–1397. 
Bringmann A, Grosche A, Pannicke T, Reichenbach A (2013) GABA and glutamate uptake 
and metabolism in retinal glial (Müller) cells. Front Endocrinol (Lausanne) 4:48. 
Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne 
NN, Reichenbach A (2006) Müller cells in the healthy and diseased retina. Prog Retin 
Eye Res 25:397–424. 
Bringmann A, Pannicke T, Moll V, Milenkovic I, Faude F, Enzmann V, Wolf S, Reichenbach 
A  (2001)  Upregulation  of  P2X(7)  receptor  currents  in  Müller  glial  cells  during 
proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 42:860–867. 
Bringmann  A,  Pannicke  T,  Uhlmann  S,  Kohen  L, Wiedemann  P,  Reichenbach  A  (2002) 
Membrane conductance of Müller glial cells in proliferative diabetic retinopathy. Can J 
Ophthalmol 37:221–227. 
Bringmann A, Wiedemann P (2012) Müller glial cells in retinal disease. Ophthalmologica 
227:1–19. 
Buisman HP, Steinberg TH, Fischbarg J, Silverstein SC, Vogelzang S, Ince C, Ypey DL, 
Leijh  PC  (1988)  Extracellular  ATP  induces  a  large  nonselective  conductance  in 
macrophage plasma membranes. Proc Natl Acad Sci U S A 85:7988–7992. 
173 
Burnstock G (2007) Physiology and Pathophysiology of Purinergic Neurotransmission. Auton 
Neurosci:659 –797. 
Burnstock  G,  Campbell  G,  Satchell  D,  Smythe  A  (1970)  Evidence  that  adenosine 
triphosphate  or  a  related  nucleotide  is  the  transmitter  substance  released  by  non-
adrenergic inhibitory nerves in the gut. Br J Pharmacol 40:668–688. 
Burnstock G, Krügel U, Abbracchio MP, Illes P (2011) Purinergic signalling: From normal 
behaviour to pathological brain function. Prog Neurobiol 95:229–274. 
Burnstock G, Satchell DG, Smythe A (1972) A comparison of the excitatory and inhibitory 
effects of non-adrenergic , non-cholinergic nerve stimulation and exogenously applied 
ATP on a variety of smooth muscle preparations from different vertebrate species. Br J 
Pharmacol 46:234–242. 
Buttery RG, Hinrichsen CF, Weller WL, Haight JR (1991) How thick should a retina be? A 
comparative  study  of  mammalian  species  with  and  without  intraretinal  vasculature. 
Vision Res 31:169–187. 
Carter-Dawson LD, LaVail MM (1979) Rods and cones in the mouse retina. I. Structural 
analysis using light and electron microscopy. J Comp Neurol 188:245–262. 
Chakfe Y, Seguin R, Antel JP, Malo D, Henderson D, Philippe S (2002) ADP and AMP 
induce interleukin-1-beta release from microglial cells through activation of ATP-primed 
P2X7 receptor channels. J Neurosci 22:3061–3069. 
Chen L, Yang P, Kijlstra A (2002) Distribution, markers, and functions of retinal microglia. 
Ocul Immunol Inflamm 10:27–39. 
Chessell I, Simon J, Hibell A., Michel A., Barnard E., Humphrey PP. (1998a) Cloning and 
functional characterisation of the mouse P2X7 receptor. FEBS Lett 439:26–30. 
Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, 
Richardson J, Peck WL, Grahames CB a, Casula MA, Yiangou Y, Birch R, Anand P, 
Buell  GN  (2005)  Disruption  of  the  P2X7  purinoceptor  gene  abolishes  chronic 
inflammatory and neuropathic pain. Pain 114:386–396. 
Chessell  IP,  Michel  AD,  Humphrey  PP  (1997)  Properties  of  the  pore-forming  P2X7 
purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol 121:1429–1437. 
Chessell  IP,  Michel  AD,  Humphrey  PPA  (1998b)  Effects  of  antagonists  at  the  human 
recombinant P2X7 receptor. Br J Pharmacol:1314–1320. 
Clark AK, Staniland AA, Marchand F, Kaan TKY, McMahon SB, Malcangio M (2010) P2X7-
dependent  release  of  interleukin-1beta  and  nociception  in  the  spinal  cord  following 
lipopolysaccharide. J Neurosci 30:573–582. 
Cockcroft S, Gomperts BD (1980) The ATP4- receptor of rat mast cells. Biochem J 188:789–
798. 
Coddou C, Yan Z, Obsil T, Huidobro-toro JP, Stojilkovic SS (2011) Activation and regulation 
of purinergic P2X receptor channels. Pharmacol Rev 63:641–683. 
174 
Cohen  ED,  Miller  RF  (1999)  The  network-selective  actions  of  quinoxalines  on  the 
neurocircuitry operations of the rabbit retina. Brain Res 831:206–228. 
Coleman  PA,  Miller  F  (1988)  Do  N-methyl-D-aspartate  receptors  mediate  synaptic 
responses in the mudpuppy retina? J Neurosci 8:4728–4733. 
Coogan AN, O’Connor JJ (1999) Interleukin-1beta inhibits a tetraethylammonium-induced 
synaptic potentiation in the rat dentate gyrus in vitro. Eur J Pharmacol 374:197–206. 
Costa G, Pereira T, Neto a M, Cristóvão a J, Ambrósio AF, Santos PF (2009) High glucose 
changes extracellular adenosine triphosphate levels in rat retinal cultures. J Neurosci 
Res 87:1375–1380. 
Costa-Junior  HM,  Sarmento  Vieira  F,  Coutinho-Silva  R  (2011)  C  terminus  of  the  P2X7 
receptor: treasure hunting. Purinergic Signal 7:7–19. 
Cunningham AJ, Murray CA, O’Neill LAJ, Lynch MA, O’Connor JJ (1996) Interleukin-1β (IL-
1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate 
gyrus in vitro. Neurosci Lett 203:17–20. 
D’Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carrì MT, 
Volonté C (2009) The proinflammatory action of microglial P2 receptors is enhanced in 
SOD1 models for amyotrophic lateral sclerosis. J Immunol 183:4648–4656. 
D’Amico M, Samengo I, Navarra P, Taglialatela M,  Martire  M (2010) AMPA- and P2X7-
receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated 
from the rat caudal brainstem. Neurochem Int 57:623–628. 
Dacheux RF, Miller RF (1981) An intracellular electrophysiological study of the ontogeny of 
functional synapses in the rabbit retina. I. Receptors, horizontal, and bipolar cells. J 
Comp Neurol 198:307–326. 
Dalmau  I,  Vela  JM,  González  B,  Castellano  B  (1998)  Expression  of  purine  metabolism-
related  enzymes  by  microglial  cells  in  the  developing  rat  brain.  J  Comp  Neurol 
398:333–346. 
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB 
(2005)  ATP  mediates  rapid  microglial  response  to  local  brain  injury  in  vivo.  Nat 
Neurosci 8:752–758. 
Denlinger LC, Fisette PL, Sommer J a, Watters JJ, Prabhu U, Dubyak GR, Proctor RA, 
Bertics PJ (2001) Cutting edge: the nucleotide receptor P2X7 contains multiple protein- 
and  lipid-interaction  motifs  including  a  potential  binding  site  for  bacterial 
lipopolysaccharide. J Immunol 167:1871–1876. 
Denlinger  LC,  Sommer  JA,  Parker  K,  Fisette  PL,  Watters  JW,  Richard  A,  Dubyak  GR, 
Bertics PJ, Gudipaty L, Proctor RA (2003) Mutation of a dibasic amino acid motif within 
the  C  terminus  of  the  P2X7  nucleotide  receptor  results  in  trafficking  defects  and 
impaired function. J Immunol 171:1304–1311. 
Deuchars S, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF, Buckley NJ, Parson 
SH, Deuchars J (2001) Neuronal P2X7 receptors are targeted to presynaptic terminals 
in the central and peripheral nervous systems. J Neurosci 21:7143–7152. 
175 
DiVirgilio F (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and 
cell death. Immunol Today 16:524–528. 
Dong  CJ,  Hare  WA  (2000)  Contribution  to  the  kinetics  and  amplitude  of  the 
electroretinogram b-wave by third-order retinal neurons in the rabbit retina. Vision Res 
40:579–589. 
Dong CJ, Hare WA (2002) GABAc feedback pathway modulates the amplitude and kinetics 
of ERG b-wave in a mammalian retina in vivo. Vision Res 42:1081–1087. 
Donnelly-Roberts DL, Jarvis MF (2007) Discovery of P2X7 receptor-selective antagonists 
offers new insights into P2X7 receptor function and indicates a role in chronic pain 
states. Br J Pharmacol 151:571–579. 
Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF (2009a) Mammalian P2X7 receptor 
pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J 
Pharmacol 157:1203–1214. 
Donnelly-Roberts DL, Namovic MT, Surber B, Vaidyanathan SX, Perez-Medrano A, Wang Y, 
Carroll  W,  Jarvis  MF  (2009b)  [3H]A-804598  ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-
quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 
receptors. Neuropharmacology 56:223–229. 
Dowling JE (1970) Organization of vertebrate retinas. Invest Ophthalmol 9:655–680. 
Dreher Z, Robinson SR, Distler C (1992) Müller cells in vascular and avascular retinae: a 
survey of seven mammals. J Comp Neurol 323:59–80. 
Dubyak GR (2007) Go it alone no more — P2X7 joins the society of heteromeric ATP-gated 
receptor channels. Mol Pharmacol 72:1402–1405. 
Dubyak GR (2012) P2X7 receptor regulation of non-classical secretion from immune effector 
cells. Cell Microbiol 14:1697–1706. 
Dvoriantchikova G, Ivanov D, Panchin Y, Shestopalov VI (2006) Expression of pannexin 
family of proteins in the retina. FEBS Lett 580:2178–2182. 
Edwards F, Gibb A, Colquhoun D (1992) ATP receptor-mediated synaptic currents in the 
central nervous system. Nature 359:144–147. 
Egan TM, Haines WR, Voigt MM (1998) A domain contributing to the ion channel of ATP-
gated  P2X2  receptors  identified  by  the  substituted  cysteine  accessibility  method.  J 
Neurosci 18:2350–2359. 
Egan TM, Samways DSK, Li Z (2006) Biophysics of P2X receptors. Eur J Physiol 452:501–
512. 
Eldred J, Sanderson J, Wormstone M, Reddan JR, Duncan G (2003) Stress-induced ATP 
release from and growth modulation of human lens and retinal pigment epithelial cells. 
Biochem Soc Trans 31:1213–1215. 
Engel T, Gomez-Villafuertes R, Tanaka K, Mesuret G, Sanz-Rodriguez A, Garcia-Huerta P, 
Miras-Portugal MT, Henshall DC, Diaz-Hernandez M (2011) Seizure suppression and 
176 
neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in 
mice. FASEB J 26:1–13. 
Enroth-Cugell C (1977) Convergence of rod and cone signals in the cat’s retina. J Physiol 
269:297–318. 
Euler  T,  Schneider  H,  Wassle  H  (1996)  Glutamate  responses  of  bipolar  cells  in  a  slice 
preparation of the rat retina. J neurosc 16:2934–2944. 
Evans RJ, Lewis C, Virginio C, Lundstrom K, Buell G, Surprenant A, North R (1996) Ionic 
permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X 
receptors) expressed in mammalian cells. J Physiol 497.2:413–422. 
Feng Y-H, Wang L, Wang Q, Li X, Zeng R, Gorodeski GI (2005) ATP stimulates GRK-3 
phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am J 
Physiol Cell Physiol 288:C1342–56. 
Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F (1997a) Purinergic modulation of 
interleukin-1b release from micrgolial cells stimulated with bacterial endotoxin. J Exp 
Med 185:579–582. 
Ferrari D, Chiozzi P, Falzoni S, Susino MD, Melchiorri L, Baricordi OR, Di Virgilio F (1997b) 
Extracellular ATP triggers IL-1beta release by activating the putinergic P2Z receptor of 
human macrophages. J Immunol 159:1451–1458. 
Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F (2006) 
The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877–
3883. 
Fields RD (2011) Nonsynaptic and nonvesicular ATP release from neurons and relevance to 
neuron-glia signaling. Semin Cell Dev Biol 22:214–219. 
Di Filippo M, Chiasserini D, Gardoni F, Viviani B, Tozzi A, Giampà C, Costa C, Tantucci M, 
Zianni E, Boraso M, Siliquini S, De Iure A, Ghiglieri V, Colcelli E, Baker D, Sarchielli P, 
Fusco FR, Di Luca M, Calabresi P (2013) Effects of central and peripheral inflammation 
on hippocampal synaptic plasticity. Neurobiol Dis 52:229–236. 
Di Filippo M, Sarchielli P, Picconi B, Calabresi P (2008) Neuroinflammation and synaptic 
plasticity:  theoretical  basis  for  a  novel,  immune-centred,  therapeutic  approach  to 
neurological disorders. Trends Pharmacol Sci 29:402–412. 
Fletcher EL (2010) Mechanisms of photoreceptor death during retinal degeneration. Optom 
Vis Sci 87:269–275. 
Fogal B, Hewett S (2008) Interleukin-1b: a bridge between inflammation and excitotoxicity? J 
Neurochem 106:1–23. 
Fontainhas AM, Wang M, Liang KJ, Chen S, Mettu P, Damani M, Fariss RN, Li W, Wong WT 
(2011)  Microglial  morphology  and  dynamic  behavior  is  regulated  by  ionotropic 
glutamatergic and GABAergic neurotransmission. PLoS One 6:e15973. 
177 
Franke H, Klimke K, Brinckmann U, Grosche J, Francke M, Sperlagh B, Reichenbach A, 
Liebert UG, Illes P (2005) P2X(7) receptor-mRNA and -protein in the mouse retina; 
changes during retinal degeneration in BALBCrds mice. Neurochem Int 47:235–242. 
Franke H, Schepper C, Illes P, Krügel U (2007) Involvement of P2X and P2Y receptors in 
microglial activation in vivo. Purinergic Signal 3:435–445. 
Freist  W,  Verhey  JF,  Stühmer  W,  Gauss  DH  (1998)  ATP  binding  site  of  P2X  channel 
proteins:  structural  similarities  with  class  II  aminoacyl-tRNA  synthetases.  FEBS  Lett 
434:61–65. 
Fukuda  J,  Fujita  Y,  Ohsawa  K  (1983)  ATP  content  in  isolated  mammalian  nerve  cells 
assayed by a modified luciferin-luciferase method. J Neurosci Methods 8:295–302. 
Gargett CE, Wiley JS (1997) The isoquinoline derivative KN-62 a potent antagonist of the 
P2Z-receptor of human lymphocytes. Br J Pharmacol 120:1483–1490. 
Ghosh KK, Bujan S, Haverkamp S, Feigenspan A, Wässle H (2004) Types of bipolar cells in 
the mouse retina. J Comp Neurol 469:70–82. 
Gonnord  P,  Delarasse  C,  Auger  R,  Benihoud  K,  Prigent  M,  Cuif  MH,  Lamaze  C, 
Kanellopoulos JM (2009) Palmitoylation of the P2X7 receptor, an ATP-gated channel, 
controls its expression and association with lipid rafts. FASEB J 23:795–805. 
Grunert  U,  Martine  PR  (1991)  Rod  bipolar  cells  in  the  macaque  monkey  retina: 
Immunoreactivty and connectivity. J Neurosci 11:2742–2758. 
Gu BJ, Zhang W, Worthington R, Sluyter R, Dao-Ung P, Petrou S, Barden J, Wiley JS 
(2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 
receptor. J Biol Chem 276:11135–11142. 
Guha S, Baltazar GC, Coffey EE, Tu L-A, Lim JC, Beckel JM, Patel S, Eysteinsson T, Lu W, 
O’Brien-Jenkins  A,  Laties  AM,  Mitchell  CH  (2013)  Lysosomal  alkalinization,  lipid 
oxidation,  and  reduced  phagosome  clearance  triggered  by  activation  of  the  P2X7 
receptor. FASEB J 27:4500–4509. 
Guo  C,  Masin  M,  Qureshi  OS,  Murrell-lagnado  RD  (2007)  Evidence  for  functional 
P2X4/P2X7 heteromeric receptors. Mol Pharmacol 72:1447–1456. 
Gyoneva  S,  Orr  AG,  Traynelis  SF  (2009)  Differential  regulation  of  microglial  motility  by 
ATP/ADP and adenosine. Parkinsonism Relat Disord 15 Suppl 3:S195–9. 
Gyoneva  S,  Traynelis  SF  (2013)  Norepinephrine  modulates  the  motility  of  resting  and 
activated microglia via different adrenergic receptors. J Biol Chem 288:15291–15302. 
Haines WR, Voigt MM, Migita K, Torres GE, Egan TM (2001) On the contribution of the first 
transmembrane  domain  to  whole-cell  current  through  an  ATP-gated  ionotropic  P2X 
receptor. J Neurosci 21:5885–5892. 
Halder SK, Matsunaga H, Ishii KJ, Akira S, Miyake K, Ueda H (2013) Retinal  cell type-
specific  prevention  of  ischemia-induced  damages  by  LPS-TLR4  signaling  through 
microglia. J Neurochem 126:243–260. 
178 
Hayashi  Y,  Ishibashi  H,  Hashimoto  K,  Nakanishi  H  (2006)  Potentiation  of  the  NMDA 
receptor-mediated  responses  through  the  activation  of  the  glycine  site  by  microglia 
secreting soluble factors. Glia 53:660–668. 
Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan W-B, Julius D (2006) The 
P2Y12  receptor  regulates  microglial  activation  by  extracellular  nucleotides.  Nat 
Neurosci 9:1512–1519. 
Hervás  C,  Pérez-Sen  R,  Miras-Portugal  MT  (2005)  Presence  of  diverse  functional  P2X 
receptors in rat cerebellar synaptic terminals. Biochem Pharmacol 70:770–785. 
Hibell A, Kidd EJ, Chessell IP, Humphrey PP, Michel A (2000) Apparent species differences 
in the kinetic properties of P2X(7) receptors. Br J Pharmacol 130:167–173. 
Hibell AD, Thompson KM, Simon J, Xing M, Humphrey PP, Michel AD (2001) Species- and 
agonist-dependent differences in the deactivation-kinetics of P2X7 receptors. Naunyn 
Schmiedebergs Arch Pharmacol 363:639–648. 
Higgs  MH,  Lukasiewicz  PD  (1999)  Glutamate  uptake  limits  synaptic  excitation  of  retinal 
ganglion cells. J Neurosci 19:3691–3700. 
Holt M, Cooke A, Neef A, Lagnado L (2004) High mobility of vesicles supports continuous 
exocytosis at a ribbon synapse. Curr Biol 14:173–183. 
Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, 
Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan 
JP,  Faltynek  CR,  Jarvis  MF  (2006)  A-740003  [N-(1-{[(Cyanoimino)(5-
quinolinylamino)dimethoxyphenyl)acetamide],  a  novel  and  selective  P2X7  receptor 
antagonist, dose-dependently  reduces neuropathic pain in the rat. J Pharmacol Exp 
Ther 319:1376–1385. 
Hood DC, Birch DG (1990) A quantitative measure of the electrical activity of human rod 
photoreceptors using electroretinography. Vis Neurosci 5:379–387. 
Hood DC, Birch DG (1992) A computational model of the amplitude and implicit time of the 
b-wave of the human ERG. Vis Neurosci 8:107–126. 
Hood DC, Birch DG (1997) Assessing abnormal rod photoreceptor activity with the a-wave of 
the electroretinogram: applications and methods. Doc Ophthalmol 92:253–267. 
Hu H, Lu W, Zhang M, Zhang X, Argall AJ, Patel S, Lee GE, Kim Y-C, Jacobson KA, Laties 
AM, Mitchell CH (2010) Stimulation of the P2X7 receptor kills rat retinal ganglion cells in 
vivo. Exp Eye Res 91:425–432. 
Huberman AD, Niell CM (2011) What can mice tell us about how vision  works? Trends 
Neurosci 34:464–473. 
Hume D, Perry VH, Gordon S (1983) Immunohistochemical localization of a macrophage-
specific  antigen  in  developing  mouse  retina:  phagocytosis  of  dying  neurons  and 
differentiation of microglial cells to form a regular array in the plexiform layers. J Cell 
Biol 97:253–257. 
179 
Humphreys  BD,  Virginio  C,  Surprenant  A,  Rice  J,  Dubyak  GR  (1998)  Isoquinolines  as 
antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat 
receptor homologues. Mol Pharmacol 54:22–32. 
Iandiev I, Wurm A, Pannicke T, Wiedemann P, Reichenbach A, Robson SC, Zimmermann 
H,  Bringmann  A  (2007)  Ectonucleotidases  in  Müller  glial  cells  of  the  rodent  retina: 
Involvement in inhibition of osmotic cell swelling. Purinergic Signal 3:423–433. 
Iglesias R, Locovei S, Roque A, Alberto AP, Dahl G, Spray DC, Scemes E (2008) P2X7 
receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol 
295:C752–60. 
Ikeda H, Dawes E, Hankins M (1992) Spontaneous firing level distinguishes the effects of 
NMDA and non-NMDA receptor antagonists on the ganglion cells in the cat retina. Eur 
J Pharmacol 210:53–59. 
Imura Y, Morizawa Y, Komatsu R, Shibata K, Shinozaki Y, Kasai H, Moriishi K, Moriyama Y, 
Koizumi S (2013) Microglia release ATP by exocytosis. Glia 61:1320–1330. 
Innocenti B, Pfeiffer S, Zrenner E, Kohler K, Guenther E (2004) ATP-induced non-neuronal 
cell permeabilization in the rat inner retina. J Neurosci 24:8577–8583. 
Ishii K, Kaneda M, Li H, Rockland KS, Hashikawa T (2003) Neuron-specific distribution of 
P2X7 purinergic receptors in the monkey retina. J Comp Neurol 459:267–277. 
Ito D, Imai  Y, Ohsawa K, Nakajima K, Fukuuchi  Y, Kohsaka S (1998) Microglia-specific 
localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 57:1–9. 
Jabs R, Guenther E, Marquordt K, Wheeler-Schilling TH (2000) Evidence for P2X3, P2X4, 
P2X5 but not for P2X7 containing purinergic receptors in Müller cells of the rat retina. 
Mol Brain Res 76:205–210. 
Jeon CJ, Strettoi E, Masland RH (1998) The major cell populations of the mouse retina. J 
Neurosci 18:8936–8946. 
Jiang L, Rassendren F, Mackenzie A, Zhang Y, Surprenant A, North RA (2005) N-methyl-D-
glucamine  and  propidium  dyes  utilize  different  permeation  pathways  at  rat  P2X7 
receptors. Am J Physiol Cell Physiol 289:C1295–1302. 
Jiang LH, Mackenzie AB, North RA, Surprenant A (2000) Brilliant blue G selectively blocks 
ATP-gated rat P2X(7) receptors. Mol Pharmacol 58:82–88. 
Jindrichova M, Kuzyk P, Li S, Stojilkovic SS, Zemkova H (2012) Conserved ectodomain 
cysteines are essential for rat P2X7 receptor trafficking. Purinergic Signal 8:317–325. 
Jo Y-H, Role LW (2002) Coordinate release of ATP and GABA at in vitro synapses of lateral 
hypothalamic neurons. J Neurosci 22:4794–4804. 
Jo YH, Schlichter R (1999) Synaptic corelease of ATP and GABA in cultured spinal neurons. 
Nat Neurosci 2:241–245. 
Jones  SM,  Palmer  MJ  (2009)  Activation  of  the  tonic  GABAC  receptor  current  in  retinal 
bipolar cell terminals by nonvesicular GABA release. J Neurophysiol 102:691–699. 
180 
Kaneda M, Ishii K, Morishima Y, Akagi T, Yamazaki Y, Nakanishi S, Hashikawa T (2004) 
OFF-cholinergic-pathway-selective  localization  of  P2X2  purinoceptors  in  the  mouse 
retina. J Comp Neurol 476:103–111. 
Kaneda M, Ishii T, Hosoya T (2008) Pathway-dependent modulation by P2-purinoceptors in 
the mouse retina. Eur J Neurosci 28:128–136. 
Kaneda M, Ito K, Shigematsu Y, Shimoda Y (2010) The OFF-pathway dominance of P2X(2)-
purinoceptors is formed without visual experience. Neurosci Res 66:86–91. 
Kato  Y,  Omote  H,  Miyaji  T  (2013)  Inhibitors  of  ATP  release  inhibit  vesicular  nucleotide 
transporter. Biol Pharm Bull 36:1688–1691. 
Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M (1990) Interleukin-1 beta inhibits long-
term potentiation  in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 
181:323–326. 
Kawamura H, Sugiyama T, Wu DM, Kobayashi M, Yamanishi S, Katsumura K, Puro DG 
(2003) ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat 
retina. J Physiol 551:787-99 
Kim  M,  Spelta  V,  Sim  J,  North  RA,  Surprenant  A  (2001)  Differential  assembly  of  rat 
purinergic  P2X7  receptor  in  immune  cells  of  the  brain  and  periphery.  J  Biol  Chem 
276:23262–23267. 
Klapperstück M, Schmalzing G,  Markwardt F  (2001) Characteristics of bindings sites for 
ATP4- at the Human P2X7 Receptor. Drug Dev Res 82:77–82. 
Ko MK, Saraswathy S, Parikh JG, Rao N (2011) The role of TLR4 activation in photoreceptor 
mitochondrial oxidative stress. Invest Ophthalmol Vis Sci 52:5824–5835. 
Kohno H, Chen Y, Kevany BM, Pearlman E, Miyagi M, Maeda T, Palczewski K, Maeda A 
(2013)  Photoreceptor  proteins  initiate  microglial  activation  via  Toll-like  receptor  4  in 
retinal degeneration mediated by all-trans-retinal. J Biol Chem 288:15326–15341. 
Kolb  H  (1970)  Organization  of  the  outer  plexiform  layer  of  the  primate  retina:  electron 
microscopy of Golgi-impregnated cells. Philos Trans R Soc Lond B Biol Sci 258:261–
283. 
Kolb H (1974) The connections between horizontal cells and photoreceptors in the retina of 
the cat: electron microscopy of Golgi preparations. J Comp Neurol 155:1–14. 
Kolb H (1997) Amacrine cells of the mammalian retina: neurocircuitry and functional roles. 
Eye (Lond) 11 ( Pt 6):904–923. 
Kolb H, Nelson R, Mariani a (1981) Amacrine cells, bipolar cells and ganglion cells of the cat 
retina: a Golgi study. Vision Res 21:1081–1114. 
Koulen P, Kuhn R, Wassle H, Brandstatter JH (1999) Modulation of the intracellular calcium 
concentration  in  photoreceptor  terminals  by  a  presynaptic  metabotropic  glutamate 
receptor 
181 
Kreutzberg  GW  (1996)  Microglia:  a  sensor  for  pathological  events  in  the  CNS.  Trends 
Neurosci 19:312–318. 
Križaj D, Ryskamp D, Tian N, Tezel G, Mitchell CH, Slepak VZ, Shestopalov VI (2013) From 
mechanosensitivity  to  inflammatory  responses:  New  players  in  the  pathology  of 
glaucoma. Curr Eye Res:1–15. 
Kuffler  SW  (1953)  Discharge  patterns  of  functional  organisation  of  mammalian  retina.  J 
Neurophysiol 16:37–68. 
Kukley M, Stausberg P, Adelmann G, Chessell IP, Dietrich D (2004) Ecto-nucleotidases and 
nucleoside  transporters  mediate  activation  of  adenosine  receptors  on  hippocampal 
mossy  fibers  by  P2X7  receptor  agonist  2’-3'-O-(4-benzoylbenzoyl)-ATP.  J  Neurosci 
24:7128–7139. 
Kur  J,  Newman  EA  (2014)  Purinergic  control  of  vascular  tone  in  the  retina.  J  Physiol 
592:491-504. 
Lagnado L (2000) Ribbon Synapses. Curr Biol:R631. 
Lamb TD, Pugh EN (2006) Phototransduction, dark adaptation, and rhodopsin regeneration 
the proctor lecture. Invest Ophthalmol Vis Sci 47:5137–5152. 
Langmann  T  (2007)  Microglia  activation  in  retinal  degeneration.  J  Leukoc Biol  81:1345–
1351. 
Lei B, Yao G, Zhang K, Hofeldt KJ, Chang B (2006) Study of rod- and cone-driven oscillatory 
potentials in mice. Invest Ophthalmol Vis Sci 47:2732–2738. 
León D, Sánchez-Nogueiro J, Marín-García P, Miras-Portugal M (2008) Glutamate release 
and  synapsin-I  phosphorylation  induced  by  P2X7  receptors  activation  in  cerebellar 
granule neurons. Neurochem Int 52:1148–1159. 
Li  A,  Zhang  X,  Zheng  D,  Ge  J,  Laties  AM,  Mitchell  CH  (2011)  Sustained  elevation  of 
extracellular ATP in aqueous humor from humans with primary chronic angle-closure 
glaucoma. Exp Eye Res 93:528–533. 
Li  Y,  Du  X-F,  Liu  C-S,  Wen  Z-L,  Du  J-L  (2012)  Reciprocal  regulation  between  resting 
microglial dynamics and neuronal activity in vivo. Dev Cell 23:1189–1202. 
Liang Z, Freed M a (2010) The ON pathway rectifies the OFF pathway of the mammalian 
retina. J Neurosci 30:5533–5543. 
Lin X, Fang D, Zhou H, Su SB (2013) The expression of Toll-like receptors in murine Müller 
cells, the glial cells in retina. Neurol Sci 34:1339–1346. 
Lukasiewicz P, Lawrence E, Valentino L (1995) Desensitizing glutamate receptors inputs to 
tiger salamander retinal shape excitatory ganglion cells synaptic. J Neurosci 15:6189–
6199. 
Lukasiewicz PD (2005) Synaptic mechanisms that shape visual signaling at the inner retina. 
Prog Brain Res 147:205–218. 
182 
Lukasiewicz PD, Mcreynolds JS (1985) Synaptic transmission at the N-methyl-D-aspartate 
receptors in the proximal retinal of the mudpuppy. J Physiol 367:99–115. 
Lukasiewicz  PD,  Wilson  JA,  Lawrence  JE  (1997)  AMPA-preferring  receptors  mediate 
excitatory synaptic inputs to retinal ganglion cells. Jounral Neurophysiol 77:57–64. 
Lundy PM, Hamilton MG, Mi L, Gong W, Vair C, Sawyer TW, Frew R (2002) Stimulation of 
Ca2+  influx  through  ATP  receptors  on  rat  brain  synaptosomes :  identification  of 
functional P2X7 receptor subtypes. Br J Pharmacol 135:1616–1626. 
Mackenzie A, Wilson HL, Kiss-toth E, Dower SK, North RA, Surprenant A, Sheffield S (2001) 
Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 8:825–835. 
Manookin MB, Beaudoin DL, Ernst ZR, Flagel LJ, Demb JB (2008) Disinhibition combines 
with excitation to extend the operating range of the OFF visual pathway in daylight. J 
Neurosci 28:4136–4150. 
Marcellino D, Suárez-Boomgaard D, Sánchez-Reina MD, Aguirre J, Yoshitake T, Yoshitake 
S,  Hagman  B,  Kehr  J,  Agnati  LF,  Fuxe  K,  Rivera  A  (2010)  On  the  role  of  P2X(7) 
receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: 
studies with the P2X(7) receptor antagonist A-438079. J Neural Transm 117:681–687. 
Marín-García  P,  Sánchez-Nogueiro  J,  Gómez-Villafuertes  R,  León D,  Miras-Portugal  MT 
(2008)  Synaptic  terminals  from  mice  midbrain  exhibit  functional  P2X7  receptor. 
Neuroscience 151:361–373. 
Marquez-Klaka B, Rettinger J, Bhargava Y, Eisele T, Nicke A (2007) Identification of an 
intersubunit  cross-link  between  substituted  cysteine  residues  located  in  the  putative 
ATP binding site of the P2X1 receptor. J Neurosci 27:1456–1466. 
Massey C, Miller RF (1990) Receptors of Ganglion Cells in Rabbit Retina. J Neurophysiol 
63:16–30. 
Massey S, Redburn DA, Crawford MLJ (1983) The effects of 2-amino-4-phosphonobutyric 
acid  (APB)  on  the  ERG  and  ganglion  cell  discharge  of  rabbit  retina.  Vision  Res 
23:1607–1613. 
Masu M, Iwakabe H, Tagawa Y, Miyoshi T, Yamashita M, Fukuda Y, Sasaki H, Hiroi K, 
Nakamura  Y,  Shigemoto  R  (1995)  Specific  deficit  of  the  ON  response  in  visual 
transmission by targeted disruption of the mGluR6 gene. Cell 80:757–765. 
McGaraughty S, Chu KL, Namovic MT, Donnelly-Roberts DL, Harris RR, Zhang X-F, Shieh 
C-C, Wismer  CT,  Zhu  CZ,  Gauvin  DM,  Fabiyi  AC,  Honore  P,  Gregg  RJ,  Kort  ME, 
Nelson  DW,  Carroll  W,  Marsh  K,  Faltynek  CR,  Jarvis  MF  (2007)  P2X7-related 
modulation of pathological nociception in rats. Neuroscience 146:1817–1828. 
Mclarnon JG, Ryu JK, Walker DG, Choi HB (2006) Upregulated ecxpression of purinergic 
P2X7 receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in 
peptide-injected rat hippocampus. J Neuropathol Exp Neurol 65:1090–1097. 
Metea M, Newman EA (2007) Signalling within the neurovascular unit in the mammalian 
retina. Exp Physiol 92:635-40 
183 
Michel  A,  Chessell  IP,  Humphrey  PP  (1999)  Ionic  effects  on  human  recombinant  P2X7 
receptor function. Naunyn Schmiedebergs Arch Pharmacol 359:102–109. 
Miller R, Dowling J (1970) Intracellular responses of the Muller (glial) cells of mudpuppy 
retina: Their relation to b-wave of the electroretinogram. J Neurophysiol 33:323–341. 
Mitchell CH, Lu W, Hu H, Zhang X, Reigada D, Zhang M (2009) The P2X(7) receptor in 
retinal ganglion cells: A neuronal model of pressure-induced damage and protection by 
a shifting purinergic balance. Purinergic Signal 5:241–249. 
Mitchell CH, Reigada D (2008) Purinergic signalling in the subretinal space: a role in the 
communication between the retina and the RPE. Purinergic Signal 4:101–107. 
Mittman  S,  Taylor  WR,  Copenhagen  DR  (1990)  Concomitant  activation  of  two  types  of 
glutamate receptor mediates excitation of salamander retinal ganglion cells. J Physiol 
428:175–197. 
Monif M, Burnstock G, Williams DA (2010) Microglia: proliferation and activation driven by 
the P2X7 receptor. Int J Biochem Cell Biol 42:1753–1756. 
Moore  SF,  Mackenzie  AB  (2008)  Species  and  agonist  dependent  zinc  modulation  of 
endogenous  and  recombinant  ATP-gated  P2X7  receptors.  Biochem  Pharmacol 
76:1740–1747. 
Morgans CW, Zhang J, Jeffrey BG, Nelson SM, Burke NS, Duvoisin RM, Brown RL (2009) 
TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc 
Natl Acad Sci U S A 106:19174–19178. 
Mori M, Heuss C, Gähwiler BH, Gerber U (2001) Fast synaptic transmission mediated by 
P2X  receptors  in  CA3  pyramidal  cells  of  rat  hippocampal  slice  cultures.  J  Physiol 
535:115–123. 
Morigiwa  K,  Quan  M,  Murakami  M,  Yamashita  M,  Fukuda  Y  (2000)  P2  Purinoceptor 
expression and functional changes of hypoxia-activated cultured rat retinal microglia. 
Neurosci Lett 282:153–156. 
Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, Mizuno N, Nakanishi S (1993) 
Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 
with  a  high  agonist  selectivity  for  L-2-amino-4-phosphonobutyrate.  J  Biol  Chem 
268:11868–11873. 
Nawy S, Jahr C (1990) Suppression by glutamate of cGMP-activated conductance in retinal 
bipolar cells. Nature 346:269–271. 
Nelson  DW,  Gregg  RJ,  Kort  ME,  Perez-Medrano  A,  Voight  EA,  Wang  Y,  Grayson  G, 
Namovic MT, Donnelly-Roberts DL, Niforatos W, Honore P, Jarvis MF, Faltynek CR, 
Carroll  WA  (2006)  Structure-activity  relationship  studies  on  a  series  of  novel, 
substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J Med Chem 49:3659–3666. 
Newman  EA  (2001)  Propagation  of  intercellular  calcium  waves  in  retinal  astrocytes  and 
Müller cells. J Neurosci 21:2215–2223. 
Newman EA (2004) Glial modulation of synaptic transmission in the retina. Glia 47:268–274. 
184 
Newman EA (2005) Calcium increases in retinal glial cells evoked by light-induced neuronal 
activity. J Neurosci 25:5502–5510. 
Newman EA (2003) Glial cell inhibition of neurons by release of ATP. J Neurosci 23:1659–
1666. 
Nicke A (2008) Homotrimeric complexes are the dominant assembly state of native P2X7 
subunits. Biochem Biophys Res Commun 377:803–808. 
Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic 
surveillants of brain parenchyma in vivo. Science (80- ) 308:1314–1318. 
Niyadurupola N, Sidaway P, Ma N, Rhodes JD, Broadway DC, Sanderson J (2013) P2X7 
receptor  activation mediates  retinal  ganglion  cell  death  in  a  human  retina  model  of 
ischemic neurodegeneration. Invest Ophthalmol Vis Sci 54:2163–2170. 
Nomura  A,  Shigemoto  R,  Nakamura  Y,  Okamoto  N,  Mizuno  N,  Nakanishi  S  (1994) 
Developmentally  regulated  postsynaptic  localization  of  a  metabotropic  glutamate 
receptor in rat rod bipolar cells. Cell 77:361–369. 
North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013–1067. 
North  RA,  Surprenant  A  (2000)  Pharmacology  of  cloned  P2X  Receptors.  Annu  Rev 
Pharmacol Toxicol 40:563–580. 
Notomi S, Hisatomi T, Kanemaru T, Takeda A, Ikeda Y, Enaida H, Kroemer G, Ishibashi T 
(2011) Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in 
photoreceptor cell death. Am J Pathol 179:2798–2809. 
Notomi S, Hisatomi T, Murakami Y, Terasaki H, Sonoda S, Asato R, Takeda A, Ikeda Y, 
Enaida  H,  Sakamoto  T,  Ishibashi  T  (2013)  Dynamic  increase  in  extracellular  ATP 
accelerates  photoreceptor  cell  apoptosis  via  ligation  of  P2RX7  in  subretinal 
hemorrhage. PLoS One 8:e53338. 
Okawa H, Sampath AP (2007) Optimization of single-photon response transmission at the 
rod-to-rod bipolar synapse. Physiology (Bethesda) 22:279–286. 
Oliveira Simões Pereira T de, da Costa GNF, Santiago ARS, Ambrósio AF, dos Santos PFM 
(2010)  High  glucose  enhances  intracellular  Ca2+  responses  triggered  by  purinergic 
stimulation in retinal neurons and microglia. Brain Res 1316:129–138. 
Opie NL, Greferath U, Vessey K, Burkitt AN, Meffin H, Grayden DB, Fletcher EL (2012) 
Retinal prosthesis safety: Alterations in microglia morphology due to thermal damage 
and retinal implant contact. Invest Ophthalmol Vis Sci 53:7802–7812. 
Pankratov Y, Castro E, Miras-portugal MT, Krishtal O (1998) A purinergic component of the 
excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the 
rat hippocampus. Eur J Neurosci 10:3898–3902. 
Pankratov Y, Lalo U, Verkhratsky A, North RA (2006) Vesicular release of ATP at central 
synapses. Eur J Physiol:589–597. 
185 
Pankratov Y, Lalo U, Verkhratsky A, North RA (2007) Quantal release of ATP in mouse 
cortex. J Gen Physiol 129:257–265. 
Pannicke T, Fischer W, Biedermann B, Schädlich H, Grosche J, Faude F, Wiedemann P, 
Allgaier C, Illes P, Burnstock G, Reichenbach A (2000) P2X7 receptors in Müller glial 
cells from the human retina. J Neurosci 20:5965–5972. 
Pannicke T, Uckermann O, Iandiev I, Wiedemann P, Reichenbach A, Bringmann A (2005) 
Ocular  inflammation  alters  swelling  and  membrane characteristics  of  rat  Müller  glial 
cells. J Neuroimmunol 161:145–154. 
Park  BS,  Song DH,  Kim  HM,  Choi  B-S,  Lee  H,  Lee  J-O  (2009)  The  structural  basis  of 
lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191–1195. 
Parvathenani  LK,  Tertyshnikova  S,  Greco  CR,  Roberts  SB,  Robertson  B,  Posmantur  R 
(2003) P2X7 mediates superoxide production in primary microglia and is up-regulated 
in a transgenic mouse model of Alzheimer’s disease. J Biol Chem 278:13309–13317. 
Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A (2011) Microglia activation triggers 
astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci U S 
A 109:E197–205. 
Peachey NS, Ball SL (2003) Electrophysiological analysis of visual function in mutant mice. 
Doc Ophthalmol 107:13–36. 
Pearson  RA,  Dale  N,  Llaudet  E,  Mobbs  P  (2005)  ATP  released  via  gap  junction 
hemichannels  from  the  pigment  epithelium  regulates  neural  retinal  progenitor 
proliferation. Neuron 46:731–744. 
Peichl L, Wässle H (1979) Size, scatter and coverage of ganglion cell receptive field centres 
in the cat retina. J Physiol 291:117–141. 
Pelegrin P, Barroso-gutierrez C, Surprenant A (2008) P2X7 receptor differentially couples to 
distinct release pathways for IL-1beta in mouse macrophage. J Immunol  180:7147–
7157. 
Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-
1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071–5082. 
Pelegrin P, Surprenant A (2009) The P2X(7) receptor-pannexin connection to dye uptake 
and IL-1beta release. Purinergic Signal 5:129–137. 
Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, Takano T, Tian G-F, Goldman S, 
Nedergaard M (2009) Systemic administration of an antagonist of the ATP-sensitive 
receptor P2X7 improves recovery after spinal cord injury. PNAS 106:12489–12493. 
Perregaux D, Gabels A (1994) Interleukin-lP Maturation and Release in Response to ATP 
and Nigericin. 
Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages 
and microglia in the adult and developing mouse brain. Neuroscience 15:313–326. 
186 
Plata-Salamán CR, Ffrench-Mullen JM (1992) Interleukin-1 beta depresses calcium currents 
in  CA1  hippocampal  neurons  at  pathophysiological  concentrations.  Brain  Res  Bull 
29:221–223. 
Praetorius HA, Leipziger J (2009) ATP release from non-excitable cells. Purinergic Signal 
5:433–446. 
Puthussery T, Fletcher E (2009) Extracellular ATP induces retinal photoreceptor apoptosis 
through activation of purinoceptors in rodents. J Comp Neurol 513:430–440. 
Puthussery T, Fletcher EL (2004) Synaptic localization of P2X7 receptors in the rat retina. J 
Comp Neurol 472:13–23. 
Puthussery  T, Fletcher EL (2007) Neuronal expression of P2X3 purinoceptors in the rat 
retina. Neuroscience 146:403–414. 
Puthussery  T,  Yee  P,  Vingrys  AJ,  Fletcher  EL  (2006)  Evidence  for  the  involvement  of 
purinergic P2X receptors in outer retinal processing. Eur J Neurosci 24:7–19. 
Raivich G (2005) Like cops on the beat: the active role of resting microglia. Trends Neurosci 
28:571–573. 
Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW (1999) Neuroglial 
activation repertoire in the injured brain: graded response, molecular mechanisms and 
cues to physiological function. Brain Res Rev 30:77–105. 
Rassendren F, Buell G, Newbolt A, North RA (1997a) Identification of amino acid residues 
contributing to the pore of a P2X receptor Franc. EMBO J 16:3446–3454. 
Rassendren  F,  Buell  GN,  Virginio  C,  Collo  G,  North  RA,  Surprenant  A  (1997b)  The 
permeabilizing ATP receptor, P2X7. J Biol Chem 272:5482–5486. 
Reigada D, Lu W, Mitchell CH (2006) Glutamate acts at NMDA receptors on fresh bovine 
and  on  cultured  human  retinal  pigment  epithelial  cells  to  trigger  release  of  ATP.  J 
Physiol 575:707–720. 
Reigada D, Lu W, Zhang M, Mitchell CH (2008) Elevated pressure triggers a physiological 
release of ATP from the retina: Possible role for pannexin hemichannels. Neuroscience 
157:396–404. 
Reigada D, Lu W, Zhang X, Friedman C, Pendrak K, Mcglinn A, Stone RA, Laties AM, 
Mitchell CH (2005) Degradation of extracellular ATP by the retinal pigment epithelium. 
Am J Physiol Cell Physiol 289:617–624. 
Reigada D, Mitchell CH (2005) Release of ATP from retinal pigment epithelial cells involves 
both CFTR and vesicular transport. 6085:132–140. 
Resta V, Novelli E, Vozzi G, Scarpa C, Caleo M, Ahluwalia A, Solini A, Santini E, Parisi V, Di 
Virgilio F, Galli-Resta L (2007) Acute retinal ganglion cell injury caused by intraocular 
pressure  spikes  is  mediated  by  endogenous  extracellular  ATP.  Eur  J  Neurosci 
25:2741–2754. 
187 
Ricatti  MJ,  Alfie  LD,  Lavoie  EG,  Sévigny  J,  Schwarzbaum  PJ,  Faillace  MP  (2009) 
Immunocytochemical localization of NTPDases1 and 2 in the neural retina of mouse 
and zebrafish. Synapse 63:291–307. 
Richardson  PJ,  Brown  SJ  (1987)  ATP release  from  affinity-purified  rat  cholinergic  nerve 
terminals. J Neurochem 48:622–630. 
Roberts J, Evans RJ (2004) ATP binding at human P2X1 receptors. Contribution of aromatic 
and basic amino acids revealed using mutagenesis and partial agonists. J Biol Chem 
279:9043–9055. 
Roberts J, Vial C, Digby HR, Agboh KC, Wen H, Atterbury-Thomas A, Evans RJ (2006) 
Molecular properties of P2X receptors. Eur J Physiol 452:486–500. 
Robertson SJ, Edwards FA (1998) ATP and glutamate are released from separate neurones 
in the rat medial habenula nucleus : frequency dependence and adenosine-mediated 
inhibition of release. J Physiol 508:691–701. 
Roger S, Gillet L, Baroja-Mazo A, Surprenant A, Pelegrin P (2010) C-terminal calmodulin-
binding motif differentially controls human and rat P2X7 receptor current facilitation. J 
Biol Chem 285:17514–17524. 
Roger  S,  Pelegrin  P,  Surprenant  A  (2008)  Facilitation  of  P2X7  receptor  currents  and 
membrane  blebbing  via  constitutive  and  dynamic  calmodulin  binding.  J  Neurosci 
28:6393–6401. 
Rosolen  SG,  Kolomiets  B,  Varela  O,  Picaud  S  (2008)  Retinal  electrophysiology  for 
toxicology studies: applications and limits of ERG in animals and ex vivo recordings. 
Exp Toxicol Pathol 60:17–32. 
Santos  AM,  Calvente  R,  Tassi  M,  Mari  L,  Carrasco  M,  Marti  D  (2008)  Embryonic  and 
postnatal development of microglial cells in the mouse retina. Comp Gen Pharmacol 
239:224 –239. 
Santos PF, Caramelo OL, Carvalho AP, Duarte CB (1999) Characterization of ATP release 
from cultures enriched in cholinergic amacrine-like neurons. J Neurobiol 41:340–348. 
Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, Fellin R, Trabace L, Di 
Virgilio  F  (2009)  Activation  of  microglia  by  amyloid  {beta}  requires  P2X7  receptor 
expression. J Immunol 182:4378–4385. 
Sanz JM, Di Virgilio F (2000) Kinetics and mechanism of ATP-dependent IL-1 beta release 
from microglial cells. J Immunol 164:4893–4898. 
Sasaki T, Kaneko A (1996) L-Glutamate-induced responses in OFF-type bipolar cells of the 
cat retina. Vision Res 36:787–795. 
Sawada K, Echigo N, Juge N, Miyaji T, Otsuka M, Omote H, Yamamoto A, Moriyama Y 
(2008) Identification of a vesicular nucleotide transporter. PNAS 105:5683–5686. 
Schiller PH (1992) The ON and OFF channels of the visual system. Trends Neurosci 15:86–
92. 
188 
Schiller PH (2010) Parallel  information  processing channels created in  the  retina. PNAS 
107:17087–17094. 
Schneider  H,  Pitossi  F,  Balschun  D,  Wagner  A,  Del  Rey  A,  Besedovsky  H  (1998)  A 
neuromodulatory role of interleukin-1β in the hippocampus. Proc Natl Acad Sci U S A 
95:7778–7783. 
Sharpe LT, Stockman A (1999) Rod pathways: the importance of seeing nothing. Trends 
Neurosci 22:497–504. 
Shiells RA, Falk G (1990) Glutamate receptors of rod bipolar cells are linked to a cyclic GMP 
cascade via a G-protein. Proceedings Biol Sci 242:91–94. 
Shigematsu  Y,  Shimoda  Y,  Kaneda  M  (2007)  Distribution  of  immunoreactivity  for  P2X3, 
P2X5, and P2X6-purinoceptors in mouse retina. J Mol Histol 38:369–371. 
Singer JH (2007) Multivesicular release and saturation of glutamatergic signalling at retinal 
ribbon synapses. J Physiol 580:23–29. 
Sjӧstrand FS (1953) The ultrastructure of the outer segments of rods and cones of the eye 
as revealed by the electron microscope. J Cell Comp Physiol 42:15–44. 
Slaughter MM, Miller RF (1981) 2-amino-4-phosphonobutyric acid: A new pharmacological 
tool for retina research. Science (80- ) 211:182–185. 
Slaughter  MM,  Miller  RF  (1983)  The  role  of  excitatory  amino  acid  transmitters  in  the 
mudpuppy  retina:  an  analysis  with  kainic  acid  and  N-methyl  aspartate.  J  Neurosci 
3:1701–1711. 
Smart  ML,  Gu  B,  Panchal  RG,  Wiley  J,  Cromer  B,  Williams  D,  Petrou  S  (2003)  P2X7 
receptor cell surface expression and cytolytic pore formation are regulated by a distal 
C-terminal region. J Biol Chem 278:8853–8860. 
Sperlágh B, Haskó G, Németh Z, Vizi ES (1998) ATP released by LPS increases nitric oxide 
production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int 
33:209–215. 
Sperlágh B, Köfalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, Vizi ES (2002) 
Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat 
hippocampus. J Neurochem 81:1196–1211. 
Sperlagh B, Vizi ES (1996) Neuronal synthesis , storage and release of ATP Be ata. Semin 
Neurosci 8:175–186. 
Sperlágh B, Vizi ES, Wirkner K, Illes P (2006) P2X7 receptors in the nervous system. Prog 
Neurobiol 78:327–346. 
Stanimirovic  D,  Friedman  A  (2012)  Pathophysiology  of  the  neurovascular  unit:  disease 
cause or consequence? J Cereb Blood Flow Metab 32:1207-21. 
Steinberg TH, Newman a S, Swanson J, Silverstein SC (1987) ATP4- permeabilizes the 
plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 262:8884–
8888. 
189 
Sterling P, Freed M, Smith R (1988) Architecture of rod and cone circuits to the On-beta 
ganglion cell. J Neurosci 8:623–642. 
Stockton R a, Slaughter MM (1989) B-wave of the electroretinogram. A reflection of ON 
bipolar cell activity. J Gen Physiol 93:101–122. 
Streit WJ, Walter S a, Pennell N a (1999) Reactive microgliosis. Prog Neurobiol 57:563–581. 
Strettoi  E,  Raviola  E,  Dacheux  RF  (1992)  Synaptic  connections  of  the  narrow-field, 
bistratified rod amacrine cell (AII) in the rabbit retina. J Comp Neurol 325:152–168. 
Sugiyama  T,  Kawamura  H,  Yamanishi  S,  Kobayashi  M,  Katsumura  K,  Puro  DG  (2005) 
Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal 
microvessels. Am J Physiol Cell Physiol 288:C568–76. 
Sugiyama T, Kobayashi M, Kawamura H, Li Q, Puro DG (2004) Enhancement of P2X7-
induced  pore  formation  and  apoptosis:  An  early  effect  of  diabetes  on  the  retinal 
microvasculature. Invest Ophthalmol Vis Sci 45:1026–1032. 
Sugiyama T, Lee SY, Horie T, Oku H, Takai S, Tanioka H, Kuriki Y, Kojima S, Ikeda T 
(2013) P2X₇ receptor activation may be involved in neuronal loss in the retinal ganglion 
cell layer after acute elevation of intraocular pressure in rats. Mol Vis 19:2080–2091. 
Sugiyama T, Oku H, Komori A, Ikeda T (2006) Effect of P2X7 receptor activation on the 
retinal blood velocity of diabetic rabbits. Arch Ophthalmol 124:1143–1149. 
Surprenant A, Rassendren F, Kawashima E, North R, Buell G (1996) The cytolytic P2Z 
receptor  for  extracellular  ATP  identified  as  a  P2X  receptor  (P2X7).  Science  (80-  ) 
272:735–738. 
Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, Nakata Y (2004) Production and release of 
neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 
24:1–7. 
Taschenberger H, Jüttner R, Grantyn R (1999) Ca2+-permeable P2X receptor channels in 
cultured rat retinal ganglion cells. J Neurosci 19:3353–3366. 
Tautenhahn  M,  Leichsenring  A,  Servettini  I,  Pesic  M,  Sperlagh  B,  Nörenberg W,  Illes  P 
(2012) Purinergic modulation of the excitatory synaptic input onto rat striatal neurons. 
Neuropharmacology 62:1756–1766. 
Teixeira  JM,  Oliveira  MCG,  Parada  CA,  Tambeli  CH  (2010)  Peripheral  mechanisms 
underlying  the essential  role of P2X7  receptors in  the development of inflammatory 
hyperalgesia. Eur J Pharmacol 644:55–60. 
Torres  GE,  Egan  TM,  Voigt  MM  (1999)  Hetero-oligomeric  assembly  of  P2X  receptor 
subunits. J Biol Chem 274:6653–6659. 
Tremblay M-È, Lowery RL, Majewska AK (2010) Microglial interactions with synapses are 
modulated by visual experience. PLoS Biol 8:e1000527. 
Trueblood KE, Mohr S, Dubyak GR (2011) Purinergic regulation of high-glucose-induced 
caspase-1 activation in the rat retinal Müller cell line rMC-1. :1213–1223. 
190 
Trümpler J, Dedek K, Schubert T, de Sevilla Müller LP, Seeliger M, Humphries P, Biel M, 
Weiler R (2008) Rod and cone contributions to horizontal cell light responses in the 
mouse retina. J Neurosci 28:6818–6825. 
Tu Z, Portillo J-AC, Howell S, Bu H, Subauste CS, Al-Ubaidi MR, Pearlman E, Lin F (2011) 
Photoreceptor cells constitutively express functional TLR4. J Neuroimmunol 230:183–
187. 
Turola E, Furlan R, Bianco F, Matteoli M, Verderio C (2012) Microglial microvesicle secretion 
and intercellular signaling. Front Physiol 3:149. 
Uckermann  O,  Wolf  A,  Kutzera  F,  Kalisch  F,  Beck-sickinger  AG,  Wiedemann  P, 
Reichenbach  A,  Bringmann  A  (2006)  Glutamate  release  by  neurons  evoked  a 
purinergic inhibitory mechanism of osmotic glial swelling in the rat retina: activation by 
neuropeptide Y. J Neurosci Res 83:538–550. 
Vereker  E,  O’Donnell  E,  Lynch  A,  Kelly  A,  Nolan  Y,  Lynch  M  a  (2001)  Evidence  that 
interleukin-1beta and reactive oxygen species production play a pivotal role in stress-
induced impairment of LTP in the rat dentate gyrus. Eur J Neurosci 14:1809–1819. 
Vessey K, Wilkinson-Berka JL, Fletcher EL (2011) Characterization of retinal function and 
glial cell response in a mouse model of oxygen-induced retinopathy. J Comp Neurol 
519:506–527. 
Vessey KA, Fletcher EL (2012) Rode and cone pathway signalling is altered in the P2X7 
receptor knock out mouse. PLoS One 7:e29990. 
Vessey KA, Greferath U, Aplin FP, Jobling AI, Phipps JA, Ho T, de Iongh RU, Fletcher EL 
(2014) Adenosine triphosphate-induced photoreceptor death and retinal remodelling in 
rats. J Comp Neurol 522:2928–2950. 
Vessey KA, Jobling AI, Greferath U, Fletcher EL (2012) The role of the P2X7 receptor in the 
retina: cell signalling and dysfunction. Adv Exp Med Biol 723:813–819. 
Vianna  E,  Ferreira  A,  Naffah-Mazzacoratti  M,  Sanabria  E,  Funke  M,  Cavalheiro  EA, 
Fernandes  MJS  (2002)  Evidence  that  ATP  participates  in  the  pathophysiology  of 
pilocarpine-induced  temporal  lobe  epilepsy:  Fluorometric,  immunohistochemical,  and 
western blot studies. Epilepsia 43:227–229. 
Di  Virgilio  F  (2007)  Liaisons  dangereuses:  P2X(7)  and  the  inflammasome.  Trends 
Pharmacol Sci 28:465–472. 
Virginio C, Church D, North R, Surprenant A (1997) Effects of divalent cations, protons and 
calmidazolium at the rat P2X7 receptor. Neuropharmacology 36:1285–1294. 
Virginio C, MacKenzie A, North RA, Surprenant A (1999) Kinetics of cell lysis, dye uptake 
and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 519:335–
346. 
Völgyi B, Chheda S, Bloomfield S a (2009) Tracer coupling patterns of the ganglion cell 
subtypes in the mouse retina. J Comp Neurol 512:664–687. 
191 
Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin 
Eye Res 17:485–521. 
Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009) Resting microglia directly 
monitor the functional state of synapses in vivo and determine the fate of ischemic 
terminals. J Neurosci 29:3974–3980. 
Wald G (1968) The molecular basis of visual excitation. Nature 219:800–807. 
Wang C-M, Chang Y-Y, Sun SH (2003) Activation of P2X7 purinoceptor-stimulated TGF-β1 
mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 
astrocyte cell line, RBA-2. Cell Signal 15:1129–1137. 
Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, 
Nedergaard  M  (2004)  P2X7  receptor  inhibition  improves  recovery  after  spinal  cord 
injury. Nat Med 10:821–827. 
Ward MM, Fletcher EL (2009) Subsets of retinal neurons and glia express P2Y1 receptors. 
Neuroscience 160:555–566. 
Ward MM, Puthussery T, Fletcher EL (2008) Localization and possible function of P2Y(4) 
receptors in the rodent retina. Neuroscience 155:1262–1274. 
Wässle H (2004) Parallel processing in the mammalian retina. Nat Rev Neurosci 5:747–757. 
Wässle H, Koulen P, Brandstätter JH, Fletcher EL, Becker CM (1998) Glycine and GABA 
receptors in the mammalian retina. Vision Res 38:1411–1430. 
Wheeler-Schilling TH, Marquordt K, Kohler K, Guenther E, Jabs R (2001) Identification of 
purinergic receptors in retinal ganglion cells. Brain Res Mol Brain Res 92:177–180. 
Wheeler-Schilling  TH, Marquordt K, Kohler K, Jabs R, Guenther E (2000) Expression of 
purinergic receptors in bipolar cells of the rat retina. Brain Res Mol Brain Res 76:415–
418. 
Wieraszko a, Goldsmith G, Seyfried TN (1989) Stimulation-dependent release of adenosine 
triphosphate from hippocampal slices. Brain Res 485:244–250. 
Wiley JS, Dao-ung LP, Gu BJ, Sluyter R, Shemon AN, Li C, Taper J, Gallo J (2002) A loss-
of-function  polymorphic  mutation  in  the  cytolytic  P2X7  receptor  gene  and  chronic 
lymphocytic leukaemia : a molecular study. Lancet 359:1114–1119. 
Wiley JS, Dao-Ung L-P, Li C, Shemon AN, Gu BJ, Smart ML, Fuller SJ, Barden J, Petrou S, 
Sluyter  R  (2003)  An  Ile-568  to  Asn  polymorphism  prevents  normal  trafficking  and 
function of the human P2X7 receptor. J Biol Chem 278:17108–17113. 
Wilkinson WJ, Jiang L, Surprenant A, North RA (2006) Role of Ectodomain Lysines in the 
Subunits of the Heteromeric P2X2/3 Receptor. Mol Pharmacol 70:1159–1163. 
Winkler BS (1972) The electroretinogram of the isolated rat retina. Vision Res 12:1183–
1198. 
192 
Winkler BS (1973) Dependence of fast components of the electroretinogram of the isolated 
rat retina on the ionic environment. Vision Res 13:457–463. 
Wurm A, Pannicke T, Iandiev I, Francke M, Hollborn M, Wiedemann P, Reichenbach  A, 
Osborne NN, Bringmann A (2011) Purinergic signaling involved in Müller cell function in 
the mammalian retina. Prog Retin Eye Res 30:324–342. 
Xia  J,  Lim  JC,  Lu W,  Beckel  JM,  Macarak  EJ,  Laties  AM,  Mitchell  CH  (2012)  Neurons 
respond directly to mechanical deformation with pannexin-mediated ATP release and 
autostimulation of P2X7 receptors. J Physiol 10:2285–2304. 
Xie  Y,  Zacharias  E,  Hoff  P,  Tegtmeier  F  (1995)  Ion  channel  involvement  in  anoxic 
depolarization  induced  by  cardiac  arrest  in  rat  brain.  J  Cereb  Blood  Flow  Metab 
15:587–594. 
Yazejian B, Fain GL (1992) Excitatory amino acid receptors on isolated retinal ganglion cells 
from the goldfish. J Neurophysiol 67:94–107. 
Yazulla  S,  Studholme  KM  (2004)  Vanilloid  receptor  like  1  (VRL1)  immunoreactivity  in 
mammalian retina: colocalization with somatostatin and purinergic P2X1 receptors. J 
Comp Neurol 474:407–418. 
Young MT, Pelegrin P, Surprenant A (2007) Amino acid residues in the P2X7 receptor that 
mediate differential sensitivity to ATP and BzATP. Mol Pharmacol 71:92–100. 
Yu W, Miller RF (1996) The mechanism by which NBQX enhances NMDA currents in retinal 
ganglion cells. Brain Res 709:184–196. 
Zeise ML, Madamba S, Siggins GR (1992) Interleukin-1 beta increases synaptic inhibition in 
rat hippocampal pyramidal neurons in vitro. Regul Pept 39:1–7. 
Zhang  K,  Yao  G,  Gao  Y,  Hofeldt  KJ,  Lei  B  (2007)  Frequency  spectrum  and  amplitude 
analysis of dark- and light-adapted oscillatory potentials in albino mouse, rat and rabbit. 
Doc Ophthalmol 115:85–93. 
Zhang X, Li A, Ge J, Reigada D, Laties AM, Mitchell CH (2007) Acute increase of intraocular 
pressure releases ATP into the anterior chamber. Exp Eye Res 85:637–643. 
Zhang X, Zhang M, Laties AM, Mitchell CH (2005) Stimulation of P2X7 receptors elevates 
Ca2+ and kills retinal ganglion cells. Invest Ophthalmol Vis Sci 46:2183–2191. 
Zhou ZJ, Marshak DW, Fain GL (1994) Amino acid receptors of midget and parasol ganglion 
cells in primate retina. Proc Natl Acad Sci U S A 91:4907–4911. 
Ziganshin  AU,  Hoyle  CH  V.,  Burnstock  G  (1994)  Ecto-enzymes  and  metabolism  of 
extracellular ATP. Drug Dev Res 32:134–146. 
Zimmermann  H  (2000)  Extracellular  metabolism  of  ATP  and  other  nucleotides.  Naunyn 
Schmiedebergs Arch Pharmacol 362:299–309. 
 
193